Tables | Volume 32 | HIV Surveillance | Reports | Resource Library | HIV/AIDS

Table 1a. Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2015–2019—United States
	2015		2016		2017		2018		2019
	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a
Gender
Male	31,822	—	31,362	—	30,457	—	29,742	—	28,813	—
Female	7,392	—	7,520	—	7,306	—	7,071	—	6,897	—
Transgender male-to-female^b	589	—	640	—	581	—	596	—	623	—
Transgender female-to-male^b	32	—	21	—	36	—	48	—	46	—
Additional gender identity^c	10	—	12	—	13	—	14	—	19	—
Age at diagnosis (yr)
<13	142	0.3	128	0.2	104	0.2	89	0.2	61	0.1
13–14	26	0.3	25	0.3	26	0.3	20	0.2	21	0.3
15–19	1,766	8.4	1,710	8.1	1,777	8.4	1,715	8.1	1,640	7.8
20–24	7,278	32.1	6,917	31.0	6,478	29.4	6,100	28.0	5,927	27.4
25–29	7,571	33.8	7,958	34.7	7,717	33.1	7,710	32.8	7,341	31.2
30–34	5,439	25.1	5,644	25.9	5,644	25.7	5,672	25.7	5,673	25.3
35–39	4,233	20.8	4,213	20.3	4,274	20.2	4,213	19.6	4,104	18.9
40–44	3,374	16.8	3,244	16.5	2,967	15.2	2,968	15.1	2,964	14.9
45–49	3,297	15.9	3,049	14.6	2,929	14.0	2,766	13.4	2,565	12.6
50–54	2,991	13.4	2,847	13.1	2,640	12.4	2,467	11.8	2,301	11.2
55–59	1,882	8.7	1,881	8.6	1,873	8.5	1,841	8.4	1,827	8.4
60–64	995	5.2	1,080	5.6	1,087	5.5	1,040	5.1	1,100	5.3
≥65	851	1.8	859	1.7	877	1.7	870	1.7	874	1.6
Race/ethnicity
American Indian/Alaska Native	172	7.3	217	9.1	206	8.6	182	7.5	210	8.6
Asian	918	5.3	927	5.2	921	5.1	854	4.6	737	3.9
Black/African American	16,757	42.0	16,571	41.2	15,988	39.4	15,493	37.9	15,334	37.3
Hispanic/Latino^d	10,329	18.4	10,619	18.5	10,476	17.9	10,540	17.7	10,120	16.7
Native Hawaiian/other Pacific Islander	66	11.9	40	7.1	52	9.0	64	10.9	66	11.1
White	10,068	5.1	9,770	4.9	9,562	4.8	9,309	4.7	9,013	4.6
Multiracial	1,535	23.4	1,411	20.9	1,188	17.1	1,029	14.5	918	12.6
Transmission category^e
Male adult or adolescent^f
Male-to-male sexual contact	26,273	—	25,947	—	25,337	—	24,556	—	23,866	—
Injection drug use	1,295	—	1,203	—	1,301	—	1,407	—	1,375	—
Male-to-male sexual contact and injection drug use	1,499	—	1,498	—	1,421	—	1,408	—	1,457	—
Heterosexual contact^g	3,249	—	3,275	—	2,913	—	2,903	—	2,685	—
Perinatal^h	14	—	8	—	12	—	14	—	14	—
Otherⁱ	17	—	16	—	22	—	21	—	23	—
Subtotal	32,347	24.7	31,948	24.2	31,005	23.3	30,308	22.6	29,419	21.8
Female adult or adolescent^f
Injection drug use	1,033	—	1,000	—	1,053	—	1,084	—	1,106	—
Heterosexual contact^g	6,298	—	6,437	—	6,198	—	5,958	—	5,787	—
Perinatal^h	18	—	37	—	26	—	24	—	21	—
Otherⁱ	7	—	6	—	7	—	8	—	5	—
Subtotal	7,356	5.4	7,479	5.4	7,284	5.2	7,074	5.0	6,918	4.9
Child (<13 yrs at diagnosis)
Perinatal	111	—	102	—	86	—	67	—	49	—
Otherⁱ	31	—	26	—	18	—	22	—	12	—
Subtotal	142	0.3	128	0.2	104	0.2	89	0.2	61	0.1
Region of residence^j
Northeast	6,466	11.5	6,216	11.1	6,009	10.7	5,570	9.9	5,275	9.4
Midwest	5,239	7.7	5,184	7.6	5,104	7.5	4,947	7.2	4,759	7.0
South	20,395	16.9	20,284	16.6	19,722	16.0	19,412	15.6	19,135	15.2
West	7,745	10.2	7,871	10.3	7,558	9.8	7,542	9.7	7,229	9.2

Total	39,845	12.4	39,555	12.2	38,393	11.8	37,471	11.5	36,398	11.1

Note: Numbers less than 12 should be interpreted with caution.

^aRates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data.
^b”Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
^cAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
^dHispanic/Latino persons can be of any race.
^eData have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
^fData presented based on sex at birth and include transgender persons.
^gHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
^hIndividuals were ≥13 years of age at time of diagnosis of HIV infection.
ⁱIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
^jData are based on residence at time of diagnosis of HIV infection.

Table 1b. Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2015–2019—United States and 6 dependent areas
	2015		2016		2017		2018		2019
	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a
Gender
Male	32,292	—	31,808	—	30,826	—	30,109	—	29,133	—
Female	7,504	—	7,625	—	7,400	—	7,152	—	6,978	—
Transgender male-to-female^b	593	—	642	—	583	—	597	—	625	—
Transgender female-to-male^b	32	—	21	—	36	—	48	—	46	—
Additional gender identity^c	10	—	12	—	13	—	14	—	19	—
Age at diagnosis (yr)
<13	142	0.3	128	0.2	104	0.2	89	0.2	61	0.1
13–14	26	0.3	25	0.3	26	0.3	20	0.2	21	0.2
15–19	1,773	8.3	1,721	8.0	1,790	8.4	1,731	8.1	1,646	7.7
20–24	7,359	32.1	6,991	30.9	6,543	29.3	6,158	27.9	5,981	27.3
25–29	7,668	33.8	8,027	34.7	7,782	33.0	7,787	32.8	7,396	31.1
30–34	5,500	25.2	5,710	25.9	5,708	25.8	5,730	25.7	5,731	25.3
35–39	4,303	20.9	4,285	20.4	4,327	20.2	4,247	19.5	4,143	18.9
40–44	3,439	16.9	3,301	16.6	3,004	15.2	3,012	15.1	3,004	14.9
45–49	3,364	16.0	3,108	14.7	2,970	14.0	2,810	13.4	2,602	12.6
50–54	3,049	13.5	2,893	13.1	2,692	12.5	2,517	11.9	2,329	11.2
55–59	1,915	8.7	1,930	8.7	1,907	8.6	1,868	8.4	1,863	8.4
60–64	1,010	5.2	1,105	5.6	1,108	5.5	1,060	5.2	1,123	5.4
≥65	883	1.8	884	1.8	897	1.7	891	1.7	901	1.6
Race/ethnicity
American Indian/Alaska Native	172	—	217	—	206	—	182	—	210	—
Asian	922	—	928	—	924	—	858	—	743	—
Black/African American	16,766	—	16,577	—	15,992	—	15,500	—	15,340	—
Hispanic/Latino^d	10,896	—	11,157	—	10,926	—	10,970	—	10,502	—
Native Hawaiian/other Pacific Islander	69	—	46	—	55	—	66	—	70	—
White	10,070	—	9,772	—	9,566	—	9,313	—	9,018	—
Multiracial	1,536	—	1,411	—	1,189	—	1,031	—	918	—
Transmission category^e
Male adult or adolescent^f
Male-to-male sexual contact	26,585	—	26,244	—	25,580	—	24,819	—	24,084	—
Injection drug use	1,348	—	1,241	—	1,333	—	1,432	—	1,397	—
Male-to-male sexual contact and injection drug use	1,522	—	1,510	—	1,432	—	1,420	—	1,468	—
Heterosexual contact^g	3,335	—	3,377	—	2,997	—	2,970	—	2,754	—
Perinatal^h	14	—	8	—	12	—	14	—	14	—
Otherⁱ	17	—	16	—	22	—	21	—	23	—
Subtotal	32,821	24.8	32,396	24.2	31,376	23.3	30,676	22.6	29,741	21.8
Female adult or adolescent^f
Injection drug use	1,040	—	1,011	—	1,062	—	1,086	—	1,111	—
Heterosexual contact^g	6,402	—	6,530	—	6,283	—	6,037	—	5,863	—
Perinatal^h	18	—	37	—	26	—	24	—	21	—
Otherⁱ	7	—	6	—	7	—	8	—	5	—
Subtotal	7,468	5.4	7,584	5.4	7,378	5.2	7,155	5.0	6,999	4.9
Child (<13 yrs at diagnosis)
Perinatal	111	—	102	—	86	—	67	—	49	—
Otherⁱ	31	—	26	—	18	—	22	—	12	—
Subtotal	142	0.3	128	0.2	104	0.2	89	0.2	61	0.1
Region of residence^j
Northeast	6,466	11.5	6,216	11.1	6,009	10.7	5,570	9.9	5,275	9.4
Midwest	5,239	7.7	5,184	7.6	5,104	7.5	4,947	7.2	4,759	7.0
South	20,395	16.9	20,284	16.6	19,722	16.0	19,412	15.6	19,135	15.2
West	7,745	10.2	7,871	10.3	7,558	9.8	7,542	9.7	7,229	9.2
U.S. dependent areas	586	15.1	553	14.5	465	12.5	449	12.5	403	11.2
Total	40,431	12.5	40,108	12.3	38,858	11.8	37,920	11.5	36,801	11.1

Note: Numbers less than 12 should be interpreted with caution.

^aRates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data. Rates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas.
^b“Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
^cAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
^dHispanic/Latino persons can be of any race.
^eData have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
^fData presented based on sex at birth and include transgender persons.
^gHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
^hIndividuals were ≥13 years of age at time of diagnosis of HIV infection.
ⁱIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
^jData are based on residence at time of diagnosis of HIV infection.

Table 2a. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2019—United States
	American Indian/Alaska Native		Asian		Black/African American		Hispanic/Latino^a		Native Hawaiian/other Pacific Islander		White		Multiracial		Total
	No.	Rate^b	No.	Rate^b	No.	Rate^b	No.	Rate^b	No.	Rate^b	No.	Rate^b	No.	Rate^b	No.	Rate^b
Gender
Male	161	—	626	—	11,208	—	8,648	—	52	—	7,419	—	699	—	28,813	—
Female	44	—	99	—	3,812	—	1,237	—	9	—	1,498	—	198	—	6,897	—
Transgender male-to-female^c	5	—	11	—	289	—	219	—	5	—	80	—	14	—	623	—
Transgender female-to-male^c	0	—	1	—	19	—	12	—	0	—	11	—	3	—	46	—
Additional gender identity^d	0	—	0	—	6	—	4	—	0	—	5	—	4	—	19	—
Age at diagnosis (yr)
<13	1	0.2	5	0.2	35	0.5	8	0.1	0	0.0	7	0.0	5	0.2	61	0.1
13–14	0	0.0	0	0.0	14	1.2	6	0.3	0	0.0	1	0.0	0	0.0	21	0.3
15–19	9	5.1	22	2.0	931	32.1	441	8.7	2	4.8	189	1.7	46	6.1	1,640	7.8
20–24	37	20.4	102	8.1	2,978	97.3	1,647	34.0	8	18.6	1,000	8.6	155	23.0	5,927	27.4
25–29	39	19.4	146	9.3	3,140	89.9	2,167	43.9	23	45.2	1,623	12.8	203	34.8	7,341	31.2
30–34	26	14.9	119	7.2	2,225	73.5	1,710	37.3	12	23.1	1,420	11.4	161	36.5	5,673	25.3
35–39	38	23.9	97	6.1	1,463	52.6	1,273	28.2	9	18.3	1,128	9.2	96	25.5	4,104	18.9
40–44	19	13.4	57	3.9	1,091	43.1	926	22.3	5	12.3	800	7.1	66	21.4	2,964	14.9
45–49	12	8.4	74	5.2	939	36.6	688	18.0	1	2.7	794	6.5	57	20.7	2,565	12.6
50–54	16	11.0	47	3.9	867	34.2	566	17.1	4	11.4	756	5.8	45	18.9	2,301	11.2
55–59	7	4.5	31	2.8	719	27.5	328	11.5	1	2.9	694	4.7	47	20.0	1,827	8.4
60–64	3	2.1	19	1.9	511	21.8	202	9.1	1	3.5	348	2.4	16	7.8	1,100	5.3
≥65	3	1.0	18	0.7	421	8.5	158	3.4	0	0.0	253	0.6	21	4.9	874	1.6
Transmission category^e
Male adult or adolescent^f
Male-to-male sexual contact	126	—	573	—	9,122	—	7,613	—	52	—	5,802	—	577	—	23,866	—
Injection drug use	15	—	14	—	408	—	304	—	1	—	599	—	33	—	1,375	—
Male-to-male sexual contact and injection drug use	15	—	13	—	298	—	394	—	2	—	683	—	52	—	1,457	—
Heterosexual contact^g	8	—	31	—	1,644	—	544	—	2	—	407	—	49	—	2,685	—
Perinatal^h	0	—	1	—	8	—	3	—	0	—	1	—	0	—	14	—
Otherⁱ	0	—	2	—	9	—	6	—	0	—	6	—	1	—	23	—
Subtotal	165	16.9	635	8.3	11,489	71.7	8,864	37.5	57	23.2	7,498	8.9	711	30.1	29,419	21.8
Female adult or adolescent^f
Injection drug use	18	—	6	—	323	—	170	—	0	—	549	—	40	—	1,106	—
Heterosexual contact^g	27	—	90	—	3,471	—	1,074	—	9	—	954	—	162	—	5,787	—
Perinatal^h	0	—	0	—	15	—	4	—	0	—	2	—	0	—	21	—
Otherⁱ	0	—	0	—	1	—	0	—	0	—	2	—	0	—	5	—
Subtotal	44	4.3	97	1.1	3,810	21.3	1,248	5.3	9	3.7	1,508	1.7	202	8.1	6,918	4.9
Child (<13 yrs at diagnosis)
Perinatal	1	—	3	—	28	—	7	—	0	—	7	—	3	—	49	—
Otherⁱ	0	—	2	—	7	—	1	—	0	—	0	—	2	—	12	—
Subtotal	1	0.2	5	0.2	35	0.5	8	0.1	0	0.0	7	0.0	5	0.2	61	0.1
Region of residence^j
Northeast	5	3.9	137	3.6	2,155	34.0	1,654	19.9	1	4.6	1,125	3.1	198	20.1	5,275	9.4
Midwest	33	7.9	74	3.1	2,269	31.6	664	12.0	11	30.0	1,571	3.1	137	9.9	4,759	7.0
South	64	7.9	195	4.3	9,638	40.1	4,657	20.2	14	14.4	4,128	5.8	439	18.1	19,135	15.2
West	108	10.0	331	4.0	1,272	35.2	3,145	13.3	40	9.1	2,189	5.6	144	5.8	7,229	9.2
Total	210	8.6	737	3.9	15,334	37.3	10,120	16.7	66	11.1	9,013	4.6	918	12.6	36,398	11.1

Note: Numbers less than 12, and rates based on these numbers, should be interpreted with caution.

^aHispanic/Latino persons can be of any race.
^bRates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data.
^c“Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
^dAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
^eData have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
^fData presented based on sex at birth and include transgender persons.
^gHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
^hIndividuals were ≥13 years of age at time of diagnosis of HIV infection.
ⁱIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
^jData are based on residence at time of diagnosis of HIV infection.

Table 2b. Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2019—United States and 6 dependent areas
	American Indian/Alaska Native	Asian	Black/African American	Hispanic/Latino^a	Native Hawaiian/other Pacific Islander	White	Multiracial	Total
	No.	No.	No.	No.	No.	No.	No.	No.
Gender
Male	161	632	11,212	8,950	55	7,424	699	29,133
Female	44	99	3,814	1,315	10	1,498	198	6,978
Transgender male-to-female^b	5	11	289	221	5	80	14	625
Transgender female-to-male^b	0	1	19	12	0	11	3	46
Additional gender identity^c	0	0	6	4	0	5	4	19
Age at diagnosis (yr)
<13	1	5	35	8	0	7	5	61
13–14	0	0	14	6	0	1	0	21
15–19	9	22	931	447	2	189	46	1,646
20–24	37	102	2,979	1,699	9	1,000	155	5,981
25–29	39	150	3,140	2,217	24	1,623	203	7,396
30–34	26	120	2,225	1,764	12	1,423	161	5,731
35–39	38	98	1,463	1,311	9	1,128	96	4,143
40–44	19	57	1,092	964	6	800	66	3,004
45–49	12	74	940	723	1	795	57	2,602
50–54	16	47	868	592	5	756	45	2,329
55–59	7	31	720	363	1	694	47	1,863
60–64	3	19	511	225	1	348	16	1,123
≥65	3	18	422	183	0	254	21	901
Transmission category^d
Male adult or adolescent^e
Male-to-male sexual contact	126	578	9,123	7,820	54	5,805	577	24,084
Injection drug use	15	14	409	326	1	599	33	1,397
Male-to-male sexual contact and injection drug use	15	14	298	403	3	684	52	1,468
Heterosexual contact^f	8	31	1,646	611	2	408	49	2,754
Perinatal^g	0	1	8	3	0	1	0	14
Other^h	0	2	9	6	0	6	1	23
Subtotal	165	641	11,493	9,168	60	7,503	711	29,741
Female adult or adolescent^e
Injection drug use	18	6	323	175	0	549	40	1,111
Heterosexual contact^f	27	90	3,473	1,147	10	954	162	5,863
Perinatal^g	0	0	15	4	0	2	0	21
Other^h	0	0	1	0	0	2	0	5
Subtotal	44	97	3,812	1,326	10	1,508	202	6,999
Child (<13 yrs at diagnosis)
Perinatal	1	3	28	7	0	7	3	49
Other^h	0	2	7	1	0	0	2	12
Subtotal	1	5	35	8	0	7	5	61
Region of residenceⁱ
Northeast	5	137	2,155	1,654	1	1,125	198	5,275
Midwest	33	74	2,269	664	11	1,571	137	4,759
South	64	195	9,638	4,657	14	4,128	439	19,135
West	108	331	1,272	3,145	40	2,189	144	7,229
U.S. dependent areas	0	6	6	382	4	5	0	403
Total	210	743	15,340	10,502	70	9,018	918	36,801

Note: Numbers less than 12 should be interpreted with caution.

^aHispanic/Latino persons can be of any race.
^b“Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
^cAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
^dData have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
^eData presented based on sex at birth and includes transgender persons.
^fHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
^gIndividuals were ≥13 years of age at time of diagnosis of HIV infection.
^hIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
ⁱData are based on residence at time of diagnosis of HIV infection.

Table 3a. Diagnoses of HIV infection among adults and adolescents, by year of diagnosis, sex at birth, and selected characteristics, 2015–2019—United States
	2015		2016		2017		2018		2019
	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a
Male adult or adolescent
Age at diagnosis (yr)
13–14	12	0.3	9	0.2	13	0.3	11	0.3	12	0.3
15–19	1,513	14.0	1,461	13.5	1,531	14.2	1,471	13.7	1,437	13.4
20–24	6,458	55.5	6,179	53.8	5,701	50.4	5,382	48.2	5,201	47.0
25–29	6,597	57.9	6,900	59.2	6,738	56.7	6,759	56.4	6,398	53.3
30–34	4,452	41.0	4,610	41.9	4,630	41.8	4,719	42.2	4,708	41.5
35–39	3,286	32.4	3,249	31.3	3,344	31.6	3,286	30.5	3,209	29.5
40–44	2,566	25.7	2,477	25.4	2,227	22.9	2,185	22.3	2,216	22.4
45–49	2,537	24.7	2,275	22.0	2,165	20.9	2,047	20.0	1,890	18.7
50–54	2,252	20.6	2,123	19.8	1,980	18.9	1,808	17.6	1,677	16.6
55–59	1,348	12.8	1,308	12.3	1,313	12.3	1,297	12.2	1,317	12.4
60–64	700	7.7	734	7.9	755	7.9	720	7.4	748	7.6
≥65	626	3.0	623	2.9	608	2.7	623	2.7	606	2.5
Race/ethnicity
American Indian/Alaska Native	125	13.3	176	18.6	161	16.8	153	15.8	165	16.9
Asian	787	11.4	777	10.9	799	10.9	748	10.0	635	8.3
Black/African American	12,412	80.6	12,179	78.2	11,737	74.6	11,521	72.6	11,489	71.7
Hispanic/Latino^b	8,999	41.6	9,282	41.9	9,149	40.4	9,173	39.6	8,864	37.5
Native Hawaiian/other Pacific Islander	60	26.5	34	14.7	43	18.2	59	24.5	57	23.2
White	8,687	10.4	8,341	9.9	8,130	9.7	7,842	9.3	7,498	8.9
Multiracial	1,277	62.3	1,159	54.5	986	44.8	812	35.6	711	30.1
Region of residence^c
Northeast	5,040	21.9	4,803	20.8	4,664	20.2	4,344	18.8	4,128	17.9
Midwest	4,259	15.3	4,211	15.1	4,139	14.8	4,012	14.3	3,786	13.5
South	16,201	33.1	16,086	32.4	15,582	31.1	15,411	30.4	15,252	29.8
West	6,847	22.0	6,848	21.7	6,620	20.7	6,541	20.3	6,253	19.2
Subtotal	32,347	24.7	31,948	24.2	31,005	23.3	30,308	22.6	29,419	21.8
Female adult or adolescent
Age at diagnosis (yr)
13–14	14	0.3	16	0.4	13	0.3	9	0.2	9	0.2
15–19	253	2.5	249	2.4	246	2.4	244	2.4	203	2.0
20–24	820	7.4	738	6.8	777	7.2	718	6.7	726	6.9
25–29	974	8.8	1,058	9.4	979	8.6	951	8.3	943	8.2
30–34	987	9.2	1,034	9.5	1,014	9.3	953	8.7	965	8.7
35–39	947	9.3	964	9.3	930	8.8	927	8.6	895	8.2
40–44	808	8.0	767	7.7	740	7.5	783	7.9	748	7.5
45–49	760	7.3	774	7.3	764	7.2	719	6.9	675	6.5
50–54	739	6.5	724	6.5	660	6.1	659	6.2	624	6.0
55–59	534	4.8	573	5.1	560	5.0	544	4.8	510	4.5
60–64	295	3.0	346	3.4	332	3.2	320	3.0	352	3.3
≥65	225	0.8	236	0.9	269	1.0	247	0.8	268	0.9
Race/ethnicity
American Indian/Alaska Native	45	4.6	41	4.1	45	4.5	29	2.9	44	4.3
Asian	120	1.5	142	1.8	116	1.4	101	1.2	97	1.1
Black/African American	4,258	24.7	4,314	24.7	4,194	23.8	3,920	22.1	3,810	21.3
Hispanic/Latino^b	1,317	6.2	1,319	6.0	1,311	5.9	1,357	5.9	1,248	5.3
Native Hawaiian/other Pacific Islander	6	2.7	6	2.6	8	3.4	5	2.1	9	3.7
White	1,364	1.6	1,412	1.6	1,416	1.6	1,451	1.7	1,508	1.7
Multiracial	246	11.2	245	10.8	194	8.3	211	8.7	202	8.1
Region of residence^c
Northeast	1,400	5.7	1,400	5.7	1,336	5.4	1,218	4.9	1,140	4.6
Midwest	953	3.3	943	3.3	947	3.3	920	3.2	964	3.3
South	4,130	8.0	4,134	7.9	4,076	7.7	3,953	7.4	3,848	7.1
West	873	2.8	1,002	3.1	925	2.9	983	3.0	966	2.9
Subtotal	7,356	5.4	7,479	5.4	7,284	5.2	7,074	5.0	6,918	4.9
Total	39,703	14.8	39,427	14.6	38,289	14.1	37,382	13.6	36,337	13.2

Note: Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.

^aRates are per 100,000 population.
^bHispanic/Latino persons can be of any race.
^cData are based on residence at time of diagnosis of HIV infection.

Table 3b. Diagnoses of HIV infection among adults and adolescents, by year of diagnosis, sex at birth, and selected characteristics, 2015–2019—United States and 6 dependent areas
	2015		2016		2017		2018		2019
	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a
Male adult or adolescent
Age at diagnosis (yr)
13–14	12	0.3	9	0.2	13	0.3	11	0.3	12	0.3
15–19	1,518	13.9	1,470	13.4	1,540	14.1	1,485	13.7	1,443	13.3
20–24	6,529	55.4	6,247	53.8	5,761	50.4	5,432	48.1	5,250	46.9
25–29	6,682	58.0	6,963	59.1	6,791	56.6	6,829	56.4	6,447	53.2
30–34	4,506	41.0	4,667	42.1	4,687	41.9	4,770	42.3	4,757	41.5
35–39	3,345	32.6	3,303	31.5	3,385	31.6	3,316	30.5	3,243	29.5
40–44	2,615	25.9	2,518	25.5	2,257	23.0	2,221	22.5	2,242	22.4
45–49	2,589	24.9	2,319	22.1	2,191	20.9	2,077	20.0	1,917	18.8
50–54	2,296	20.8	2,160	19.9	2,020	19.0	1,846	17.8	1,699	16.7
55–59	1,369	12.8	1,343	12.5	1,336	12.4	1,316	12.2	1,340	12.5
60–64	714	7.8	752	8.0	771	8.0	735	7.5	766	7.7
≥65	646	3.0	645	2.9	624	2.7	638	2.7	625	2.6
Race/ethnicity
American Indian/Alaska Native	125	—	176	—	161	—	153	—	165	—
Asian	791	—	778	—	802	—	752	—	641	—
Black/African American	12,417	—	12,185	—	11,739	—	11,528	—	11,493	—
Hispanic/Latino^b	9,459	—	9,715	—	9,509	—	9,522	—	9,168	—
Native Hawaiian/other Pacific Islander	63	—	40	—	46	—	61	—	60	—
White	8,689	—	8,343	—	8,132	—	7,846	—	7,503	—
Multiracial	1,277	—	1,159	—	987	—	814	—	711	—
Region of residence^c
Northeast	5,040	21.9	4,803	20.8	4,664	20.2	4,344	18.8	4,128	17.9
Midwest	4,259	15.3	4,211	15.1	4,139	14.8	4,012	14.3	3,786	13.5
South	16,201	33.1	16,086	32.4	15,582	31.1	15,411	30.4	15,252	29.8
West	6,847	22.0	6,848	21.7	6,620	20.7	6,541	20.3	6,253	19.2
U.S. dependent areas	474	30.4	448	29.2	371	24.5	368	25.0	322	21.8
Subtotal	32,821	24.8	32,396	24.2	31,376	23.3	30,676	22.6	29,741	21.8
Female adult or adolescent
Age at diagnosis (yr)
13–14	14	0.3	16	0.4	13	0.3	9	0.2	9	0.2
15–19	255	2.4	251	2.4	250	2.4	246	2.4	203	1.9
20–24	830	7.4	744	6.8	782	7.2	726	6.7	731	6.8
25–29	986	8.8	1,064	9.3	991	8.6	958	8.2	949	8.2
30–34	994	9.1	1,043	9.5	1,021	9.3	960	8.7	974	8.7
35–39	958	9.3	982	9.3	942	8.8	931	8.6	900	8.2
40–44	824	8.0	783	7.8	747	7.5	791	7.9	762	7.5
45–49	775	7.3	789	7.4	779	7.3	733	6.9	685	6.6
50–54	753	6.6	733	6.5	672	6.1	671	6.3	630	6.0
55–59	546	4.8	587	5.1	571	5.0	552	4.8	523	4.6
60–64	296	2.9	353	3.4	337	3.2	325	3.0	357	3.3
≥65	237	0.9	239	0.9	273	1.0	253	0.9	276	0.9
Race/ethnicity
American Indian/Alaska Native	45	—	41	—	45	—	29	—	44	—
Asian	120	—	142	—	116	—	101	—	97	—
Black/African American	4,262	—	4,314	—	4,196	—	3,920	—	3,812	—
Hispanic/Latino^b	1,424	—	1,424	—	1,401	—	1,438	—	1,326	—
Native Hawaiian/other Pacific Islander	6	—	6	—	8	—	5	—	10	—
White	1,364	—	1,412	—	1,418	—	1,451	—	1,508	—
Multiracial	247	—	245	—	194	—	211	—	202	—
Region of residence^c
Northeast	1,400	5.7	1,400	5.7	1,336	5.4	1,218	4.9	1,140	4.6
Midwest	953	3.3	943	3.3	947	3.3	920	3.2	964	3.3
South	4,130	8.0	4,134	7.9	4,076	7.7	3,953	7.4	3,848	7.1
West	873	2.8	1,002	3.1	925	2.9	983	3.0	966	2.9
U.S. dependent areas	112	6.5	105	6.1	94	5.6	81	4.9	81	4.9
Subtotal	7,468	5.4	7,584	5.4	7,378	5.2	7,155	5.0	6,999	4.9
Total	40,289	14.9	39,980	14.6	38,754	14.1	37,831	13.6	36,740	13.2

Note: Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.

^aRates are per 100,000 population. Rates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas.
^bHispanic/Latino persons can be of any race.
^cData are based on residence at time of diagnosis of HIV infection.

Table 4a. Diagnoses of HIV infection among transgender adults and adolescents, by year of diagnosis and selected characteristics, 2015–2019—United States
	2015	2016	2017	2018	2019
	No.	No.	No.	No.	No.
Transgender male-to-female adult or adolescent^a
Age at diagnosis (yr)
13–14	0	0	0	0	0
15–19	65	56	53	36	35
20–24	158	188	141	155	158
25–29	166	179	164	175	156
30–34	73	88	106	92	129
35–39	53	64	52	68	57
40–44	22	26	28	33	40
45–49	27	15	18	22	20
50–54	18	9	8	6	16
55–59	5	8	6	5	7
60–64	2	3	5	2	4
≥65	0	3	0	2	1
Race/ethnicity
American Indian/Alaska Native	4	3	2	10	5
Asian	14	7	16	10	11
Black/African American	288	316	282	279	289
Hispanic/Latino^b	216	217	194	214	219
Native Hawaiian/other Pacific Islander	3	2	3	3	5
White	35	55	66	54	80
Multiracial	29	39	18	26	14
Region of residence^c
Northeast	138	144	100	111	102
Midwest	91	88	91	94	80
South	252	280	262	256	270
West	108	127	128	135	171
Subtotal	589	639	581	596	623
Transgender female-to-male adult or adolescent^a
Age at diagnosis (yr)
13–14	0	0	0	0	0
15–19	2	1	3	2	0
20–24	5	4	8	9	11
25–29	7	5	16	18	19
30–34	7	3	3	8	12
35–39	3	4	3	5	2
40–44	5	1	0	4	0
45–49	2	2	2	1	2
50–54	1	1	0	1	0
55–59	0	0	1	0	0
60–64	0	0	0	0	0
≥65	0	0	0	0	0
Race/ethnicity
American Indian/Alaska Native	1	0	0	0	0
Asian	0	1	3	0	1
Black/African American	13	5	12	19	19
Hispanic/Latino^b	9	6	7	10	12
Native Hawaiian/other Pacific Islander	0	0	0	0	0
White	7	6	11	17	11
Multiracial	2	3	3	2	3
Region of residence^c
Northeast	4	1	6	7	5
Midwest	9	5	9	7	6
South	14	6	13	16	19
West	5	9	8	18	16
Subtotal	32	21	36	48	46
Total	621	660	617	644	669

Note: Additional gender identity not included due to small numbers. Numbers less than 12 should be interpreted with caution.

^a“Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
^bHispanic/Latino persons can be of any race.
^cData are based on residence at time of diagnosis of HIV infection.

Table 4b. Diagnoses of HIV infection among transgender adults and adolescents, by year of diagnosis and selected characteristics, 2015–2019—United States and 6 dependent areas
	2015	2016	2017	2018	2019
	No.	No.	No.	No.	No.
Transgender male-to-female adult or adolescent^a
Age at diagnosis (yr)
13–14	0	0	0	0	0
15–19	66	56	53	36	35
20–24	158	189	142	155	159
25–29	168	179	165	175	157
30–34	74	89	106	92	129
35–39	53	64	52	69	57
40–44	22	26	28	33	40
45–49	27	15	18	22	20
50–54	18	9	8	6	16
55–59	5	8	6	5	7
60–64	2	3	5	2	4
≥65	0	3	0	2	1
Race/ethnicity
American Indian/Alaska Native	4	3	2	10	5
Asian	14	7	16	10	11
Black/African American	288	316	282	279	289
Hispanic/Latino^b	220	219	196	215	221
Native Hawaiian/other Pacific Islander	3	2	3	3	5
White	35	55	66	54	80
Multiracial	29	39	18	26	14
Region of residence^c
Northeast	138	144	100	111	102
Midwest	91	88	91	94	80
South	252	280	262	256	270
West	108	127	128	135	171
US dependent areas	4	2	2	1	2
Subtotal	593	641	583	597	625
Transgender female-to-male adult or adolescent^a
Age at diagnosis (yr)
13–14	0	0	0	0	0
15–19	2	1	3	2	0
20–24	5	4	8	9	11
25–29	7	5	16	18	19
30–34	7	3	3	8	12
35–39	3	4	3	5	2
40–44	5	1	0	4	0
45–49	2	2	2	1	2
50–54	1	1	0	1	0
55–59	0	0	1	0	0
60–64	0	0	0	0	0
≥65	0	0	0	0	0
Race/ethnicity
American Indian/Alaska Native	1	0	0	0	0
Asian	0	1	3	0	1
Black/African American	13	5	12	19	19
Hispanic/Latino^b	9	6	7	10	12
Native Hawaiian/other Pacific Islander	0	0	0	0	0
White	7	6	11	17	11
Multiracial	2	3	3	2	3
Region of residence^c
Northeast	4	1	6	7	5
Midwest	9	5	9	7	6
South	14	6	13	16	19
West	5	9	8	18	16
US dependent areas	0	0	0	0	0
Subtotal	32	21	36	48	46
Total	625	662	619	645	671

Note: Additional gender identity not included due to small numbers. Numbers less than 12 should be interpreted with caution.

^a“Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
^bHispanic/Latino persons can be of any race.
^cData are based on residence at time of diagnosis of HIV infection.

Table 5a. Diagnoses of HIV infection attributed to male-to-male sexual contact and male-to-male sexual contact and injection drug use, by year of diagnosis and selected characteristics, 2015–2019—United States
	Male-to-male sexual contact					Male-to-male sexual contact and injection drug use
	2015	2016	2017	2018	2019	2015	2016	2017	2018	2019
	No.	No.	No.	No.	No.	No.	No.	No.	No.	No.
American Indian/Alaska Native
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	0	0	0	0
15–19	4	2	2	7	7	1	0	0	0	1
20–24	30	24	18	25	26	0	4	3	2	3
25–29	21	37	32	22	29	1	5	6	7	6
30–34	16	30	18	20	18	0	3	6	5	1
35–39	12	11	15	10	19	3	2	1	2	2
40–44	6	14	12	9	6	0	0	2	1	0
45–49	5	6	6	7	6	0	0	1	3	1
50–54	5	5	8	6	9	0	1	0	1	1
55–59	4	3	2	3	5	0	0	0	0	0
60–64	0	3	2	2	2	0	0	1	0	0
≥65	0	1	1	3	0	0	1	1	0	0
Region of residence^a
Northeast	3	7	2	5	5	0	0	0	0	0
Midwest	9	12	12	13	10	0	1	3	5	3
South	30	32	28	20	41	1	6	10	4	3
West	60	84	75	75	71	4	10	8	13	9
Total	102	135	116	113	126	6	16	21	22	15
Asian
Age at diagnosis (yr)
13–14	1	0	0	1	0	0	0	0	0	0
15–19	21	19	23	22	19	0	1	0	0	0
20–24	118	109	148	106	91	3	3	2	1	3
25–29	169	155	152	165	130	4	2	4	4	2
30–34	105	123	110	119	93	3	3	5	2	5
35–39	72	78	90	71	76	3	1	1	2	1
40–44	81	86	72	61	44	4	1	1	1	0
45–49	62	51	67	57	52	2	1	3	1	1
50–54	34	31	34	23	34	1	1	0	0	0
55–59	15	18	19	19	18	0	0	0	0	0
60–64	4	8	9	11	7	0	0	0	0	0
≥65	5	11	7	10	9	0	1	0	0	0
Region of residence^a
Northeast	110	136	128	130	106	3	3	3	1	3
Midwest	82	61	78	67	53	4	4	1	0	1
South	143	142	145	162	144	4	1	1	2	4
West	352	349	380	305	270	10	7	12	8	5
Total	687	689	731	665	574	20	14	15	12	13
Black/African American
Age at diagnosis (yr)
13–14	8	3	4	7	8	0	0	0	0	0
15–19	827	782	836	788	781	15	16	10	9	11
20–24	2,884	2,784	2,506	2,383	2,369	60	53	40	46	39
25–29	2,400	2,502	2,431	2,457	2,328	49	70	66	76	83
30–34	1,167	1,187	1,306	1,253	1,409	38	50	46	51	64
35–39	704	707	737	729	749	33	32	34	25	33
40–44	477	443	421	432	456	19	15	17	17	20
45–49	447	371	349	350	340	21	18	13	9	17
50–54	346	336	323	307	283	14	12	23	18	14
55–59	204	204	205	198	203	15	10	11	10	10
60–64	85	93	114	100	114	5	8	5	6	5
≥65	79	66	65	77	81	4	4	4	4	3
Region of residence^a
Northeast	1,206	1,151	1,160	1,093	1,124	32	34	37	50	38
Midwest	1,546	1,598	1,521	1,470	1,427	41	61	45	51	46
South	6,059	5,886	5,792	5,676	5,766	164	153	135	127	164
West	814	844	822	842	805	38	41	51	43	51
Total	9,626	9,478	9,296	9,081	9,122	274	289	268	270	298
Hispanic/Latino^b
Age at diagnosis (yr)
13–14	1	2	5	0	2	0	0	0	0	0
15–19	348	342	356	345	378	16	14	12	11	8
20–24	1,641	1,568	1,447	1,448	1,399	76	83	70	68	68
25–29	1,683	1,896	1,847	1,906	1,772	96	91	101	117	96
30–34	1,242	1,375	1,377	1,375	1,345	77	81	75	61	68
35–39	938	962	964	951	930	48	45	57	47	62
40–44	589	630	612	587	625	33	38	24	29	37
45–49	556	487	532	509	467	25	17	21	22	20
50–54	367	372	355	347	350	10	20	16	21	19
55–59	176	161	183	202	186	6	7	9	5	9
60–64	62	79	74	85	90	3	5	4	4	4
≥65	61	52	74	67	71	2	3	2	1	3
Region of residence^a
Northeast	1,301	1,238	1,270	1,161	1,136	59	56	40	53	55
Midwest	504	502	512	523	505	29	29	28	29	35
South	3,414	3,602	3,570	3,619	3,460	159	167	163	143	159
West	2,445	2,584	2,474	2,520	2,513	144	150	160	162	145
Total	7,663	7,926	7,826	7,823	7,613	391	401	390	387	394
Native Hawaiian/other Pacific Islander
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	0	0	0	0
15–19	2	1	1	3	1	0	0	0	0	0
20–24	9	1	9	7	7	0	0	0	2	0
25–29	11	7	9	10	19	0	2	0	1	0
30–34	10	4	8	13	10	0	2	0	1	1
35–39	7	7	2	8	6	1	0	1	0	1
40–44	2	3	5	2	4	0	0	0	0	0
45–49	5	1	1	2	1	0	0	0	0	0
50–54	5	2	1	1	3	0	0	0	0	0
55–59	2	0	0	4	1	0	0	0	0	0
60–64	0	0	0	1	1	0	0	0	0	0
≥65	0	1	0	1	0	0	1	0	0	0
Region of residence^a
Northeast	1	3	3	2	1	0	1	0	0	0
Midwest	1	1	2	2	6	0	0	0	0	0
South	15	5	6	10	13	1	0	0	0	0
West	35	18	25	37	32	0	4	1	4	2
Total	52	26	36	51	52	1	5	1	4	2
White
Age at diagnosis (yr)
13–14	1	0	1	0	1	0	0	0	0	0
15–19	142	151	165	169	130	16	18	12	10	14
20–24	919	862	920	799	737	102	92	82	69	66
25–29	1,213	1,188	1,196	1,101	1,097	156	154	157	164	157
30–34	976	941	868	940	885	126	127	119	132	142
35–39	734	669	723	649	661	96	81	94	110	104
40–44	691	610	489	516	458	53	66	60	51	64
45–49	742	709	609	558	466	54	54	56	45	50
50–54	797	728	676	539	497	63	40	38	39	33
55–59	421	450	435	435	459	36	33	24	24	28
60–64	247	238	244	248	233	14	14	15	7	16
≥65	190	200	182	210	179	4	8	9	6	10
Region of residence^a
Northeast	1,019	957	842	760	710	73	66	79	75	62
Midwest	1,238	1,195	1,219	1,095	983	132	134	104	127	142
South	2,927	2,883	2,764	2,704	2,616	279	259	272	249	274
West	1,889	1,713	1,683	1,604	1,493	237	228	210	205	206
Total	7,073	6,747	6,508	6,164	5,802	721	687	665	656	683
Multiracial
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	0	0	0	0
15–19	62	49	55	37	35	4	3	2	3	0
20–24	275	246	183	156	127	20	20	12	6	5
25–29	268	228	217	162	137	24	24	12	22	14
30–34	152	138	133	100	104	19	14	7	9	18
35–39	91	73	73	78	61	7	8	12	10	4
40–44	60	68	45	40	30	6	4	3	1	6
45–49	58	51	39	31	28	3	7	4	4	1
50–54	49	36	42	26	17	1	5	5	1	2
55–59	25	29	20	12	29	2	2	3	0	1
60–64	17	18	12	9	6	2	1	0	0	0
≥65	15	9	6	10	4	0	0	0	0	1
Region of residence^a
Northeast	240	195	160	125	122	19	15	10	5	5
Midwest	139	128	129	100	71	10	15	10	11	9
South	460	414	376	300	286	29	36	27	21	26
West	233	209	159	135	99	29	20	13	20	11
Total	1,072	946	825	660	577	86	86	60	56	52
Total
Age at diagnosis (yr)
13–14	11	5	10	8	11	0	0	0	0	0
15–19	1,405	1,346	1,437	1,371	1,352	53	52	36	34	33
20–24	5,876	5,594	5,232	4,924	4,755	261	255	209	195	184
25–29	5,764	6,014	5,884	5,824	5,512	331	347	344	390	357
30–34	3,667	3,798	3,818	3,819	3,864	262	279	257	262	298
35–39	2,557	2,507	2,603	2,497	2,502	191	169	199	197	206
40–44	1,905	1,852	1,656	1,646	1,623	114	123	105	100	128
45–49	1,875	1,676	1,603	1,514	1,359	106	97	98	83	90
50–54	1,602	1,510	1,439	1,249	1,191	89	78	82	79	69
55–59	847	866	865	872	900	58	52	47	39	49
60–64	415	438	455	455	453	23	29	26	17	25
≥65	349	340	336	378	344	10	18	16	12	17
Region of residence^a
Northeast	3,880	3,686	3,564	3,276	3,203	185	173	167	184	162
Midwest	3,519	3,496	3,473	3,270	3,054	215	245	192	222	235
South	13,047	12,965	12,681	12,490	12,325	637	621	607	545	630
West	5,827	5,800	5,619	5,519	5,284	462	459	455	456	430
Total	26,273	25,947	25,337	24,556	23,866	1,499	1,498	1,421	1,408	1,457

Note: Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
Data have been statistically adjusted to account for missing transmission category, therefore values may not sum to column total.
Persons whose transmission category is classified as male-to-male sexual contact or male-to-male sexual contact and injection drug use are presented based on sex at birth and include transgender persons.

^aData are based on residence at time of diagnosis of HIV infection.
^bHispanic/Latino persons can be of any race.

Table 5b. Diagnoses of HIV infection attributed to male-to-male sexual contact and male-to-male sexual contact and injection drug use, by year of diagnosis and selected characteristics, 2015–2019—United States and 6 dependent areas
	Male-to-male sexual contact					Male-to-male sexual contact and injection drug use
	2015	2016	2017	2018	2019	2015	2016	2017	2018	2019
	No.	No.	No.	No.	No.	No.	No.	No.	No.	No.
American Indian/Alaska Native
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	0	0	0	0
15–19	4	2	2	7	7	1	0	0	0	1
20–24	30	24	18	25	26	0	4	3	2	3
25–29	21	37	32	22	29	1	5	6	7	6
30–34	16	30	18	20	18	0	3	6	5	1
35–39	12	11	15	10	19	3	2	1	2	2
40–44	6	14	12	9	6	0	0	2	1	0
45–49	5	6	6	7	6	0	0	1	3	1
50–54	5	5	8	6	9	0	1	0	1	1
55–59	4	3	2	3	5	0	0	0	0	0
60–64	0	3	2	2	2	0	0	1	0	0
≥65	0	1	1	3	0	0	1	1	0	0
Region of residence^a
Northeast	3	7	2	5	5	0	0	0	0	0
Midwest	9	12	12	13	10	0	1	3	5	3
South	30	32	28	20	41	1	6	10	4	3
West	60	84	75	75	71	4	10	8	13	9
U.S. dependent areas	0	0	0	0	0	0	0	0	0	0
Total	102	135	116	113	126	6	16	21	22	15
Asian
Age at diagnosis (yr)
13–14	1	0	0	1	0	0	0	0	0	0
15–19	21	19	23	22	19	0	1	0	0	0
20–24	118	109	148	106	91	3	3	2	1	3
25–29	170	155	152	166	133	4	2	4	4	3
30–34	106	123	112	121	94	3	3	5	2	5
35–39	72	79	91	71	77	3	1	1	2	1
40–44	81	86	72	61	44	4	1	1	1	0
45–49	62	51	67	57	52	2	1	3	1	1
50–54	34	31	34	23	34	1	1	0	0	0
55–59	15	18	19	19	18	0	0	0	0	0
60–64	4	8	9	11	7	0	0	0	0	0
≥65	5	11	7	10	9	0	1	0	0	0
Region of residence^a
Northeast	110	136	128	130	106	3	3	3	1	3
Midwest	82	61	78	67	53	4	4	1	0	1
South	143	142	145	162	144	4	1	1	2	4
West	352	349	380	305	270	10	7	12	8	5
U.S. dependent areas	3	1	3	3	5	0	0	0	0	1
Total	690	690	734	668	579	20	14	15	12	14
Black/African American
Age at diagnosis (yr)
13–14	8	3	4	7	8	0	0	0	0	0
15–19	827	782	836	788	781	15	16	10	9	11
20–24	2,885	2,785	2,506	2,383	2,370	60	53	40	46	39
25–29	2,401	2,502	2,431	2,459	2,328	49	70	66	76	83
30–34	1,167	1,188	1,306	1,254	1,409	38	50	46	51	64
35–39	704	707	737	729	749	33	32	34	25	33
40–44	478	444	422	433	456	19	15	17	17	20
45–49	448	371	349	350	340	21	18	13	9	17
50–54	346	336	323	307	283	14	12	23	18	14
55–59	204	204	205	198	203	15	10	11	10	10
60–64	85	93	114	100	114	5	8	5	6	5
≥65	79	66	65	77	81	4	4	4	4	3
Region of residence^a
Northeast	1,206	1,151	1,160	1,093	1,124	32	34	37	50	38
Midwest	1,546	1,598	1,521	1,470	1,427	41	61	45	51	46
South	6,059	5,886	5,792	5,676	5,766	164	153	135	127	164
West	814	844	822	842	805	38	41	51	43	51
U.S. dependent areas	5	3	1	4	1	0	0	0	0	0
Total	9,630	9,481	9,298	9,084	9,123	274	289	268	271	298
Hispanic/Latino^b
Age at diagnosis (yr)
13–14	1	2	5	0	2	0	0	0	0	0
15–19	352	350	364	358	384	16	15	12	12	8
20–24	1,700	1,629	1,497	1,494	1,439	80	83	71	69	71
25–29	1,750	1,951	1,890	1,959	1,811	99	93	105	120	98
30–34	1,279	1,418	1,416	1,409	1,382	79	83	77	64	69
35–39	975	998	989	972	954	51	48	59	48	63
40–44	620	649	629	612	638	38	39	24	29	37
45–49	582	507	548	531	479	26	18	23	22	20
50–54	383	396	376	364	365	12	20	16	21	19
55–59	184	178	194	213	194	6	7	9	6	10
60–64	70	81	77	93	99	3	5	4	5	4
≥65	67	55	76	70	73	4	3	2	3	4
Region of residence^a
Northeast	1,301	1,238	1,270	1,161	1,136	59	56	40	53	55
Midwest	504	502	512	523	505	29	29	28	29	35
South	3,414	3,602	3,570	3,619	3,460	159	167	163	143	159
West	2,445	2,584	2,474	2,520	2,513	144	150	160	162	145
U.S. dependent areas	301	287	234	251	207	23	10	11	12	8
Total	7,963	8,212	8,060	8,074	7,820	413	412	402	398	403
Native Hawaiian/other Pacific Islander
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	0	0	0	0
15–19	2	1	1	3	1	0	0	0	0	0
20–24	10	3	9	7	7	0	0	0	2	0
25–29	12	7	9	10	19	0	3	0	1	1
30–34	10	6	8	13	10	0	2	0	1	1
35–39	7	7	2	9	6	1	0	1	0	1
40–44	2	3	5	2	5	0	0	0	0	0
45–49	5	1	1	2	1	0	0	0	0	0
50–54	5	2	2	1	4	0	0	0	0	0
55–59	2	1	1	4	1	0	0	0	0	0
60–64	0	0	0	1	1	0	0	0	0	0
≥65	0	1	0	1	0	0	1	0	0	0
Region of residence^a
Northeast	1	3	3	2	1	0	1	0	0	0
Midwest	1	1	2	2	6	0	0	0	0	0
South	15	5	6	10	13	1	0	0	0	0
West	35	18	25	37	32	0	4	1	4	2
U.S. dependent areas	2	4	2	1	2	0	1	0	0	1
Total	54	31	38	52	54	1	6	1	4	3
White
Age at diagnosis (yr)
13–14	1	0	1	0	1	0	0	0	0	0
15–19	142	151	165	169	130	16	18	12	10	14
20–24	919	863	920	799	737	102	92	82	69	66
25–29	1,213	1,188	1,196	1,101	1,097	156	154	157	164	157
30–34	976	942	868	940	887	126	127	119	132	143
35–39	734	669	724	649	661	96	81	94	110	104
40–44	691	610	489	518	458	53	66	60	51	64
45–49	742	709	609	558	466	54	54	56	45	50
50–54	799	728	677	540	497	63	40	38	39	33
55–59	421	450	435	436	459	36	33	24	24	28
60–64	247	238	244	248	233	14	14	15	7	16
≥65	190	200	182	210	180	4	8	9	6	10
Region of residence^a
Northeast	1,019	957	842	760	710	73	66	79	75	62
Midwest	1,238	1,195	1,219	1,095	983	132	134	104	127	142
South	2,927	2,883	2,764	2,704	2,616	279	259	272	249	274
West	1,889	1,713	1,683	1,604	1,493	237	228	210	205	206
U.S. dependent areas	2	2	2	4	3	0	0	0	0	1
Total	7,074	6,749	6,510	6,168	5,805	721	687	665	656	684
Multiracial
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	0	0	0	0
15–19	62	49	55	37	35	4	3	2	3	0
20–24	275	246	183	156	127	20	20	12	6	5
25–29	268	228	217	162	137	24	24	12	22	14
30–34	152	138	133	100	104	19	14	7	9	18
35–39	91	73	74	78	61	7	8	12	10	4
40–44	60	68	45	40	30	6	4	3	1	6
45–49	58	51	39	31	28	3	7	4	4	1
50–54	49	36	42	26	17	1	5	5	1	2
55–59	25	29	20	12	29	2	2	3	0	1
60–64	17	18	12	9	6	2	1	0	0	0
≥65	15	9	6	10	4	0	0	0	0	1
Region of residence^a
Northeast	240	195	160	125	122	19	15	10	5	5
Midwest	139	128	129	100	71	10	15	10	11	9
South	460	414	376	300	286	29	36	27	21	26
West	233	209	159	135	99	29	20	13	20	11
U.S. dependent areas	0	0	1	0	0	0	0	0	0	0
Total	1,072	946	826	660	577	86	86	60	56	52
Total
Age at diagnosis (yr)
13–14	11	5	10	8	11	0	0	0	0	0
15–19	1,409	1,354	1,445	1,384	1,358	53	53	36	34	33
20–24	5,937	5,658	5,282	4,970	4,797	265	255	210	196	187
25–29	5,834	6,069	5,926	5,880	5,554	334	350	348	393	361
30–34	3,705	3,845	3,859	3,856	3,904	264	281	259	265	300
35–39	2,596	2,543	2,631	2,518	2,527	194	172	201	198	208
40–44	1,937	1,873	1,675	1,673	1,638	120	124	105	100	128
45–49	1,903	1,696	1,619	1,536	1,371	107	98	100	83	90
50–54	1,620	1,534	1,462	1,266	1,207	91	78	82	79	69
55–59	855	883	876	885	909	58	52	47	41	50
60–64	424	441	458	463	462	23	29	26	18	25
≥65	356	343	338	380	347	12	18	16	13	18
Region of residence^a
Northeast	3,880	3,686	3,564	3,276	3,203	185	173	167	184	162
Midwest	3,519	3,496	3,473	3,270	3,054	215	245	192	222	235
South	13,047	12,965	12,681	12,490	12,325	637	621	607	545	630
West	5,827	5,800	5,619	5,519	5,284	462	459	455	456	430
U.S. dependent areas	312	297	243	264	218	23	11	11	12	11
Total	26,585	26,244	25,580	24,819	24,084	1,522	1,510	1,432	1,420	1,469

Note: Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
Data have been statistically adjusted to account for missing transmission category, therefore values may not sum to column total.
Persons whose transmission category is classified as male-to-male sexual contact or male-to-male sexual contact and injection drug use are presented based on sex at birth and include transgender persons.

^aData are based on residence at time of diagnosis of HIV infection.
^bHispanic/Latino persons can be of any race.

Table 6a. Diagnoses of HIV infection attributed to injection drug use, by year of diagnosis and selected characteristics, 2015–2019—United States
	Male					Female
	2015	2016	2017	2018	2019	2015	2016	2017	2018	2019
	No.	No.	No.	No.	No.	No.	No.	No.	No.	No.
American Indian/Alaska Native
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	0	0	0	0
15–19	0	0	0	1	0	0	0	0	0	0
20–24	0	3	0	0	2	1	1	1	0	2
25–29	2	4	6	1	1	2	4	2	2	1
30–34	2	0	3	3	2	2	1	1	3	1
35–39	1	1	0	0	4	1	1	3	3	7
40–44	0	2	2	0	3	1	1	2	0	2
45–49	0	2	0	1	1	2	1	1	1	0
50–54	1	0	3	2	1	0	4	2	2	2
55–59	1	3	0	0	0	2	0	1	1	0
60–64	0	0	1	0	0	1	1	0	1	0
≥65	0	0	1	0	0	0	0	1	0	1
Region of residence^a
Northeast	0	0	1	0	0	0	1	1	0	0
Midwest	0	0	2	3	4	1	1	1	2	4
South	2	3	2	1	3	4	1	4	7	6
West	5	13	11	6	8	9	11	9	5	7
Total	8	16	17	10	15	13	14	15	13	18
Asian
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	0	0	0	0
15–19	0	0	0	0	0	0	0	0	0	0
20–24	0	1	0	1	0	0	1	0	0	0
25–29	1	1	0	1	2	1	1	2	0	1
30–34	7	2	1	2	0	2	1	0	2	2
35–39	1	3	3	0	3	1	1	0	1	1
40–44	4	1	3	2	1	0	0	1	1	1
45–49	2	2	3	1	2	1	1	0	0	1
50–54	2	1	2	1	2	0	0	1	0	0
55–59	0	1	0	0	1	0	0	0	0	0
60–64	1	0	0	1	1	1	1	0	0	0
≥65	1	1	0	0	0	0	0	1	0	0
Region of residence^a
Northeast	8	3	4	5	3	1	1	1	1	1
Midwest	1	2	0	1	3	0	1	0	0	0
South	3	2	2	4	2	2	2	1	2	1
West	8	7	6	1	6	3	3	3	2	4
Total	19	13	12	10	14	5	7	6	5	6
Black/African American
Age at diagnosis (yr)
13–14	0	0	0	0	0	2	2	0	0	0
15–19	4	5	5	5	4	8	8	8	7	7
20–24	26	21	17	21	23	25	20	28	23	27
25–29	34	33	38	47	55	41	36	33	30	43
30–34	41	34	49	48	58	28	36	37	38	37
35–39	40	45	43	60	40	34	34	36	35	42
40–44	47	43	31	33	43	36	25	37	27	32
45–49	44	42	44	46	31	43	30	40	33	33
50–54	66	58	45	48	39	43	49	38	36	29
55–59	61	45	55	49	40	37	39	30	34	28
60–64	33	37	33	35	43	24	26	24	22	23
≥65	29	31	31	33	31	14	15	17	16	22
Region of residence^a
Northeast	125	109	123	121	116	94	70	88	80	87
Midwest	48	51	61	59	56	51	48	56	48	45
South	209	187	176	199	196	153	163	149	139	151
West	42	45	32	46	40	36	40	36	34	41
Total	424	392	391	425	408	333	321	328	301	323
Hispanic/Latino^b
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	0	0	0	0
15–19	1	2	5	3	1	4	4	6	2	6
20–24	26	20	20	25	17	28	14	21	21	17
25–29	35	36	41	37	43	18	35	22	22	21
30–34	45	51	61	66	48	20	28	36	30	23
35–39	52	45	45	54	48	21	17	25	29	33
40–44	41	28	44	39	45	18	17	21	16	17
45–49	36	33	41	39	24	22	18	18	20	18
50–54	37	42	40	40	30	17	17	16	17	15
55–59	26	25	23	28	22	11	16	8	13	9
60–64	10	11	12	13	14	4	7	7	12	7
≥65	15	14	13	8	11	5	7	3	6	4
Region of residence^a
Northeast	107	99	118	106	89	46	52	47	55	45
Midwest	19	13	17	13	11	10	11	9	9	9
South	104	97	104	119	93	68	71	72	72	67
West	93	98	106	111	112	42	46	52	52	48
Total	323	307	344	349	304	166	180	181	188	170
Native Hawaiian/other Pacific Islander
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	0	0	0	0
15–19	0	0	0	0	0	0	0	0	0	0
20–24	0	0	0	0	0	0	0	0	0	0
25–29	0	0	0	0	1	1	0	0	0	0
30–34	0	0	0	0	0	0	0	0	0	0
35–39	1	0	1	0	0	0	0	0	0	0
40–44	1	0	0	0	0	0	0	0	0	0
45–49	0	0	0	1	0	0	0	0	0	0
50–54	0	0	1	0	0	0	2	0	0	0
55–59	0	0	0	0	0	0	0	0	0	0
60–64	0	0	0	0	0	0	0	0	0	0
≥65	0	0	0	0	0	0	0	0	0	0
Region of residence^a
Northeast	1	0	0	0	0	0	0	0	0	0
Midwest	0	0	0	0	1	0	0	0	0	0
South	0	0	0	0	0	0	0	0	0	0
West	1	0	2	1	0	1	2	0	0	0
Total	2	0	2	1	1	1	2	0	0	0
White
Age at diagnosis (yr)
13–14	0	0	0	0	0	1	0	0	0	0
15–19	1	4	4	3	0	9	5	9	8	7
20–24	40	28	36	37	41	51	42	51	51	42
25–29	80	76	86	98	104	88	94	88	80	86
30–34	77	61	91	106	112	85	68	92	97	104
35–39	52	63	73	110	100	55	59	77	93	94
40–44	49	42	47	61	67	59	44	53	68	72
45–49	65	50	57	48	65	47	42	36	49	54
50–54	55	51	38	51	42	40	38	40	42	36
55–59	32	27	37	32	43	26	18	30	27	36
60–64	20	17	19	20	15	11	15	8	9	14
≥65	11	16	18	8	9	6	9	6	6	4
Region of residence^a
Northeast	74	81	98	115	95	72	87	91	91	80
Midwest	140	83	95	120	103	132	88	91	110	96
South	146	152	194	208	270	195	174	214	215	267
West	122	120	119	133	132	77	84	93	113	106
Total	481	436	506	574	599	476	432	490	530	549
Multiracial
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	0	0	0	0
15–19	0	1	0	1	0	1	1	2	3	2
20–24	3	3	2	4	4	3	3	5	6	2
25–29	5	9	5	6	4	3	6	7	11	10
30–34	8	0	3	4	9	9	3	3	4	3
35–39	1	7	3	4	2	3	8	5	4	6
40–44	2	6	3	4	2	1	4	2	5	6
45–49	2	2	5	2	3	4	7	3	4	3
50–54	7	6	3	7	4	5	5	3	5	5
55–59	4	4	3	3	3	8	6	3	1	3
60–64	2	2	2	1	0	1	0	0	3	1
≥65	3	0	1	0	2	1	1	0	2	1
Region of residence^a
Northeast	9	8	9	6	12	8	9	12	11	8
Midwest	7	3	7	8	6	6	6	5	9	8
South	14	16	9	12	9	15	18	11	17	17
West	7	13	6	12	5	10	11	6	10	6
Total	37	39	30	37	33	38	44	33	46	40
Total
Age at diagnosis (yr)
13–14	0	0	0	0	0	3	2	0	0	0
15–19	6	12	14	13	6	23	18	26	20	21
20–24	96	75	75	87	87	108	81	106	101	91
25–29	157	159	177	189	211	152	176	154	146	161
30–34	180	148	209	230	230	145	137	169	174	170
35–39	148	165	168	228	199	114	119	147	164	181
40–44	144	121	129	139	162	115	92	116	116	130
45–49	149	130	149	139	126	118	100	98	109	110
50–54	168	158	132	149	119	104	115	100	102	88
55–59	125	105	119	113	110	83	80	70	76	76
60–64	65	67	66	71	73	42	49	40	48	46
≥65	59	63	64	50	54	26	32	28	29	32
Region of residence^a
Northeast	323	300	352	352	315	221	219	240	238	221
Midwest	216	153	181	204	184	199	154	163	179	163
South	478	456	486	542	572	436	429	451	452	509
West	278	295	282	310	303	177	197	199	216	212
Total	1,295	1,203	1,301	1,407	1,375	1,033	1,000	1,053	1,084	1,106

Note: Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
Data have been statistically adjusted to account for missing transmission category, therefore values may not sum to column total.
Persons whose transmission category is classified as injection drug use are presented based on sex at birth and include transgender persons.

^aData are based on residence at time of diagnosis of HIV infection.
^bHispanic/Latino persons can be of any race.

Table 6b. Diagnoses of HIV infection attributed to injection drug use, by year of diagnosis and selected characteristics, 2015–2019—United States and 6 dependent areas
	Male					Female
	2015	2016	2017	2018	2019	2015	2016	2017	2018	2019
	No.	No.	No.	No.	No.	No.	No.	No.	No.	No.
American Indian/Alaska Native
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	0	0	0	0
15–19	0	0	0	1	0	0	0	0	0	0
20–24	0	3	0	0	2	1	1	1	0	2
25–29	2	4	6	1	1	2	4	2	2	1
30–34	2	0	3	3	2	2	1	1	3	1
35–39	1	1	0	0	4	1	1	3	3	7
40–44	0	2	2	0	3	1	1	2	0	2
45–49	0	2	0	1	1	2	1	1	1	0
50–54	1	0	3	2	1	0	4	2	2	2
55–59	1	3	0	0	0	2	0	1	1	0
60–64	0	0	1	0	0	1	1	0	1	0
≥65	0	0	1	0	0	0	0	1	0	1
Region of residence^a
Northeast	0	0	1	0	0	0	1	1	0	0
Midwest	0	0	2	3	4	1	1	1	2	4
South	2	3	2	1	3	4	1	4	7	6
West	5	13	11	6	8	9	11	9	5	7
U.S. dependent areas	0	0	0	0	0	0	0	0	0	0
Total	8	16	17	10	15	13	14	15	13	18
Asian
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	0	0	0	0
15–19	0	0	0	0	0	0	0	0	0	0
20–24	0	1	0	1	0	0	1	0	0	0
25–29	1	1	0	1	2	1	1	2	0	1
30–34	7	2	1	2	0	2	1	0	2	2
35–39	2	3	3	0	3	1	1	0	1	1
40–44	4	1	3	3	1	0	0	1	1	1
45–49	2	2	3	1	2	1	1	0	0	1
50–54	2	1	2	1	2	0	0	1	0	0
55–59	0	1	0	0	1	0	0	0	0	0
60–64	1	0	0	1	1	1	1	0	0	0
≥65	1	1	0	0	0	0	0	1	0	0
Region of residence^a
Northeast	8	3	4	5	3	1	1	1	1	1
Midwest	1	2	0	1	3	0	1	0	0	0
South	3	2	2	4	2	2	2	1	2	1
West	8	7	6	1	6	3	3	3	2	4
U.S. dependent areas	1	0	0	1	0	0	0	0	0	0
Total	20	13	12	11	14	5	7	6	5	6
Black/African American
Age at diagnosis (yr)
13–14	0	0	0	0	0	2	2	0	0	0
15–19	4	5	5	5	4	8	8	8	7	7
20–24	26	21	17	21	23	25	20	28	23	27
25–29	34	33	38	47	55	41	36	33	30	43
30–34	41	34	50	48	58	28	36	37	38	37
35–39	40	45	43	60	40	34	34	36	35	42
40–44	47	43	31	34	43	36	25	37	27	32
45–49	44	42	44	46	31	43	30	40	33	33
50–54	66	58	45	48	39	43	49	38	36	29
55–59	61	45	55	50	41	37	39	30	34	28
60–64	33	38	33	35	43	24	26	24	22	23
≥65	29	31	31	33	31	14	15	17	16	22
Region of residence^a
Northeast	125	109	123	121	116	94	70	88	80	87
Midwest	48	51	61	59	56	51	48	56	48	45
South	209	187	176	199	196	153	163	149	139	151
West	42	45	32	46	40	36	40	36	34	41
U.S. dependent areas	0	1	0	1	1	0	0	0	0	0
Total	425	393	391	426	409	334	321	328	301	323
Hispanic/Latino^b
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	0	0	0	0
15–19	2	2	5	3	1	4	4	6	2	6
20–24	27	23	20	25	18	30	15	21	21	17
25–29	39	37	43	39	44	19	36	22	22	21
30–34	52	53	65	68	49	21	29	36	31	23
35–39	58	51	45	55	52	23	19	27	29	34
40–44	47	33	45	43	49	19	19	21	16	17
45–49	42	37	44	42	26	22	19	21	21	20
50–54	47	44	49	45	32	18	19	17	17	16
55–59	32	32	27	29	24	11	16	9	13	10
60–64	13	15	16	15	16	4	9	8	12	7
≥65	17	17	17	11	15	5	7	3	6	4
Region of residence^a
Northeast	107	99	118	106	89	46	52	47	55	45
Midwest	19	13	17	13	11	10	11	9	9	9
South	104	97	104	119	93	68	71	72	72	67
West	93	98	106	111	112	42	46	52	52	48
U.S. dependent areas	51	36	32	23	22	7	12	9	2	5
Total	374	343	376	372	326	173	191	190	189	175
Native Hawaiian/other Pacific Islander
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	0	0	0	0
15–19	0	0	0	0	0	0	0	0	0	0
20–24	0	0	0	0	0	0	0	0	0	0
25–29	0	0	0	0	1	1	0	0	0	0
30–34	0	0	0	0	0	0	0	0	0	0
35–39	1	0	1	0	0	0	0	0	0	0
40–44	1	0	0	0	0	0	0	0	0	0
45–49	0	0	0	1	0	0	0	0	0	0
50–54	0	0	1	0	0	0	2	0	0	0
55–59	0	0	0	0	0	0	0	0	0	0
60–64	0	0	0	0	0	0	0	0	0	0
≥65	0	0	0	0	0	0	0	0	0	0
Region of residence^a
Northeast	1	0	0	0	0	0	0	0	0	0
Midwest	0	0	0	0	1	0	0	0	0	0
South	0	0	0	0	0	0	0	0	0	0
West	1	0	2	1	0	1	2	0	0	0
U.S. dependent areas	0	1	0	0	0	0	0	0	0	0
Total	3	1	2	2	1	1	2	0	0	0
White
Age at diagnosis (yr)
13–14	0	0	0	0	0	1	0	0	0	0
15–19	1	4	4	3	0	9	5	10	8	7
20–24	40	28	36	37	41	51	42	51	51	42
25–29	80	76	86	98	104	88	94	88	80	86
30–34	77	61	91	106	112	85	68	92	97	104
35–39	52	63	73	110	100	55	59	77	93	94
40–44	49	42	47	61	67	59	44	53	68	72
45–49	65	50	57	48	65	47	42	36	49	54
50–54	55	51	38	51	42	40	38	40	42	36
55–59	32	27	37	32	43	26	18	30	27	36
60–64	20	17	19	20	15	11	15	8	9	14
≥65	11	16	18	8	9	6	9	6	6	4
Region of residence^a
Northeast	74	81	98	115	95	72	87	91	91	80
Midwest	140	83	95	120	103	132	88	91	110	96
South	146	152	194	208	270	195	174	214	215	267
West	122	120	119	133	132	77	84	93	113	106
U.S. dependent areas	0	0	0	0	0	0	0	0	0	0
Total	481	436	506	574	599	476	432	490	530	549
Multiracial
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	0	0	0	0
15–19	0	1	0	1	0	1	1	2	3	2
20–24	3	3	2	4	4	3	3	5	6	2
25–29	5	9	5	6	4	3	6	7	11	10
30–34	8	0	3	4	9	9	3	3	4	3
35–39	1	7	3	4	2	3	8	5	4	6
40–44	2	6	3	4	2	1	4	2	5	6
45–49	2	2	5	2	3	4	7	3	4	3
50–54	7	6	3	7	4	5	5	3	5	5
55–59	4	4	3	3	3	8	6	3	1	3
60–64	2	2	2	2	0	1	0	0	3	1
≥65	3	0	1	0	2	1	1	0	2	1
Region of residence^a
Northeast	9	8	9	6	12	8	9	12	11	8
Midwest	7	3	7	8	6	6	6	5	9	8
South	14	16	9	12	9	15	18	11	17	17
West	7	13	6	12	5	10	11	6	10	6
U.S. dependent areas	0	0	0	0	0	0	0	0	0	0
Total	37	39	30	37	33	38	44	33	46	40
Total
Age at diagnosis (yr)
13–14	0	0	0	0	0	3	2	0	0	0
15–19	7	12	14	14	6	23	18	26	20	21
20–24	97	78	75	87	87	109	82	106	101	91
25–29	161	160	179	191	212	153	177	154	146	161
30–34	187	150	213	232	230	146	138	169	175	170
35–39	155	171	168	229	203	116	121	149	164	182
40–44	150	126	131	144	166	116	94	116	116	130
45–49	155	135	152	142	128	118	101	101	109	112
50–54	178	160	141	155	121	105	117	101	102	89
55–59	131	112	123	114	113	83	80	71	76	77
60–64	67	72	70	73	75	42	51	41	48	46
≥65	61	65	68	52	57	27	32	28	29	32
Region of residence^a
Northeast	323	300	352	352	315	221	219	240	238	221
Midwest	216	153	181	204	184	199	154	163	179	163
South	478	456	486	542	572	436	429	451	452	509
West	278	295	282	310	303	177	197	199	216	212
U.S. dependent areas	53	38	32	25	23	7	12	9	2	5
Total	1,348	1,241	1,333	1,432	1,397	1,040	1,011	1,062	1,086	1,111

Note: Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
Data have been statistically adjusted to account for missing transmission category, therefore values may not sum to column total.
Persons whose transmission category is classified as injection drug use are presented based on sex at birth and include transgender persons.

^aData are based on residence at time of diagnosis of HIV infection.
^bHispanic/Latino persons can be of any race.

Table 7a. Diagnoses of HIV infection attributed to heterosexual contact, by year of diagnosis, race/ethnicity and selected characteristics, 2015–2019—United States
	Male					Female
	2015	2016	2017	2018	2019	2015	2016	2017	2018	2019
	No.	No.	No.	No.	No.	No.	No.	No.	No.	No.
American Indian/Alaska Native
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	0	0	0	0
15–19	0	0	0	1	0	1	0	0	1	1
20–24	1	0	0	1	2	2	0	2	1	2
25–29	0	0	1	1	0	6	4	5	2	2
30–34	1	1	2	1	1	6	3	2	1	4
35–39	1	1	3	1	0	5	7	5	2	6
40–44	0	1	0	0	2	5	6	3	3	6
45–49	3	1	0	0	0	3	3	6	3	3
50–54	2	1	0	1	1	2	1	5	2	2
55–59	1	0	1	1	1	2	2	1	2	1
60–64	0	0	0	0	0	0	1	2	0	1
≥65	0	1	0	0	0	1	1	0	0	1
Region of residence^a
Northeast	2	0	0	1	0	1	3	0	0	0
Midwest	1	1	0	1	2	6	1	4	1	10
South	2	2	4	2	5	13	9	5	7	5
West	4	5	4	3	1	11	14	22	7	12
Total	9	8	8	8	8	32	27	30	16	27
Asian
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	1	0	0	0
15–19	0	0	0	0	1	2	0	1	0	2
20–24	0	3	2	5	0	14	9	7	7	7
25–29	6	1	2	1	3	16	19	19	17	8
30–34	4	9	4	8	2	18	29	8	16	16
35–39	16	14	10	9	2	18	25	25	10	15
40–44	9	4	4	11	5	16	15	10	12	6
45–49	8	8	6	6	4	9	11	12	7	14
50–54	7	5	2	5	6	7	10	11	8	4
55–59	5	4	2	3	3	3	8	7	9	8
60–64	1	4	4	5	3	7	4	7	4	7
≥65	4	5	3	5	3	4	5	4	6	5
Region of residence^a
Northeast	9	8	9	14	11	20	32	18	28	12
Midwest	7	11	6	3	1	17	12	18	6	12
South	24	23	11	23	11	38	41	29	24	30
West	20	17	14	19	7	39	49	44	37	37
Total	60	59	39	59	31	114	134	109	94	90
Black/African American
Age at diagnosis (yr)
13–14	1	0	0	0	0	7	6	5	3	5
15–19	29	40	23	31	28	148	140	139	134	95
20–24	166	154	128	114	121	437	390	407	393	389
25–29	237	251	199	225	174	508	548	505	476	454
30–34	207	230	195	236	190	517	515	521	455	464
35–39	222	234	221	210	182	526	534	482	447	417
40–44	253	229	186	165	170	418	414	401	417	369
45–49	249	221	185	168	193	387	424	389	355	325
50–54	261	227	201	201	179	376	375	336	328	323
55–59	213	182	184	165	159	281	304	294	293	278
60–64	128	122	129	105	128	171	188	196	167	196
≥65	108	119	114	108	123	134	124	169	130	159
Region of residence^a
Northeast	385	347	324	267	247	699	669	656	562	534
Midwest	196	195	188	204	190	490	503	515	484	491
South	1,396	1,376	1,190	1,182	1,142	2,468	2,498	2,432	2,269	2,185
West	96	91	63	75	65	254	292	240	283	261
Total	2,073	2,009	1,765	1,728	1,644	3,911	3,962	3,844	3,599	3,471
Hispanic/Latino^b
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	1	2	3	4
15–19	7	5	8	7	7	47	34	40	35	37
20–24	32	55	30	31	27	142	115	125	107	117
25–29	54	79	72	67	79	147	155	163	157	154
30–34	89	92	82	88	74	154	182	155	155	152
35–39	110	91	85	89	72	155	141	139	171	127
40–44	84	84	85	75	75	138	133	115	118	126
45–49	70	86	61	80	59	112	110	133	125	101
50–54	65	57	58	70	55	122	107	98	115	97
55–59	46	39	42	48	37	63	76	74	83	64
60–64	26	32	32	21	36	35	43	44	52	51
≥65	34	25	29	32	24	30	41	38	45	44
Region of residence^a
Northeast	151	162	139	141	108	278	304	259	238	219
Midwest	39	41	30	36	33	53	58	62	58	69
South	346	337	320	346	317	590	547	581	628	551
West	81	106	95	84	86	225	228	223	241	235
Total	616	645	583	606	544	1,146	1,137	1,126	1,165	1,074
Native Hawaiian/other Pacific Islander
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	0	0	0	0
15–19	0	0	0	0	0	0	0	0	1	1
20–24	0	0	0	0	0	2	1	0	0	1
25–29	0	0	1	0	1	0	0	2	0	2
30–34	0	0	1	2	0	1	1	3	2	1
35–39	2	1	0	0	0	0	1	2	0	2
40–44	0	0	0	0	0	0	0	0	0	1
45–49	1	1	1	0	0	0	0	0	0	0
50–54	1	0	0	0	0	1	1	0	1	1
55–59	0	0	0	0	0	1	0	1	1	0
60–64	0	0	0	0	0	0	0	0	0	0
≥65	0	0	1	0	0	0	0	0	0	0
Region of residence^a
Northeast	0	0	1	1	0	0	0	1	1	0
Midwest	0	1	0	0	0	2	0	0	0	4
South	0	1	1	1	0	1	0	2	1	1
West	5	0	2	0	1	2	4	5	3	4
Total	5	3	4	2	2	5	4	8	5	9
White
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	0	1	2	0
15–19	2	4	5	2	4	18	31	28	32	33
20–24	14	32	16	20	18	88	104	97	89	95
25–29	37	35	47	50	49	115	132	108	123	129
30–34	33	46	49	60	44	114	138	128	123	133
35–39	31	47	45	51	42	99	109	110	112	126
40–44	50	51	50	44	45	100	90	81	104	94
45–49	64	46	51	49	53	105	103	108	101	105
50–54	45	75	62	44	51	102	101	97	96	95
55–59	44	52	48	51	49	86	89	101	70	78
60–64	37	35	35	41	24	32	55	40	39	46
≥65	49	42	35	29	28	24	23	23	26	21
Region of residence^a
Northeast	76	98	84	83	65	121	126	116	111	113
Midwest	48	50	52	57	63	156	160	154	166	179
South	221	250	232	237	213	466	498	493	478	482
West	60	67	74	65	66	139	191	159	163	181
Total	406	465	442	441	407	882	975	922	917	954
Multiracial
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	0	1	0	0
15–19	3	0	1	1	0	10	7	5	12	9
20–24	8	8	4	3	2	21	31	27	15	15
25–29	9	12	8	8	8	26	22	20	25	30
30–34	8	5	12	13	4	30	28	25	26	23
35–39	6	19	8	5	3	29	27	21	20	20
40–44	7	11	11	4	5	16	16	12	11	17
45–49	9	8	8	7	6	27	24	18	20	17
50–54	11	9	4	9	4	24	14	13	9	15
55–59	9	8	5	1	6	14	15	10	9	5
60–64	3	4	6	3	2	7	5	3	10	6
≥65	8	3	4	4	7	3	9	5	8	6
Region of residence^a
Northeast	24	26	19	19	13	54	41	40	35	37
Midwest	8	12	9	6	13	21	39	22	21	30
South	40	43	38	31	20	111	99	72	82	76
West	8	6	6	2	3	21	20	25	25	19
Total	81	87	71	59	49	208	199	159	163	162
Total
Age at diagnosis (yr)
13–14	1	0	0	0	0	7	8	8	7	9
15–19	40	49	37	43	40	226	212	213	216	178
20–24	221	253	180	174	171	706	651	664	611	625
25–29	343	378	331	353	314	819	879	822	799	779
30–34	342	384	345	408	315	841	896	842	777	793
35–39	388	407	372	364	300	833	844	783	762	711
40–44	402	380	335	299	301	692	673	623	665	618
45–49	404	372	313	311	315	642	674	666	610	565
50–54	392	375	326	329	296	634	609	559	557	536
55–59	318	284	282	269	256	450	493	489	467	433
60–64	195	198	205	175	193	252	296	292	272	306
≥65	202	196	186	179	185	196	203	239	215	235
Region of residence^a
Northeast	647	642	575	526	444	1,173	1,176	1,091	974	915
Midwest	299	311	285	306	302	745	773	776	735	793
South	2,030	2,031	1,796	1,824	1,709	3,688	3,691	3,614	3,490	3,330
West	273	292	257	247	229	692	797	718	759	749
Total	3,249	3,275	2,913	2,903	2,685	6,298	6,437	6,198	5,958	5,787

Note: Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
Data have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
Persons whose transmission category is classified as heterosexual contact are presented based on sex at birth and includes transgender persons.
Persons whose transmission category is classified as heterosexual contact are persons who have ever had heterosexual contact with a person known to have, or with a risk factor for, HIV infection (e.g., a person who injects drugs). The heterosexual contact category excludes men who have ever had sexual contact with both men and women.

^aData are based on residence at time of diagnosis of HIV infection.
^bHispanic/Latino persons can be of any race.

Table 7b. Diagnoses of HIV infection attributed to heterosexual contact, by year of diagnosis, race/ethnicity and selected characteristics, 2015–2019—United States and 6 dependent areas
	Male					Female
	2015	2016	2017	2018	2019	2015	2016	2017	2018	2019
	No.	No.	No.	No.	No.	No.	No.	No.	No.	No.
American Indian/Alaska Native
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	0	0	0	0
15–19	0	0	0	1	0	1	0	0	1	1
20–24	1	0	0	1	2	2	0	2	1	2
25–29	0	0	1	1	0	6	4	5	2	2
30–34	1	1	2	1	1	6	3	2	1	4
35–39	1	1	3	1	0	5	7	5	2	6
40–44	0	1	0	0	2	5	6	3	3	6
45–49	3	1	0	0	0	3	3	6	3	3
50–54	2	1	0	1	1	2	1	5	2	2
55–59	1	0	1	1	1	2	2	1	2	1
60–64	0	0	0	0	0	0	1	2	0	1
≥65	0	1	0	0	0	1	1	0	0	1
Region of residence^a
Northeast	2	0	0	1	0	1	3	0	0	0
Midwest	1	1	0	1	2	6	1	4	1	10
South	2	2	4	2	5	13	9	5	7	5
West	4	5	4	3	1	11	14	22	7	12
U.S. dependent areas	0	0	0	0	0	0	0	0	0	0
Total	9	8	8	8	8	32	27	30	16	27
Asian
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	1	0	0	0
15–19	0	0	0	0	1	2	0	1	0	2
20–24	0	3	2	5	0	14	9	7	7	7
25–29	6	1	2	1	3	16	19	19	17	8
30–34	4	9	4	8	2	18	29	8	16	16
35–39	16	14	10	9	2	18	25	25	10	15
40–44	9	4	4	11	5	16	15	10	12	6
45–49	8	8	6	6	4	9	11	12	7	14
50–54	7	5	2	5	6	7	10	11	8	4
55–59	5	4	2	3	3	3	8	7	9	8
60–64	1	4	4	5	3	7	4	7	4	7
≥65	4	5	3	5	3	4	5	4	6	5
Region of residence^a
Northeast	9	8	9	14	11	20	32	18	28	12
Midwest	7	11	6	3	1	17	12	18	6	12
South	24	23	11	23	11	38	41	29	24	30
West	20	17	14	19	7	39	49	44	37	37
U.S. dependent areas	0	0	0	0	0	0	0	0	0	0
Total	60	59	39	59	31	114	134	109	94	90
Black/African American
Age at diagnosis (yr)
13–14	1	0	0	0	0	7	6	5	3	5
15–19	29	40	23	31	28	148	140	139	134	95
20–24	166	154	128	114	121	437	390	407	393	389
25–29	237	251	199	226	174	510	548	505	476	454
30–34	207	230	195	236	190	517	515	522	455	464
35–39	222	234	221	210	182	526	534	482	447	417
40–44	253	229	186	166	170	418	414	401	417	369
45–49	249	222	185	168	193	387	424	390	355	326
50–54	261	227	201	201	179	376	375	336	328	323
55–59	213	182	184	165	159	281	304	294	293	278
60–64	128	123	129	105	128	171	188	196	167	196
≥65	108	119	114	108	124	136	124	169	130	159
Region of residence^a
Northeast	385	347	324	267	247	699	669	656	562	534
Midwest	196	195	188	204	190	490	503	515	484	491
South	1,396	1,376	1,190	1,182	1,142	2,468	2,498	2,432	2,269	2,185
West	96	91	63	75	65	254	292	240	283	261
U.S. dependent areas	0	2	0	2	2	4	0	2	0	2
Total	2,073	2,011	1,765	1,731	1,646	3,915	3,962	3,846	3,599	3,473
Hispanic/Latino^b
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	1	2	3	4
15–19	7	5	9	7	7	49	36	43	37	37
20–24	38	56	38	34	31	150	120	130	115	121
25–29	61	83	77	75	83	156	160	175	164	160
30–34	96	98	91	97	80	160	190	160	161	161
35–39	120	100	96	94	76	164	157	149	175	131
40–44	90	98	95	77	81	153	147	122	126	140
45–49	87	104	67	84	71	127	124	144	139	108
50–54	78	68	65	84	59	135	114	108	127	101
55–59	53	49	49	52	48	75	90	84	91	76
60–64	29	42	41	25	43	36	49	48	57	56
≥65	43	42	39	41	33	40	43	42	51	52
Region of residence^a
Northeast	151	162	139	141	108	278	304	259	238	219
Midwest	39	41	30	36	33	53	58	62	58	69
South	346	337	320	346	317	590	547	581	628	551
West	81	106	95	84	86	225	228	223	241	235
U.S. dependent areas	86	100	83	63	67	100	93	81	80	73
Total	702	745	666	669	611	1,246	1,230	1,207	1,245	1,147
Native Hawaiian/other Pacific Islander
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	0	0	0	0
15–19	0	0	0	0	0	0	0	0	1	1
20–24	0	0	1	0	0	2	1	0	0	2
25–29	0	0	1	0	1	0	0	2	0	2
30–34	0	0	1	2	0	1	1	3	2	1
35–39	2	1	0	0	0	0	1	2	0	2
40–44	0	0	0	0	0	0	0	0	0	1
45–49	1	1	1	0	0	0	0	0	0	0
50–54	2	0	0	0	0	1	1	0	1	1
55–59	0	0	0	0	0	1	0	1	1	0
60–64	0	0	0	0	0	0	0	0	0	0
≥65	0	0	1	0	0	0	0	0	0	0
Region of residence^a
Northeast	0	0	1	1	0	0	0	1	1	0
Midwest	0	1	0	0	0	2	0	0	0	4
South	0	1	1	1	0	1	0	2	1	1
West	5	0	2	0	1	2	4	5	3	4
U.S. dependent areas	0	0	1	0	0	0	0	0	0	1
Total	5	3	5	3	2	5	4	8	5	10
White
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	0	1	2	0
15–19	2	4	5	2	4	18	31	28	32	33
20–24	14	32	16	20	18	88	104	97	89	95
25–29	37	35	47	50	49	115	132	108	123	129
30–34	33	46	49	60	44	114	138	128	123	133
35–39	31	47	45	51	42	99	109	110	112	126
40–44	50	51	50	44	45	100	90	81	104	94
45–49	64	46	51	49	54	105	103	108	101	105
50–54	45	75	62	44	51	102	101	98	96	95
55–59	44	52	48	51	49	86	89	101	70	78
60–64	37	35	35	41	24	32	55	40	39	46
≥65	49	42	35	29	28	24	23	23	26	21
Region of residence^a
Northeast	76	98	84	83	65	121	126	116	111	113
Midwest	48	50	52	57	63	156	160	154	166	179
South	221	250	232	237	213	466	498	493	478	482
West	60	67	74	65	66	139	191	159	163	181
U.S. dependent areas	0	0	0	0	1	0	0	2	0	0
Total	406	465	442	441	408	882	975	924	917	954
Multiracial
Age at diagnosis (yr)
13–14	0	0	0	0	0	0	0	1	0	0
15–19	3	0	1	1	0	10	7	5	12	9
20–24	8	8	4	3	2	22	31	27	15	15
25–29	9	12	8	8	8	26	22	20	25	30
30–34	8	5	12	13	4	30	28	25	26	23
35–39	6	19	8	6	3	29	27	21	20	20
40–44	7	11	11	4	5	16	16	12	11	17
45–49	9	8	8	7	6	27	24	18	20	17
50–54	11	9	4	9	4	24	14	13	9	15
55–59	9	8	5	1	6	14	15	10	9	5
60–64	3	4	6	4	2	7	5	3	10	6
≥65	8	3	4	4	7	3	9	5	8	6
Region of residence^a
Northeast	24	26	19	19	13	54	41	40	35	37
Midwest	8	12	9	6	13	21	39	22	21	30
South	40	43	38	31	20	111	99	72	82	76
West	8	6	6	2	3	21	20	25	25	19
U.S. dependent areas	0	0	0	2	0	1	0	0	0	0
Total	81	87	71	60	49	209	199	159	163	162
Total
Age at diagnosis (yr)
13–14	1	0	0	0	0	7	8	8	7	9
15–19	40	49	38	43	40	228	214	216	218	178
20–24	226	254	189	177	174	715	656	669	619	630
25–29	351	382	335	362	317	830	884	834	806	785
30–34	349	390	354	417	322	847	904	848	783	802
35–39	398	416	384	370	304	842	860	793	766	715
40–44	409	394	346	302	308	707	687	630	673	632
45–49	421	390	318	315	328	657	688	678	624	573
50–54	406	386	333	343	300	647	616	570	569	541
55–59	325	294	289	273	267	462	507	499	475	445
60–64	198	209	214	180	200	253	301	295	277	311
≥65	212	213	197	188	195	208	205	243	221	243
Region of residence^a
Northeast	647	642	575	526	444	1,173	1,176	1,091	974	915
Midwest	299	311	285	306	302	745	773	776	735	793
South	2,030	2,031	1,796	1,824	1,709	3,688	3,691	3,614	3,490	3,330
West	273	292	257	247	229	692	797	718	759	749
U.S. dependent areas	86	102	85	67	70	105	93	85	80	76
Total	3,335	3,377	2,997	2,970	2,754	6,402	6,530	6,283	6,037	5,863

Note: Numbers less than 12, and trends based on these numbers, should be interpreted with caution.
Data have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
Persons whose transmission category is classified as heterosexual contact are presented based on sex at birth and includes transgender persons.
Persons whose transmission category is classified as heterosexual contact are persons who have ever had heterosexual contact with a person known to have, or with a risk factor for, HIV infection (e.g., a person who injects drugs). The heterosexual contact category excludes men who have ever had sexual contact with both men and women.

^aData are based on residence at time of diagnosis of HIV infection.
^bHispanic/Latino persons can be of any race.

Table 8a. Diagnoses of HIV infection among adolescents and young adults, by 2-year and 3-year age groups, and selected characteristics, 2019—United States
	13–14 years of age at diagnosis		15–17 years of age at diagnosis		18–19 years of age at diagnosis		20–22 years of age at diagnosis		23–24 years of age at diagnosis		Total
	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a
Gender
Male	12	—	301	—	1,099	—	2,833	—	2,202	—	6,447	—
Female	9	—	71	—	131	—	392	—	323	—	926	—
Transgender male-to-female^b	0	—	10	—	25	—	110	—	48	—	193	—
Transgender female-to-male^b	0	—	0	—	0	—	9	—	2	—	11	—
Additional gender identity^c	0	—	0	—	3	—	5	—	3	—	11	—
Race/Ethnicity
American Indian/Alaska Native	0	0.0	1	1.0	8	11.0	20	18.4	17	23.2	46	10.7
Asian	0	0.0	6	0.9	16	3.5	55	7.7	47	8.7	124	4.4
Black/African American	14	1.2	224	13.3	707	58.6	1,775	98.0	1,203	96.3	3,923	55.3
Hispanic/Latino^d	6	0.3	102	3.4	339	16.8	894	30.7	753	38.9	2,094	17.5
Native Hawaiian/Other Pacific Islander	0	0.0	0	0.0	2	12.0	4	15.9	4	22.3	10	9.9
White	1	0.0	40	0.6	149	3.3	517	7.5	483	10.3	1,190	4.4
Multiracial	0	0.0	9	2.0	37	12.6	84	20.3	71	27.4	201	11.4
Transmission Category^e
Males
Male-to-male sexual contact	11	—	286	—	1,066	—	2,746	—	2,009	—	6,118	—
Injection drug use	0	—	1	—	4	—	34	—	53	—	92	—
Male-to-male sexual contact and injection drug use	0	—	8	—	25	—	85	—	99	—	217	—
Heterosexual contact^f	0	—	11	—	28	—	80	—	91	—	210	—
Perinatal^g	1	—	5	—	1	—	2	—	2	—	12	—
Other^h	0	—	0	—	0	—	0	—	0	—	1	—
Subtotal	12	0.3	311	4.9	1,126	25.7	2,948	44.9	2,253	50.1	6,650	25.5
Females
Injection drug use	0	—	10	—	12	—	43	—	48	—	112	—
Heterosexual contact^f	9	—	59	—	119	—	352	—	273	—	812	—
Perinatal^g	0	—	3	—	1	—	6	—	4	—	14	—
Other^h	0	—	0	—	0	—	0	—	0	—	0	—
Subtotal	9	0.2	71	1.2	132	3.1	401	6.4	325	7.6	938	3.8
Region of Residenceⁱ
Northeast	5	0.4	49	2.4	159	10.8	446	20.6	312	21.5	971	11.5
Midwest	4	0.2	56	2.1	177	9.8	475	17.2	375	20.5	1,087	10.1
South	9	0.3	229	4.8	750	22.8	1,840	37.7	1,408	42.3	4,236	21.6
West	3	0.1	48	1.6	172	8.6	588	19.4	483	22.1	1,294	10.6
Total	21	0.3	382	3.1	1,258	14.7	3,349	26.1	2,578	29.3	7,588	14.9

Note: Numbers less than 12, and rates based on these numbers, should be interpreted with caution.

^aRates are per 100,000 population. Rates are not calculated by transmission category because of the lack of denominator data.
^bTransgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
^cAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
^dHispanic/Latino persons can be of any race.
^eData have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
^fHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
^gIndividuals were ≥13 years of age at time of diagnosis of HIV infection.
^hIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
ⁱData are based on residence at time of diagnosis of HIV infection.

Table 8b. Diagnoses of HIV infection among adolescents and young adults, by 2-year and 3-year age groups, and selected characteristics, 2019—United States and 6 dependent areas
	13–14 years of age at diagnosis	15–17 years of age at diagnosis	18–19 years of age at diagnosis	20–22 years of age at diagnosis	23–24 years of age at diagnosis	Total
	No.	No.	No.	No.	No.	No.
Gender
Male	12	301	1,105	2,858	2,225	6,501
Female	9	71	131	395	325	931
Transgender male-to-female^a	0	10	25	111	48	194
Transgender female-to-male^a	0	0	0	9	2	11
Additional gender identity^b	0	0	3	5	3	11
Race/Ethnicity
American Indian/Alaska Native	0	1	8	20	17	46
Asian	0	6	16	55	47	124
Black/African American	14	224	707	1,776	1,203	3,924
Hispanic/Latino^c	6	102	345	921	778	2,152
Native Hawaiian/Other Pacific Islander	0	0	2	5	4	11
White	1	40	149	517	483	1,190
Multiracial	0	9	37	84	71	201
Transmission Category^d
Males
Male-to-male sexual contact	11	286	1,072	2,767	2,030	6,165
Injection drug use	0	1	4	34	53	93
Male-to-male sexual contact and injection drug use	0	8	25	87	100	220
Heterosexual contact^e	0	11	28	83	91	214
Perinatal^f	1	5	1	2	2	12
Other^g	0	0	0	0	0	1
Subtotal	12	311	1,132	2,974	2,276	6,705
Females
Injection drug use	0	10	12	43	48	112
Heterosexual contact^e	9	59	119	355	275	817
Perinatal^f	0	3	1	6	4	14
Other^g	0	0	0	0	0	0
Subtotal	9	71	132	404	327	943
Region of Residence^h
Northeast	5	49	159	446	312	971
Midwest	4	56	177	475	375	1,087
South	9	229	750	1,840	1,408	4,236
West	3	48	172	588	483	1,294
U.S. dependent areas	0	0	6	29	25	60
Total	21	382	1,264	3,378	2,603	7,648

Note: Numbers less than 12 should be interpreted with caution.

^aTransgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
^bAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
^cHispanic/Latino persons can be of any race.
^dData have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
^eHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
^fIndividuals were ≥13 years of age at time of diagnosis of HIV infection.
^gIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
^hData are based on residence at time of diagnosis of HIV infection.

Table 9a. Diagnoses of HIV infection among children aged less than 13 years, by year of diagnosis and race/ethnicity, 2015–2019—United States
	2015		2016		2017		2018		2019
Race/ethnicity	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a
American Indian/Alaska Native	2	0.4	0	0.0	0	0.0	0	0.0	1	0.2
Asian	11	0.4	8	0.3	6	0.2	5	0.2	5	0.2
Black/African American	87	1.2	78	1.1	57	0.8	52	0.7	35	0.5
Hispanic/Latino^b	13	0.1	18	0.1	16	0.1	10	0.1	8	0.1
Native Hawaiian/other Pacific Islander	0	0.0	0	0.0	1	0.9	0	0.0	0	0.0
White	17	0.1	17	0.1	16	0.1	16	0.1	7	0.0
Multiracial	12	0.5	7	0.3	8	0.3	6	0.2	5	0.2
Total	142	0.3	128	0.2	104	0.2	89	0.2	61	0.1

Note: Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.

^aRates are per 100,000 population.
^bHispanic/Latino persons can be of any race.

Table 9b. Diagnoses of HIV infection among children aged less than 13 years, by year of diagnosis and race/ethnicity, 2015–2019—United States and 6 dependent areas
	2015	2016	2017	2018	2019
Race/ethnicity	No.	No.	No.	No.	No.
American Indian/Alaska Native	2	0	0	0	1
Asian	11	8	6	5	5
Black/African American	87	78	57	52	35
Hispanic/Latino^a	13	18	16	10	8
Native Hawaiian/other Pacific Islander	0	0	1	0	0
White	17	17	16	16	7
Multiracial	12	7	8	6	5
Total	142	128	104	89	61

Note: Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.

^aHispanic/Latino persons can be of any race.

Table 10. Diagnoses of HIV infection among adult and adolescent Hispanic/Latino persons, by transmission category and place of birth, 2019—United States and 6 dependent areas
	Central America		Cuba		Mexico		Puerto Rico		South America		United States		Total
Transmission category^a	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.^b	%
Male adult or adolescent^c
Male-to-male sexual contact	431	82.2	275	89.4	804	88.3	302	68.5	654	91.6	2,598	84.7	7,820	85.3
Injection drug use	14	2.7	1	0.3	20	2.2	41	9.3	4	0.5	120	3.9	326	3.6
Male-to-male sexual contact and injection drug use	10	2.0	3	0.9	20	2.2	13	2.9	9	1.3	197	6.4	403	4.4
Heterosexual contact^d	69	13.1	29	9.4	65	7.2	84	19.1	46	6.4	147	4.8	611	6.7
Perinatal^e	0	0.0	0	0.0	0	0.0	0	0.0	1	0.2	2	0.1	3	0.0
Other^f	0	0.1	0	0.0	1	0.1	0	0.1	0	0.1	2	0.1	6	0.1
Subtotal	524	100	308	100	910	100	441	100	714	100	3,066	100	9,168	100
Female adult or adolescent^c
Injection drug use	5	4.0	3	5.8	4	4.6	9	8.3	3	4.8	82	19.7	175	13.2
Heterosexual contact^d	123	95.0	41	94.2	87	95.2	94	91.7	66	95.1	334	80.2	1,147	86.5
Perinatal^e	1	0.9	0	0.0	0	0.2	0	0.1	0	0.1	0	0.1	4	0.3
Other^f	0	0.2	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0
Subtotal	129	100	43	100	91	100	103	100	69	100	416	100	1,326	100
Total	653	100	351	100	1,001	100	544	100	783	100	3,482	100	10,494	100

Note: Numbers less than 12, and percentages based on these numbers, should be interpreted with caution. Hispanic/Latino persons can be of any race.

^aData have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
^bTotal includes persons whose place of birth is not among those listed and persons whose place of birth is unknown.
^cData presented based on sex at birth and includes transgender persons.
^dHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
^eIndividuals were ≥13 years of age at time of diagnosis of HIV infection.
^fIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.

Table 11a. Deaths of persons with diagnosed HIV infection, by year of death and selected characteristics, 2015–2019—United States
	2015		2016		2017		2018		2019
	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a
Gender
Male	11,850	—	12,241	—	12,257	—	12,068	—	11,701	—
Female	3,891	—	4,025	—	3,992	—	3,986	—	3,624	—
Transgender male-to-female^b	108	—	121	—	104	—	119	—	134	—
Transgender female-to-male^b	5	—	2	—	4	—	3	—	5	—
Additional gender identity^c	1	—	0	—	1	—	1	—	1	—
Age at death (yr)
<13	4	0.0	2	0.0	2	0.0	1	0.0	2	0.0
13–14	0	0.0	1	0.0	0	0.0	0	0.0	1	0.0
15–19	11	0.1	10	0.0	7	0.0	9	0.0	11	0.1
20–24	150	0.7	156	0.7	143	0.6	121	0.6	116	0.5
25–29	399	1.8	447	2.0	446	1.9	418	1.8	403	1.7
30–34	591	2.7	659	3.0	601	2.7	609	2.8	636	2.8
35–39	817	4.0	835	4.0	867	4.1	814	3.8	801	3.7
40–44	1,224	6.1	1,131	5.7	968	4.9	950	4.8	880	4.4
45–49	1,998	9.6	1,809	8.7	1,737	8.3	1,599	7.7	1,334	6.5
50–54	2,939	13.2	2,840	13.0	2,732	12.8	2,581	12.4	2,128	10.4
55–59	2,840	13.1	2,996	13.7	2,972	13.5	2,925	13.3	2,772	12.7
60–64	2,159	11.4	2,415	12.4	2,490	12.5	2,522	12.4	2,546	12.4
≥65	2,723	5.7	3,088	6.3	3,393	6.7	3,628	6.9	3,835	7.1
Race/ethnicity
American Indian/Alaska Native	61	2.6	47	2.0	46	1.9	48	2.0	51	2.1
Asian^d	81	0.5	101	0.6	88	0.5	85	0.5	95	0.5
Black/African American	7,129	17.9	7,246	18.0	7,197	17.7	6,978	17.1	6,633	16.1
Hispanic/Latino^e	2,518	4.5	2,628	4.6	2,688	4.6	2,821	4.7	2,703	4.5
Native Hawaiian/other Pacific Islander	7	1.3	14	2.5	9	1.6	13	2.2	14	2.3
White	5,022	2.5	5,320	2.7	5,254	2.7	5,147	2.6	4,922	2.5
Multiracial	1,031	15.7	1,030	15.3	1,074	15.5	1,085	15.3	1,043	14.3
Transmission category^f
Male adult or adolescent^g
Male-to-male sexual contact	6,566	—	6,897	—	7,005	—	6,876	—	6,855	—
Injection drug use	2,288	—	2,272	—	2,168	—	2,187	—	1,965	—
Male-to-male sexual contact and injection drug use	1,400	—	1,397	—	1,370	—	1,427	—	1,304	—
Heterosexual contact^h	1,597	—	1,692	—	1,711	—	1,589	—	1,614	—
Perinatalⁱ	28	—	40	—	41	—	51	—	39	—
Other^j	76	—	62	—	66	—	57	—	58	—
Subtotal	11,956	9.1	12,361	9.4	12,361	9.3	12,187	9.1	11,834	8.8
Female adult or adolescent^g
Injection drug use	1,353	—	1,384	—	1,373	—	1,319	—	1,221	—
Heterosexual contact^h	2,468	—	2,567	—	2,551	—	2,607	—	2,352	—
Perinatalⁱ	46	—	48	—	43	—	36	—	35	—
Other^j	28	—	26	—	28	—	27	—	21	—
Subtotal	3,895	2.8	4,026	2.9	3,995	2.9	3,989	2.8	3,629	2.6
Child (<13 yrs at death)
Perinatal	2	—	1	—	2	—	1	—	1	—
Other^j	2	—	1	—	0	—	0	—	1	—
Subtotal	4	0.0	2	0.0	2	0.0	1	0.0	2	0.0
Region of residence^k
Northeast	3,613	6.4	3,711	6.6	3,699	6.6	3,535	6.3	3,450	6.2
Midwest	1,821	2.7	1,858	2.7	1,911	2.8	2,000	2.9	1,850	2.7
South	7,812	6.5	8,056	6.6	8,009	6.5	7,848	6.3	7,518	6.0
West	2,609	3.4	2,764	3.6	2,739	3.5	2,794	3.6	2,647	3.4
Total^l	15,855	4.9	16,389	5.1	16,358	5.0	16,177	5.0	15,465	4.7

Note: Deaths of persons with a diagnosis of HIV infection may be due to any cause. Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.

^aRates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data.
^bTransgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
^cAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
^dIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
^eHispanic/Latino persons can be of any race.
^fData have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
^gData presented based on sex at birth and includes transgender persons.
^hHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
ⁱIncludes individuals ≥13 years of age at time of diagnosis of HIV infection.
^jIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
^kData are based on residence at death. When information on residence at death was not available, state at death (where a person’s death occurred) was used.
^lIncludes persons whose race/ethnicity is unknown.

Table 11b. Deaths of persons with diagnosed HIV infection, by year of death and selected characteristics, 2015–2019—United States and 6 dependent areas
	2015		2016		2017		2018		2019
	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a
Gender
Male	12,152	—	12,565	—	12,557	—	12,361	—	11,970	—
Female	3,998	—	4,120	—	4,100	—	4,062	—	3,705	—
Transgender male-to-female^b	108	—	121	—	106	—	120	—	136	—
Transgender female-to-male^b	5	—	2	—	4	—	3	—	5	—
Additional gender identity^c	1	—	0	—	1	—	1	—	1	—
Age at death (yr)
<13	4	0.0	2	0.0	2	0.0	1	0.0	2	0.0
13–14	0	0.0	1	0.0	0	0.0	0	0.0	1	0.0
15–19	11	0.1	11	0.1	7	0.0	9	0.0	11	0.1
20–24	152	0.7	160	0.7	145	0.7	125	0.6	118	0.5
25–29	404	1.8	454	2.0	452	1.9	426	1.8	410	1.7
30–34	612	2.8	667	3.0	616	2.8	621	2.8	648	2.9
35–39	837	4.1	867	4.1	882	4.1	833	3.8	818	3.7
40–44	1,260	6.2	1,162	5.8	1,003	5.1	981	4.9	917	4.6
45–49	2,052	9.8	1,860	8.8	1,790	8.5	1,637	7.8	1,370	6.6
50–54	3,034	13.5	2,912	13.2	2,809	13.0	2,632	12.5	2,201	10.6
55–59	2,907	13.2	3,071	13.8	3,053	13.8	2,996	13.5	2,824	12.8
60–64	2,207	11.5	2,469	12.5	2,532	12.6	2,571	12.5	2,596	12.5
≥65	2,784	5.8	3,172	6.4	3,477	6.8	3,715	7.0	3,901	7.1
Race/ethnicity
AmericanIndian/Alaska Native	61	—	47	—	46	—	48	—	51	—
Asian^d	82	—	101	—	88	—	85	—	95	—
Black/AfricanAmerican	7,135	—	7,255	—	7,202	—	6,978	—	6,634	—
Hispanic/Latino^e	2,918	—	3,034	—	3,092	—	3,185	—	3,048	—
NativeHawaiian/other Pacific Islander	8	—	16	—	9	—	16	—	17	—
White	5,022	—	5,321	—	5,255	—	5,148	—	4,923	—
Multiracial	1,032	—	1,031	—	1,074	—	1,087	—	1,045	—
Transmissioncategory^f
Male adult or adolescent^g
Male-to-male sexual contact	6,645	—	6,976	—	7,077	—	6,957	—	6,926	—
Injection drug use	2,421	—	2,403	—	2,299	—	2,309	—	2,085	—
Male-to-male sexual contact and injection drug use	1,429	—	1,428	—	1,395	—	1,448	—	1,327	—
Heterosexual contact^h	1,656	—	1,769	—	1,784	—	1,651	—	1,668	—
Perinatalⁱ	29	—	46	—	42	—	57	—	41	—
Other^j	78	—	62	—	66	—	58	—	58	—
Subtotal	12,258	9.3	12,685	9.5	12,663	9.4	12,481	9.2	12,105	8.9
Female adult or adolescent^g
Injection drug use	1,377	—	1,419	—	1,408	—	1,352	—	1,251	—
Heterosexual contact^h	2,549	—	2,624	—	2,623	—	2,648	—	2,401	—
Perinatalⁱ	47	—	50	—	44	—	38	—	36	—
Other^j	28	—	27	—	28	—	27	—	22	—
Subtotal	4,002	2.9	4,121	2.9	4,103	2.9	4,065	2.9	3,710	2.6
Child (<13 yrs at death)
Perinatal	2	—	1	—	2	—	1	—	1	—
Other^j	2	—	1	—	0	—	0	—	1	—
Subtotal	4	0.0	2	0.0	2	0.0	1	0.0	2	0.0
Regionof residence^k
Northeast	3,613	6.4	3,711	6.6	3,699	6.6	3,535	6.3	3,450	6.2
Midwest	1,821	2.7	1,858	2.7	1,911	2.8	2,000	2.9	1,850	2.7
South	7,812	6.5	8,056	6.6	8,009	6.5	7,848	6.3	7,518	6.0
West	2,609	3.4	2,764	3.6	2,739	3.5	2,794	3.6	2,647	3.4
U.S. dependent areas	409	10.6	419	11.0	410	11.0	370	10.3	352	9.8
Total^l	16,264	5.0	16,808	5.1	16,768	5.1	16,547	5.0	15,817	4.8

Note: Deaths of persons with a diagnosis of HIV infection may be due to any cause. Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.

^aRates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data.
^b”Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
^cAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
^dIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
^eHispanic/Latino persons can be of any race.
^fData have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
^gData presented based on sex at birth and includes transgender persons.
^hHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
ⁱIncludes individuals ≥13 years of age at time of diagnosis of HIV infection.
^jIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
^kData are based on residence at death. When information on residence at death was not available, state at death (where a person’s death occurred) was used.
^lIncludes persons whose race/ethnicity is unknown.

Table 12a. Deaths of persons with diagnosed HIV infection, by race/ethnicity and selected characteristics, 2019—United States
	American Indian/Alaska Native		Asian^a		Black/African American		Hispanic/Latino^b		Native Hawaiian/other Pacific Islander		White		Multiracial		Total^c
	No.	Rate^d	No.	Rate^d	No.	Rate^d	No.	Rate^d	No.	Rate^d	No.	Rate^d	No.	Rate^d	No.	Rate^d
Gender
Male	32	—	88	—	4,485	—	2,116	—	9	—	4,197	—	771	—	11,701	—
Female	18	—	6	—	2,082	—	553	—	5	—	703	—	256	—	3,624	—
Transgender male-to-female^e	1	—	1	—	64	—	32	—	0	—	21	—	15	—	134	—
Transgender female-to-male^e	0	—	0	—	1	—	2	—	0	—	1	—	1	—	5	—
Additional gender identity^f	0	—	0	—	1	—	0	—	0	—	0	—	0	—	1	—
Age at death (yr)
<13	0	0.0	0	0.0	0	0.0	1	0.0	0	0.0	0	0.0	1	0.0	2	0.0
13–14	0	0.0	0	0.0	1	0.1	0	0.0	0	0.0	0	0.0	0	0.0	1	0.0
15–19	0	0.0	0	0.0	4	0.1	2	0.0	0	0.0	3	0.0	2	0.3	11	0.1
20–24	0	0.0	2	0.2	64	2.1	26	0.5	0	0.0	19	0.2	5	0.7	116	0.5
25–29	3	1.5	1	0.1	213	6.1	70	1.4	0	0.0	91	0.7	25	4.3	403	1.7
30–34	4	2.3	7	0.4	320	10.6	135	2.9	1	1.9	140	1.1	29	6.6	636	2.8
35–39	5	3.1	9	0.6	355	12.8	185	4.1	2	4.1	188	1.5	57	15.1	801	3.7
40–44	5	3.5	10	0.7	405	16.0	172	4.1	0	0.0	220	1.9	68	22.1	880	4.4
45–49	5	3.5	10	0.7	585	22.8	257	6.7	1	2.7	382	3.1	94	34.1	1,334	6.5
50–54	9	6.2	15	1.2	834	32.9	405	12.2	4	11.4	715	5.5	146	61.4	2,128	10.4
55–59	9	5.7	15	1.3	1,117	42.8	484	17.0	2	5.8	938	6.3	207	88.1	2,772	12.7
60–64	2	1.4	10	1.0	1,140	48.7	383	17.2	1	3.5	836	5.7	173	84.8	2,546	12.4
≥65	9	3.0	16	0.6	1,595	32.0	583	12.6	3	5.0	1,390	3.4	236	55.0	3,835	7.1
Transmission category^g
Male adult or adolescent^h
Male-to-male sexual contact	19	—	65	—	2,159	—	1,159	—	7	—	3,043	—	401	—	6,855	—
Injection drug use	4	—	6	—	920	—	473	—	1	—	406	—	155	—	1,965	—
Male-to-male sexual contact and injection drug use	7	—	7	—	394	—	272	—	1	—	495	—	127	—	1,304	—
Heterosexual contactⁱ	4	—	10	—	1,041	—	224	—	0	—	242	—	93	—	1,614	—
Perinatal^j	0	—	0	—	20	—	10	—	0	—	3	—	6	—	39	—
Other^k	0	—	2	—	16	—	9	—	0	—	28	—	4	—	58	—
Subtotal	33	3.4	89	1.2	4,550	28.4	2,147	9.1	9	3.7	4,218	5.0	785	33.3	11,834	8.8
Female adult or adolescent^h
Injection drug use	6	—	0	—	579	—	219	—	0	—	319	—	98	—	1,221	—
Heterosexual contactⁱ	12	—	5	—	1,476	—	328	—	5	—	374	—	152	—	2,352	—
Perinatal^j	0	—	0	—	17	—	8	—	0	—	5	—	4	—	35	—
Other^k	0	—	0	—	11	—	0	—	0	—	6	—	3	—	21	—
Subtotal	18	1.8	6	0.1	2,083	11.6	555	2.4	5	2.0	704	0.8	257	10.3	3,629	2.6
Child (<13 yrs at death)
Perinatal	0	—	0	—	0	—	1	—	0	—	0	—	0	—	1	—
Other^k	0	—	0	—	0	—	0	—	0	—	0	—	1	—	1	—
Subtotal	0	0.0	0	0.0	0	0.0	1	0.0	0	0.0	0	0.0	1	0.0	2	0.0
Region of residence^l
Northeast	1	0.8	19	0.5	1,348	21.2	981	11.8	1	4.6	742	2.0	357	36.3	3,450	6.2
Midwest	4	1.0	5	0.2	811	11.3	150	2.7	1	2.7	751	1.5	128	9.2	1,850	2.7
South	16	2.0	21	0.5	4,043	16.8	916	4.0	1	1.0	2,116	3.0	402	16.5	7,518	6.0
West	30	2.8	50	0.6	431	11.9	656	2.8	11	2.5	1,313	3.4	156	6.3	2,647	3.4
Total	51	2.1	95	0.5	6,633	16.1	2,703	4.5	14	2.3	4,922	2.5	1,043	14.3	15,465	4.7

Note: Deaths of persons with a diagnosis of HIV infection may be due to any cause. Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020.
Numbers less than 12, and rates based on these numbers, should be interpreted with caution.

^aIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
^bHispanic/Latino persons can be of any race.
^cIncludes persons whose race/ethnicity is unknown.
^dRates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data.
^eTransgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
^fAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
^gData have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
^hData presented based on sex at birth and includes transgender persons.
ⁱHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
^jIncludes individuals ≥13 years of age at time of diagnosis of HIV infection.
^kIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
^lData are based on residence at death. When information on residence at death was not available, state at death (where a person’s death occurred) was used.

Table 12b. Deaths of persons with diagnosed HIV infection, by race/ethnicity and selected characteristics, 2019—United States and 6 dependent areas
	American Indian/Alaska Native	Asian^a	Black/African American	Hispanic/Latino^b	Native Hawaiian/other Pacific Islander	White	Multiracial	Total^c
	No.	No.	No.	No.	No.	No.	No.	No.
Gender
Male	32	88	4,486	2,379	12	4,198	772	11,970
Female	18	6	2,082	633	5	703	257	3,705
Transgender male-to-female^d	1	1	64	34	0	21	15	136
Transgender female-to-male^d	0	0	1	2	0	1	1	5
Additional gender identity^e	0	0	1	0	0	0	0	1
Age at death (yr)
<13	0	0	0	1	0	0	1	2
13–14	0	0	1	0	0	0	0	1
15–19	0	0	4	2	0	3	2	11
20–24	0	2	64	28	0	19	5	118
25–29	3	1	213	76	1	91	25	410
30–34	4	7	320	147	1	140	29	648
35–39	5	9	355	202	2	188	57	818
40–44	5	10	406	207	1	220	68	917
45–49	5	10	585	292	1	383	94	1,370
50–54	9	15	834	476	4	715	148	2,201
55–59	9	15	1,117	535	3	938	207	2,824
60–64	2	10	1,140	433	1	836	173	2,596
≥65	9	16	1,595	649	3	1,390	236	3,901
Transmission category^f
Male adult or adolescent^g
Male-to-male sexual contact	19	65	2,159	1,228	8	3,043	402	6,926
Injection drug use	4	6	921	591	2	406	155	2,085
Male-to-male sexual contact and injection drug use	7	7	394	295	1	495	127	1,327
Heterosexual contact^h	4	10	1,041	277	0	243	93	1,668
Perinatalⁱ	0	0	20	12	0	3	6	41
Other^j	0	2	16	9	0	28	4	58
Subtotal	33	89	4,551	2,412	12	4,219	786	12,105
Female adult or adolescent^g
Injection drug use	6	0	579	249	0	319	98	1,251
Heterosexual contact^h	12	5	1,476	376	5	374	153	2,401
Perinatalⁱ	0	0	17	9	0	5	4	36
Other^j	0	0	11	1	0	6	3	22
Subtotal	18	6	2,083	635	5	704	258	3,710
Child (<13 yrs at death)
Perinatal	0	0	0	1	0	0	0	1
Other^j	0	0	0	0	0	0	1	1
Subtotal	0	0	0	1	0	0	1	2
Region of residence^k
Northeast	1	19	1,348	981	1	742	357	3,450
Midwest	4	5	811	150	1	751	128	1,850
South	16	21	4,043	916	1	2,116	402	7,518
West	30	50	431	656	11	1,313	156	2,647
U.S. dependent areas	0	0	1	345	3	1	2	352
Total	51	95	6,634	3,048	17	4,923	1,045	15,817

Note: Deaths of persons with a diagnosis of HIV infection may be due to any cause. Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020.
Numbers less than 12 should be interpreted with caution.

^aIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
^bHispanic/Latino persons can be of any race.
^cIncludes persons whose race/ethnicity is unknown.
^dTransgender male-to-female" includes individuals who were assigned "male" sex at birth but have ever identified as "female" gender. "Transgender female-to-male" includes individuals who were assigned "female" sex at birth but have ever identified as "male" gender.
^eAdditional gender identity examples include "bigender," "gender queer," and "two-spirit."
^fData have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
^gData presented based on sex at birth and includes transgender persons.
^hHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
ⁱIncludes individuals ≥13 years of age at time of diagnosis of HIV infection.
^jIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
^kData are based on residence at death. When information on residence at death was not available, state at death (where a person’s death occurred) was used.

Table 13a. Deaths of adults and adolescents with diagnosed HIV infection, by year of death, sex at birth, and selected characteristics, 2015–2019—United States
	2015		2016		2017		2018		2019
	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a
Male adult or adolescent
Age at death (yr)
13–14	0	0.0	1	0.0	0	0.0	0	0.0	1	0.0
15–19	6	0.1	5	0.0	5	0.0	5	0.0	9	0.1
20–24	106	0.9	112	1.0	112	1.0	95	0.9	89	0.8
25–29	314	2.8	352	3.0	348	2.9	345	2.9	342	2.8
30–34	413	3.8	477	4.3	447	4.0	460	4.1	492	4.3
35–39	544	5.4	583	5.6	628	5.9	577	5.4	579	5.3
40–44	837	8.4	743	7.6	658	6.8	624	6.4	612	6.2
45–49	1,487	14.5	1,302	12.6	1,220	11.8	1,125	11.0	938	9.3
50–54	2,227	20.4	2,130	19.9	2,042	19.5	1,901	18.5	1,586	15.7
55–59	2,182	20.7	2,336	21.9	2,250	21.1	2,252	21.1	2,158	20.3
60–64	1,674	18.4	1,846	19.9	1,935	20.3	1,905	19.6	1,971	20.0
≥65	2,166	10.3	2,474	11.4	2,716	12.1	2,898	12.4	3,057	12.7
Race/ethnicity
American Indian/Alaska Native	44	4.7	38	4.0	32	3.3	33	3.4	33	3.4
Asian^b	74	1.1	88	1.2	73	1.0	74	1.0	89	1.2
Black/African American	4,755	30.9	4,870	31.3	4,911	31.2	4,699	29.6	4,550	28.4
Hispanic/Latino^c	2,012	9.3	2,028	9.2	2,105	9.3	2,240	9.7	2,147	9.1
Native Hawaiian/other Pacific Islander	7	3.1	10	4.3	5	2.1	12	5.0	9	3.7
White	4,278	5.1	4,559	5.4	4,426	5.3	4,313	5.1	4,218	5.0
Multiracial	781	38.1	765	36.0	808	36.7	816	35.8	785	33.3
Region of residence^d
Northeast	2,549	11.1	2,630	11.4	2,624	11.4	2,491	10.8	2,460	10.6
Midwest	1,460	5.3	1,476	5.3	1,510	5.4	1,594	5.7	1,488	5.3
South	5,681	11.6	5,844	11.8	5,832	11.6	5,687	11.2	5,587	10.9
West	2,266	7.3	2,411	7.6	2,395	7.5	2,415	7.5	2,299	7.1
Subtotal	11,956	9.1	12,361	9.4	12,361	9.3	12,187	9.1	11,834	8.8
Female adult or adolescent
Age at death (yr)
13–14	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0
15–19	5	0.0	5	0.0	2	0.0	4	0.0	2	0.0
20–24	44	0.4	44	0.4	31	0.3	26	0.2	27	0.3
25–29	85	0.8	95	0.8	98	0.9	73	0.6	61	0.5
30–34	178	1.7	182	1.7	154	1.4	149	1.4	144	1.3
35–39	273	2.7	252	2.4	239	2.3	237	2.2	222	2.0
40–44	387	3.8	388	3.9	310	3.1	326	3.3	268	2.7
45–49	511	4.9	507	4.8	517	4.9	474	4.5	396	3.8
50–54	712	6.3	710	6.4	690	6.4	680	6.4	542	5.2
55–59	658	5.9	660	5.9	722	6.4	673	6.0	614	5.5
60–64	485	4.9	569	5.6	555	5.3	617	5.8	575	5.4
≥65	557	2.1	614	2.2	677	2.4	730	2.5	778	2.6
Race/ethnicity
American Indian/Alaska Native	17	1.7	9	0.9	14	1.4	15	1.5	18	1.8
Asian^b	7	0.1	13	0.2	15	0.2	11	0.1	6	0.1
Black/African American	2,371	13.7	2,374	13.6	2,285	13.0	2,278	12.8	2,083	11.6
Hispanic/Latino^c	506	2.4	600	2.8	583	2.6	581	2.5	555	2.4
Native Hawaiian/other Pacific Islander	0	0.0	4	1.7	4	1.7	1	0.4	5	2.0
White	743	0.9	761	0.9	827	0.9	834	1.0	704	0.8
Multiracial	250	11.4	265	11.7	266	11.3	269	11.1	257	10.3
Region of residence^d
Northeast	1,063	4.3	1,081	4.4	1,075	4.4	1,043	4.2	990	4.0
Midwest	361	1.2	381	1.3	400	1.4	406	1.4	361	1.2
South	2,129	4.1	2,211	4.2	2,176	4.1	2,161	4.0	1,930	3.6
West	342	1.1	353	1.1	344	1.1	379	1.2	348	1.1
Subtotal	3,895	2.8	4,026	2.9	3,995	2.9	3,989	2.8	3,629	2.6
Total	15,851	5.9	16,387	6.1	16,356	6.0	16,176	5.9	15,463	5.6

Note: Deaths of persons with a diagnosis of HIV infection may be due to any cause. Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.

^aRates are per 100,000 population.
^bIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
^cHispanic/Latino persons can be of any race.
^dData are based on residence at death. When information on residence at death was not available, state at death (where a person’s death occurred) was used.

Table 13b. Deaths of adults and adolescents with diagnosed HIV infection, by year of death, sex at birth, and selected characteristics, 2015–2019—United States and 6 dependent areas
	2015		2016		2017		2018		2019
	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a
Male adult or adolescent
Age at death (yr)
13–14	0	0.0	1	0.0	0	0.0	0	0.0	1	0.0
15–19	6	0.1	6	0.1	5	0.0	5	0.0	9	0.1
20–24	108	0.9	115	1.0	113	1.0	99	0.9	91	0.8
25–29	317	2.8	358	3.0	352	2.9	352	2.9	347	2.9
30–34	425	3.9	482	4.3	457	4.1	468	4.2	498	4.3
35–39	559	5.4	608	5.8	639	6.0	590	5.4	590	5.4
40–44	864	8.5	763	7.7	686	7.0	649	6.6	638	6.4
45–49	1,526	14.7	1,344	12.8	1,262	12.1	1,152	11.1	964	9.5
50–54	2,299	20.8	2,186	20.2	2,101	19.8	1,939	18.7	1,645	16.1
55–59	2,230	20.9	2,393	22.2	2,307	21.4	2,308	21.4	2,198	20.4
60–64	1,713	18.6	1,891	20.1	1,964	20.4	1,947	19.8	2,011	20.2
≥65	2,211	10.4	2,538	11.5	2,777	12.2	2,972	12.6	3,113	12.8
Race/ethnicity
American Indian/Alaska Native	44	—	38	—	32	—	33	—	33	—
Asian^b	74	—	88	—	73	—	74	—	89	—
Black/African American	4,757	—	4,877	—	4,915	—	4,699	—	4,551	—
Hispanic/Latino^c	2,310	—	2,343	—	2,402	—	2,530	—	2,412	—
Native Hawaiian/other Pacific Islander	8	—	11	—	5	—	13	—	12	—
White	4,278	—	4,559	—	4,427	—	4,314	—	4,219	—
Multiracial	782	—	766	—	808	—	818	—	786	—
Region of residence^d
Northeast	2,549	11.1	2,630	11.4	2,624	11.4	2,491	10.8	2,460	10.6
Midwest	1,460	5.3	1,476	5.3	1,510	5.4	1,594	5.7	1,488	5.3
South	5,681	11.6	5,844	11.8	5,832	11.6	5,687	11.2	5,587	10.9
West	2,266	7.3	2,411	7.6	2,395	7.5	2,415	7.5	2,299	7.1
US dependent areas	302	19.4	324	21.1	302	20.0	294	20.0	271	18.3
Subtotal	12,258	9.3	12,685	9.5	12,663	9.4	12,481	9.2	12,105	8.9
Female adult or adolescent
Age at death (yr)
13–14	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0
15–19	5	0.0	5	0.0	2	0.0	4	0.0	2	0.0
20–24	44	0.4	45	0.4	32	0.3	26	0.2	27	0.3
25–29	87	0.8	96	0.8	100	0.9	74	0.6	63	0.5
30–34	187	1.7	185	1.7	159	1.4	153	1.4	150	1.3
35–39	278	2.7	259	2.5	243	2.3	243	2.2	228	2.1
40–44	396	3.9	399	4.0	317	3.2	332	3.3	279	2.8
45–49	526	5.0	516	4.8	528	4.9	485	4.6	406	3.9
50–54	735	6.4	726	6.5	708	6.4	693	6.5	556	5.3
55–59	677	6.0	678	5.9	746	6.5	688	6.0	626	5.5
60–64	494	4.9	578	5.6	568	5.4	624	5.8	585	5.4
≥65	573	2.1	634	2.3	700	2.4	743	2.5	788	2.6
Race/ethnicity
American Indian/Alaska Native	17	—	9	—	14	—	15	—	18	—
Asian^b	8	—	13	—	15	—	11	—	6	—
Black/African American	2,375	—	2,376	—	2,286	—	2,278	—	2,083	—
Hispanic/Latino^c	608	—	691	—	690	—	655	—	635	—
Native Hawaiian/other Pacific Islander	0	—	5	—	4	—	3	—	5	—
White	743	—	762	—	827	—	834	—	704	—
Multiracial	250	—	265	—	266	—	269	—	258	—
Region of residence^d
Northeast	1,063	4.3	1,081	4.4	1,075	4.4	1,043	4.2	990	4.0
Midwest	361	1.2	381	1.3	400	1.4	406	1.4	361	1.2
South	2,129	4.1	2,211	4.2	2,176	4.1	2,161	4.0	1,930	3.6
West	342	1.1	353	1.1	344	1.1	379	1.2	348	1.1
US dependent areas	107	6.2	95	5.6	108	6.4	76	4.6	81	4.9
Subtotal	4,002	2.9	4,121	2.9	4,103	2.9	4,065	2.9	3,710	2.6
Total	16,260	6.0	16,806	6.1	16,766	6.1	16,546	6.0	15,815	5.7

Note: Deaths of persons with a diagnosis of HIV infection may be due to any cause. Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020. Numbers less than 12, and rates and trends based on these numbers, should be interpreted with caution.

^aRates are per 100,000 population. Rates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas.
^bIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
^cHispanic/Latino persons can be of any race.
^dData are based on residence at death. When information on residence at death was not available, state at death (where a person’s death occurred) was used.

Table 14a. Deaths of transgender adults and adolescents with diagnosed HIV infection, by year of death and selected characteristics, 2015–2019—United States
	2015	2016	2017	2018	2019
	No.	No.	No.	No.	No.
Transgender male-to-female adult or adolescent^a
Age at death (yr)
13–14	0	0	0	0	0
15–19	0	0	0	0	0
20–24	5	1	2	1	5
25–29	11	10	8	12	13
30–34	14	10	7	9	18
35–39	7	13	15	13	16
40–44	15	12	13	12	16
45–49	13	22	18	13	15
50–54	13	13	10	18	17
55–59	12	17	18	18	16
60–64	6	11	7	11	11
≥65	12	12	6	12	7
Race/ethnicity
American Indian/Alaska Native	1	0	0	2	1
Asian^b	0	3	0	2	1
Black/African American	53	55	43	45	64
Hispanic/Latino^c	29	28	35	35	32
Native Hawaiian/other Pacific Islander	1	1	1	0	0
White	13	22	17	21	21
Multiracial	11	12	8	14	15
Region of residence^d
Northeast	25	27	24	33	39
Midwest	20	12	11	11	18
South	37	41	39	42	49
West	26	41	30	33	28
Subtotal	108	121	104	119	134
Transgender female-to-male adult or adolescent^a
Age at death (yr)
13–14	0	0	0	0	0
15–19	0	0	0	0	0
20–24	0	0	0	0	0
25–29	1	0	0	0	1
30–34	1	0	0	0	0
35–39	0	2	0	0	0
40–44	1	0	0	0	0
45–49	1	0	1	2	0
50–54	1	0	0	0	1
55–59	0	0	2	1	1
60–64	0	0	0	0	2
≥65	0	0	1	0	0
Race/ethnicity
American Indian/Alaska Native	0	0	0	0	0
Asian^b	0	0	0	0	0
Black/African American	2	1	3	0	1
Hispanic/Latino^c	2	0	0	1	2
Native Hawaiian/other Pacific Islander	0	0	0	0	0
White	1	1	0	1	1
Multiracial	0	0	1	1	1
Region of residence^d
Northeast	2	0	0	0	1
Midwest	0	0	0	0	1
South	1	2	3	2	3
West	2	0	1	1	0
Subtotal	5	2	4	3	5
Total	113	123	108	122	139

Note: Deaths of persons with a diagnosis of HIV infection may be due to any cause. Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020. Numbers less than 12 should be interpreted with caution. Additional gender identity not included due to small numbers.

^a“Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
^bIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
^cHispanic/Latino persons can be of any race.
^dData are based on residence at the time of death. When information on residence at death was not available, state at death (where a person’s death occurred) was used.

Table 14b. Deaths of transgender adults and adolescents with diagnosed HIV infection, by year of death and selected characteristics, 2015–2019—United States and dependent areas
	2015	2016	2017	2018	2019
	No.	No.	No.	No.	No.
Transgender male-to-female^a
Age at death (yr)
13–14	0	0	0	0	0
15–19	0	0	0	0	0
20–24	5	1	2	1	5
25–29	11	10	8	12	13
30–34	14	10	7	9	18
35–39	7	13	16	13	16
40–44	15	12	13	12	16
45–49	13	22	18	13	16
50–54	13	13	11	18	17
55–59	12	17	18	18	16
60–64	6	11	7	11	11
≥65	12	12	6	13	8
Race/ethnicity
American Indian/Alaska Native	1	0	0	2	1
Asian^b	0	3	0	2	1
Black/African American	53	55	43	45	64
Hispanic/Latino^c	29	28	37	36	34
Native Hawaiian/other Pacific Islander	1	1	1	0	0
White	13	22	17	21	21
Multiracial	11	12	8	14	15
Region of residence^d
Northeast	25	27	24	33	39
Midwest	20	12	11	11	18
South	37	41	39	42	49
West	26	41	30	33	28
US dependent areas	0	0	2	1	2
Subtotal	108	121	106	120	136
Transgender female-to-male adult or adolescent^a
Age at death (yr)
13–14	0	0	0	0	0
15–19	0	0	0	0	0
20–24	0	0	0	0	0
25–29	1	0	0	0	1
30–34	1	0	0	0	0
35–39	0	2	0	0	0
40–44	1	0	0	0	0
45–49	1	0	1	2	0
50–54	1	0	0	0	1
55–59	0	0	2	1	1
60–64	0	0	0	0	2
≥65	0	0	1	0	0
Race/ethnicity
American Indian/Alaska Native	0	0	0	0	0
Asian^b	0	0	0	0	0
Black/African American	2	1	3	0	1
Hispanic/Latino^c	2	0	0	1	2
Native Hawaiian/other Pacific Islander	0	0	0	0	0
White	1	1	0	1	1
Multiracial	0	0	1	1	1
Region of residence^d
Northeast	2	0	0	0	1
Midwest	0	0	0	0	1
South	1	2	3	2	3
West	2	0	1	1	0
US dependent areas	0	0	0	0	0
Subtotal	5	2	4	3	5
Total	113	123	110	123	141

Note: Deaths of persons with a diagnosis of HIV infection may be due to any cause. Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020. Numbers less than 12 should be interpreted with caution.
Additional gender identity not included due to small numbers.

^a“Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
^bIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
^cHispanic/Latino persons can be of any race.
^dData are based on residence at time of death. When information on residence at death was not available, state at death (where a person’s death occurred) was used.

Table 15a. Persons living with diagnosed HIV infection, by year and selected characteristics, 2015–2019—United States
	2015		2016		2017		2018		2019
	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a
Gender
Male	713,646	—	733,544	—	752,770	—	771,422	—	789,662	—
Female	228,294	—	232,297	—	236,243	—	239,866	—	243,651	—
Transgender male-to-female^b	8,942	—	9,481	—	9,976	—	10,479	—	11,002	—
Transgender female-to-male^b	318	—	337	—	369	—	418	—	461	—
Additional gender identity^c	135	—	148	—	164	—	182	—	201	—
Age at end of year
<13	2,346	4.4	2,227	4.2	2,074	3.9	1,915	3.6	1,693	3.2
13–14	723	8.8	676	8.2	666	8.0	664	8.0	645	7.7
15–19	4,955	23.5	4,626	21.9	4,523	21.4	4,334	20.6	4,213	20.0
20–24	30,777	135.8	29,778	133.3	28,381	128.8	26,932	123.5	25,924	119.8
25–29	65,075	290.4	68,285	298.0	70,344	301.5	70,799	301.1	69,226	294.5
30–34	75,747	350.2	79,094	362.5	82,744	377.2	87,666	396.7	93,126	415.2
35–39	86,794	427.5	89,487	430.7	91,756	433.2	93,609	434.7	95,543	439.5
40–44	101,210	502.7	97,262	494.2	95,971	490.2	96,638	491.0	98,174	492.8
45–49	142,256	685.1	136,118	651.0	130,043	622.2	123,345	595.3	117,195	574.5
50–54	166,105	746.5	166,455	763.6	162,921	763.7	157,654	755.8	150,916	737.0
55–59	127,571	587.0	135,750	618.7	144,391	657.9	152,829	697.3	160,272	732.6
60–64	79,142	416.3	87,512	449.9	96,068	482.1	104,220	513.2	112,247	545.7
≥65	68,634	144.0	78,537	159.6	89,640	176.6	101,762	194.3	115,803	214.2
Race/ethnicity
American Indian/Alaska Native	2,584	109.0	2,755	115.3	2,919	121.4	3,055	126.2	3,215	132.0
Asian^d	12,060	70.1	12,978	73.3	13,923	76.6	14,792	79.8	15,558	82.3
Black/African American	385,270	966.5	395,101	982.1	404,466	997.0	413,501	1,012.0	422,781	1,027.5
Hispanic/Latino^e	215,383	382.9	223,904	389.7	232,464	396.9	240,936	404.0	249,114	411.3
Native Hawaiian/other Pacific Islander	738	133.2	764	135.1	806	139.8	859	146.5	912	153.0
White	286,029	144.6	290,628	146.9	295,121	149.2	299,436	151.6	303,701	153.9
Multiracial	48,519	739.9	48,929	725.3	49,077	708.4	49,042	690.7	48,954	673.1
Transmission category^f
Male adult or adolescent^g
Male-to-male sexual contact	512,699	—	532,283	—	551,337	—	569,690	—	587,555	—
Injection drug use	70,420	—	69,445	—	68,695	—	68,046	—	67,603	—
Male-to-male sexual contact and injection drug use	56,302	—	56,429	—	56,525	—	56,545	—	56,719	—
Heterosexual contact^h	74,746	—	76,433	—	77,740	—	79,170	—	80,351	—
Perinatalⁱ	4,618	—	4,709	—	4,800	—	4,891	—	5,002	—
Other^j	2,824	—	2,805	—	2,812	—	2,802	—	2,804	—
Subtotal	721,610	551.2	742,105	561.9	761,910	572.3	781,144	582.7	800,035	592.8
Female adult or adolescent^g
Injection drug use	49,481	—	49,148	—	48,914	—	48,733	—	48,660	—
Heterosexual contact^h	171,086	—	175,360	—	179,492	—	183,273	—	187,127	—
Perinatalⁱ	5,170	—	5,302	—	5,455	—	5,610	—	5,743	—
Other^j	1,642	—	1,665	—	1,677	—	1,692	—	1,720	—
Subtotal	227,379	166.0	231,475	167.6	235,538	169.2	239,308	170.8	243,249	172.5
Child (<13 yrs at end of year)
Perinatal	1,926	—	1,824	—	1,698	—	1,544	—	1,366	—
Other^j	420	—	403	—	376	—	371	—	327	—
Subtotal	2,346	4.4	2,227	4.2	2,074	3.9	1,915	3.6	1,693	3.2
Region of residence^k
Northeast	226,458	404.1	230,557	411.4	232,575	414.9	234,657	418.7	236,502	422.5
Midwest	112,605	165.9	116,258	171.0	119,404	175.3	122,532	179.6	125,214	183.3
South	426,978	352.9	437,447	357.5	450,412	364.6	462,663	371.4	475,547	378.7
West	185,294	244.6	191,545	250.2	197,131	255.2	202,515	260.2	207,714	265.1
Total^l	951,335	296.7	975,807	302.2	999,522	307.6	1,022,367	312.9	1,044,977	318.4

Note: Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020.

^aRates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data.
^bTransgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
^cAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
^dIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
^eHispanic/Latino persons can be of any race.
^fData have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
^gData presented based on sex at birth and includes transgender persons.
^hHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
ⁱIncludes individuals ≥13 years of age at time of diagnosis of HIV infection.
^jncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
^kData are based on address of residence at the end of the specified year (i.e., most recent known address).
^lIncludes persons whose race/ethnicity is unknown.

Table 15b. Persons living with diagnosed HIV infection, by year and selected characteristics, 2015–2019—United States and 6 dependent areas
	2015		2016		2017		2018		2019
	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a
Gender
Male	725,350	—	745,270	—	764,355	—	782,922	—	801,239	—
Female	233,453	—	237,406	—	241,216	—	244,782	—	248,548	—
Transgender male-to-female^b	8,974	—	9,513	—	10,007	—	10,507	—	11,032	—
Transgender female-to-male^b	319	—	338	—	370	—	419	—	462	—
Additional gender identity^c	135	—	148	—	164	—	182	—	201	—
Age at end of year
<13	2,359	4.4	2,241	4.2	2,083	3.9	1,921	3.6	1,698	3.2
13–14	729	8.7	679	8.2	672	8.0	672	8.0	649	7.7
15–19	5,024	23.5	4,674	21.8	4,568	21.4	4,375	20.5	4,238	19.9
20–24	31,172	135.8	30,128	133.2	28,679	128.6	27,196	123.3	26,168	119.6
25–29	65,845	290.6	69,045	298.1	71,051	301.3	71,498	301.0	69,910	294.3
30–34	76,720	350.9	80,063	363.2	83,660	377.7	88,543	397.0	94,024	415.3
35–39	88,253	429.5	90,893	432.5	93,042	434.6	94,789	435.9	96,626	440.2
40–44	103,000	505.4	98,945	496.8	97,572	492.6	98,175	493.3	99,644	494.7
45–49	144,873	689.4	138,539	654.8	132,237	625.5	125,329	598.2	119,071	577.2
50–54	169,190	751.5	169,494	768.5	165,865	768.4	160,486	760.5	153,530	741.1
55–59	130,034	591.6	138,323	623.4	147,049	662.6	155,577	702.0	163,186	737.7
60–64	80,716	419.6	89,252	453.6	97,925	485.8	106,246	517.4	114,383	549.9
≥65	70,316	145.5	80,399	161.2	91,709	178.3	104,005	196.0	118,355	216.0
Race/ethnicity
American Indian/Alaska Native	2,586	—	2,757	—	2,921	—	3,057	—	3,217	—
Asian^d	12,111	—	13,030	—	13,979	—	14,853	—	15,624	—
Black/African American	385,592	—	395,413	—	404,773	—	413,817	—	423,101	—
Hispanic/Latino^e	231,772	—	240,271	—	248,545	—	256,864	—	265,083	—
Native Hawaiian/other Pacific Islander	765	—	795	—	842	—	894	—	947	—
White	286,110	—	290,708	—	295,204	—	299,517	—	303,793	—
Multiracial	48,540	—	48,950	—	49,099	—	49,061	—	48,972	—
Transmission category^f
Male adult or adolescent^g
Male-to-male sexual contact	517,273	—	537,017	—	556,104	—	574,555	—	592,579	—
Injection drug use	74,156	—	73,075	—	72,201	—	71,424	—	70,883	—
Male-to-male sexual contact and injection drug use	57,159	—	57,255	—	57,312	—	57,300	—	57,468	—
Heterosexual contact^h	77,145	—	78,835	—	80,133	—	81,541	—	82,745	—
Perinatalⁱ	4,756	—	4,842	—	4,932	—	5,022	—	5,134	—
Other^j	2,851	—	2,831	—	2,839	—	2,827	—	2,831	—
Subtotal	733,340	553.6	753,856	564.3	773,521	574.5	792,669	584.9	811,640	594.9
Female adult or adolescent^g
Injection drug use	50,563	—	50,200	—	49,909	—	49,693	—	49,607	—
Heterosexual contact^h	175,013	—	179,270	—	183,329	—	187,097	—	190,957	—
Perinatalⁱ	5,301	—	5,431	—	5,580	—	5,729	—	5,850	—
Other^j	1,655	—	1,677	—	1,689	—	1,703	—	1,730	—
Subtotal	232,532	167.6	236,578	169.2	240,508	170.7	244,222	172.3	248,144	173.9
Child (<13 yrs at end of year)
Perinatal	1,939	—	1,838	—	1,707	—	1,550	—	1,371	—
Other^j	420	—	403	—	376	—	371	—	327	—
Subtotal	2,359	4.4	2,241	4.2	2,083	3.9	1,921	3.6	1,698	3.2
Region of residence^k
Northeast	226,458	404.1	230,557	411.4	232,575	414.9	234,657	418.7	236,502	422.5
Midwest	112,605	165.9	116,258	171.0	119,404	175.3	122,532	179.6	125,214	183.3
South	426,978	352.9	437,447	357.5	450,412	364.6	462,663	371.4	475,547	378.7
West	185,294	244.6	191,545	250.2	197,131	255.2	202,515	260.2	207,714	265.1
U.S. dependent areas	16,896	436.1	16,868	443.1	16,590	445.4	16,445	457.8	16,505	459.5
Total^l	968,231	298.4	992,675	303.8	1,016,112	309.1	1,038,812	314.5	1,061,482	319.9

Note: Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020.

^aRates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data. Rates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas.
^bTransgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
^cAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
^dIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
^eHispanic/Latino persons can be of any race.
^fData have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
^gData presented based on sex at birth and includes transgender persons.
^hHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
ⁱIncludes individuals ≥13 years of age at time of diagnosis of HIV infection.
^jIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
^kData are based on address of residence at the end of the specified year (i.e., most recent known address).
^lIncludes persons whose race/ethnicity is unknown.

Table 16a. Persons living with diagnosed HIV infection, by race/ethnicity and selected characteristics, year-end 2019—United States
	American Indian/Alaska Native		Asian^a		Black/African American		Hispanic/Latino^b		Native Hawaiian/other Pacific Islander		White		Multiracial		Total^c
	No.	Rate^d	No.	Rate^d	No.	Rate^d	No.	Rate^d	No.	Rate^d	No.	Rate^d	No.	Rate^d	No.	Rate^d
Gender
Male	2,353	—	12,655	—	276,346	—	197,849	—	735	—	262,519	—	36,670	—	789,662	—
Female	805	—	2,713	—	141,111	—	47,309	—	143	—	39,931	—	11,432	—	243,651	—
Transgender male-to-female^e	52	—	176	—	5,040	—	3,800	—	34	—	1,108	—	792	—	11,002	—
Transgender female-to-male^e	4	—	9	—	206	—	100	—	0	—	107	—	35	—	461	—
Additional gender identity^f	1	—	5	—	78	—	56	—	0	—	36	—	25	—	201	—
Age at end of year
<13	6	1.4	108	4.1	1,003	14.0	225	1.7	2	1.9	214	0.8	135	5.6	1,693	3.2
13–14	1	1.4	30	7.1	412	36.4	83	3.9	1	5.9	77	1.8	41	12.2	645	7.7
15–19	12	6.8	96	8.7	2,508	86.6	939	18.6	5	12.1	482	4.4	170	22.5	4,213	20.0
20–24	112	61.6	411	32.7	14,142	462.1	6,601	136.3	25	58.1	3,598	31.1	1,030	153.1	25,924	119.8
25–29	269	134.0	1,240	78.7	34,525	988.4	18,259	369.7	84	165.2	11,560	91.3	3,281	561.7	69,226	294.5
30–34	354	202.2	1,665	100.2	43,060	1,422.7	25,056	546.3	112	215.2	18,209	145.8	4,662	1,055.6	93,126	415.2
35–39	391	245.7	1,822	113.8	39,455	1,417.2	27,485	609.4	129	261.6	21,505	175.4	4,749	1,260.3	95,543	439.5
40–44	332	233.3	1,971	136.4	39,350	1,552.9	28,381	684.4	108	264.8	23,201	205.2	4,811	1,560.2	98,174	492.8
45–49	392	275.0	2,426	171.9	45,441	1,770.8	31,197	817.6	108	289.5	32,069	264.0	5,511	2,001.7	117,195	574.5
50–54	447	308.0	2,031	169.1	56,018	2,207.4	36,435	1,099.9	111	316.6	48,407	372.1	7,350	3,088.7	150,916	737.0
55–59	415	264.2	1,517	135.8	58,674	2245.8	32,801	1151.5	99	288.3	59,083	397.3	7,510	3,196.5	160,272	732.6
60–64	250	177.2	1,012	100.9	43,946	1877.3	20,970	941.1	64	221.0	40,841	279.3	5,027	2,462.8	112,247	545.7
≥65	234	77.6	1,229	49.3	44,247	888.6	20,682	445.8	64	105.9	44,455	108.0	4,677	1,090.2	115,803	214.2
Transmission category^g
Male adult or adolescent^h
Male-to-male sexual contact	1,690	—	10,803	—	181,186	—	150,046	—	657	—	215,558	—	27,250	—	587,555	—
Injection drug use	236	—	436	—	31,382	—	19,436	—	24	—	13,411	—	2,604	—	67,603	—
Male-to-male sexual contact and injection drug use	293	—	393	—	15,268	—	13,730	—	44	—	22,774	—	4,167	—	56,719	—
Heterosexual contactⁱ	165	—	1,031	—	49,511	—	16,704	—	38	—	9,922	—	2,951	—	80,351	—
Perinatal^j	5	—	57	—	2,822	—	1,234	—	3	—	554	—	319	—	5,002	—
Other^k	14	—	71	—	795	—	445	—	1	—	1,340	—	132	—	2,804	—
Subtotal	2,403	246.7	12,790	166.7	280,963	1,752.4	201,595	852.0	768	312.2	2,63,558	313.7	37,423	1586.6	800,035	592.8
Female adult or adolescent^h
Injection drug use	270	—	187	—	22,915	—	9,804	—	22	—	12,538	—	2,856	—	48,660	—
Heterosexual contactⁱ	517	—	2,350	—	113,741	—	35,871	—	119	—	26,295	—	8,111	—	187,127	—
Perinatal^j	9	—	53	—	3,363	—	1,345	—	0	—	615	—	350	—	5,743	—
Other^k	11	—	70	—	796	—	274	—	1	—	482	—	79	—	1,720	—
Subtotal	806	79.0	2,660	30.8	140,815	785.4	47,294	202.5	142	58.1	39,929	45.7	11,396	456.4	243,249	172.5
Child (<13 yrs at end of year)
Perinatal	6	—	68	—	819	—	203	—	2	—	150	—	118	—	1,366	—
Other^k	0	—	40	—	184	—	22	—	0	—	64	—	17	—	327	—
Subtotal	6	1.4	108	4.1	1,003	14.0	225	1.7	2	1.9	214	0.8	135	5.6	1,693	3.2
Region of residence^l
Northeast	150	117.9	3,397	88.8	90,482	1425.7	72,891	875.3	66	300.4	54,358	149.5	14,808	1505.1	236,502	422.5
Midwest	384	92.1	1,559	65.9	53,976	751.7	15,502	279.4	51	139.2	47,785	93.0	5,837	420.2	125,214	183.3
South	789	97.3	3,121	69.0	245,579	1022.8	90,951	394.3	154	158.7	114,971	162.8	19,824	815.1	475,547	378.7
West	1,892	175.2	7,481	91.3	32,744	907.2	69,770	295.2	641	145.6	86,587	222.5	8,485	343.7	207,714	265.1
Total	3,215	132.0	15,558	82.3	422,781	1027.5	249,114	411.3	912	153.0	303,701	153.9	48,954	673.1	1,044,977	318.4

Note: Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020. Numbers less than 12, and rates based on these numbers, should be interpreted with caution.

^aIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
^bHispanic/Latino persons can be of any race.
^cIncludes persons whose race/ethnicity is unknown.
^dRates are per 100,000 population. Rates are not calculated by gender or transmission category because of the lack of denominator data.
^e“Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
^fAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
^gData have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
^hData presented based on sex at birth and includes transgender persons.
ⁱHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
^jIncludes individuals ≥13 years of age at time of diagnosis of HIV infection.
^kIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
^lData are based on address of residence at the end of the specified year (i.e., most recent known address).

Table 16b. Persons living with diagnosed HIV infection, by race/ethnicity and selected characteristics, year-end 2019—United States and 6 dependent areas
	American Indian/Alaska Native	Asian^a	Black/African American	Hispanic/Latino^b	Native Hawaiian/other Pacific Islander	White	Multiracial	Total^c
	No.	No.	No.	No.	No.	No.	No.	No.
Gender
Male	2,355	12,710	276,536	209,061	762	262,593	36,685	801,239
Female	805	2,724	141,241	52,036	150	39,949	11,435	248,548
Transgender male-to-female^d	52	176	5,040	3,829	35	1,108	792	11,032
Transgender female-to-male^d	4	9	206	101	0	107	35	462
Additional gender identity^e	1	5	78	56	0	36	25	201
Age at end of year
<13	6	108	1,004	228	3	214	135	1,698
13–14	1	30	412	87	1	77	41	649
15–19	12	96	2,510	961	5	482	171	4,238
20–24	112	411	14,143	6,840	26	3,600	1,031	26,168
25–29	269	1,244	34,531	18,927	89	11,561	3,281	69,910
30–34	354	1,671	43,073	25,921	118	18,216	4,663	94,024
35–39	391	1,830	39,481	28,526	133	21,507	4,751	96,626
40–44	332	1,976	39,372	29,813	111	23,208	4,812	99,644
45–49	392	2,433	45,486	33,001	112	32,080	5,514	119,071
50–54	448	2,040	56,076	38,955	115	48,425	7,354	153,530
55–59	416	1,531	58,713	35,637	103	59,101	7,512	163,186
60–64	250	1,018	43,983	23,049	65	40,853	5,027	114,383
≥65	234	1,236	44,317	23,138	66	44,469	4,680	118,355
Transmission category^f
Male adult or adolescent^g
Male-to-male sexual contact	1,691	10,849	181,269	154,844	679	215,617	27,263	592,579
Injection drug use	236	442	31,418	22,670	25	13,414	2,604	70,883
Male-to-male sexual contact and injection drug use	293	394	15,274	14,459	46	22,783	4,168	57,468
Heterosexual contact^h	166	1,033	49,572	19,027	42	9,925	2,951	82,745
Perinatalⁱ	5	57	2,824	1,364	3	554	319	5,134
Other^j	14	71	795	472	1	1,340	132	2,831
Subtotal	2,405	12,845	281,152	212,835	796	263,632	37,438	811,640
Female adult or adolescent^g
Injection drug use	270	189	22,931	10,728	22	12,543	2,856	49,607
Heterosexual contact^h	517	2,358	113,849	39,563	125	26,308	8,113	190,957
Perinatalⁱ	9	54	3,367	1,448	0	615	351	5,850
Other^j	11	70	798	282	1	482	79	1,730
Subtotal	806	2,671	140,945	52,020	148	39,947	11,399	248,144
Child (<13 yrs at end of year)
Perinatal	6	68	820	206	3	150	118	1,371
Other^j	0	40	184	22	0	64	17	327
Subtotal	6	108	1,004	228	3	214	135	1,698
Region of residence^k
Northeast	150	3,397	90,482	72,891	66	54,358	14,808	236,502
Midwest	384	1,559	53,976	15,502	51	47,785	5,837	125,214
South	789	3,121	245,579	90,951	154	114,971	19,824	475,547
West	1,892	7,481	32,744	69,770	641	86,587	8,485	207,714
U.S. dependent areas	2	66	320	15,969	35	92	18	16,505
Total	3,217	15,624	423,101	265,083	947	303,793	48,972	1,061,482

Note: Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020. Numbers less than 12 should be interpreted with caution.

^aIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
^bHispanic/Latino persons can be of any race.
^cIncludes persons whose race/ethnicity is unknown.
^d“Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
^eAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
^fData have been statistically adjusted to account for missing transmission category, therefore values may not sum to column subtotals and total.
^gData presented based on sex at birth and includes transgender persons.
^hHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
ⁱIncludes individuals ≥13 years of age at time of diagnosis of HIV infection.
^jIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
^kData are based on address of residence at the end of the specified year (i.e., most recent known address).

Table 17a. Adults and adolescents living with diagnosed HIV infection, by year, sex at birth, and selected characteristics, 2015–2019—United States
	2015		2016		2017		2018		2019
	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a
Male adult or adolescent
Age at end of year
13–14	336	8.0	311	7.4	299	7.1	295	6.9	304	7.1
15–19	3,122	29.0	2,953	27.3	2,966	27.5	2,858	26.6	2,833	26.4
20–24	24,765	212.8	24,170	210.6	23,113	204.4	22,037	197.4	21,292	192.4
25–29	53,410	468.9	56,677	486.3	58,949	496.2	59,600	497.0	58,532	487.6
30–34	58,452	537.8	62,252	566.5	66,179	597.8	71,450	639.6	76,801	676.4
35–39	62,394	615.3	65,291	628.8	68,053	642.5	70,512	654.5	73,122	671.8
40–44	71,635	717.1	68,463	700.8	67,791	697.5	68,532	700.7	70,436	711.0
45–49	106,574	1,035.8	101,126	976.4	95,419	921.8	89,755	875.7	84,310	836.0
50–54	128,405	1,175.6	128,283	1197.8	1,25,078	1192.7	120,177	1170.8	114,106	1131.3
55–59	98,021	928.3	104,329	978.3	111,031	1040.5	117,735	1104.6	123,538	1160.8
60–64	61,117	672.7	67,313	724.0	73,721	773.6	79,688	819.9	85,673	869.2
≥65	53,379	253.7	60,937	279.8	69,311	307.8	78,505	337.2	89,088	370.1
Race/ethnicity
American Indian/Alaska Native	1,877	200.0	2,016	212.7	2,149	224.6	2,270	235.1	2,403	246.7
Asian^b	9,823	142.6	10,574	148.6	11,389	155.4	12,140	161.9	12,790	166.7
Black/African American	251,798	1635.9	259,391	1,666.4	266,544	1,694.6	273,648	1723.3	280,963	1752.4
Hispanic/Latino^c	171,505	793.0	179,157	808.6	186,742	823.7	194,267	837.9	201,595	852.0
Native Hawaiian/other Pacific Islander	608	269.0	632	273.1	669	283.0	719	298.1	768	312.2
White	248,632	296.7	252,552	300.9	256,433	305.3	260,102	309.6	263,558	313.7
Multiracial	36,824	1796.6	37,244	1752.7	37,446	1700.9	37,460	1644.2	37,423	1586.6
Region of residence^d
Northeast	158,956	691.0	162,350	704.4	164,219	711.3	166,141	718.8	167,941	726.3
Midwest	88,896	320.2	91,806	329.5	94,294	337.2	96,766	344.9	98,809	351.0
South	312,392	637.9	321,138	647.8	331,632	661.6	341,792	675.3	352,323	689.3
West	161,366	517.6	166,811	528.2	171,765	537.7	176,445	546.7	180,962	555.4
Subtotal	721,610	551.2	742,105	561.9	761,910	572.3	781,144	582.7	800,035	592.8
Female adult or adolescent
Age at end of year
13–14	387	9.6	365	9.1	367	9.0	369	9.1	341	8.4
15–19	1,833	17.8	1,673	16.2	1,557	15.1	1,476	14.3	1,380	13.4
20–24	6,012	54.5	5,608	51.6	5,268	49.1	4,895	46.0	4,632	43.8
25–29	11,665	105.9	11,608	103.1	11,395	99.5	11,199	97.2	10,694	93.0
30–34	17,295	160.7	16,842	155.5	16,565	152.5	16,216	148.4	16,325	147.4
35–39	24,400	240.1	24,196	232.7	23,703	223.9	23,097	214.7	22,421	206.6
40–44	29,575	291.6	28,799	290.6	28,180	285.9	28,106	283.9	27,738	277.0
45–49	35,682	340.7	34,992	331.6	34,624	328.2	33,590	320.9	32,885	318.9
50–54	37,700	332.7	38,172	344.3	37,843	348.9	37,477	353.7	36,810	354.3
55–59	29,550	264.5	31,421	278.6	33,360	295.9	35,094	311.7	36,734	327.0
60–64	18,025	181.6	20,199	199.0	22,347	214.9	24,532	231.7	26,574	248.0
≥65	15,255	57.3	17,600	64.2	20,329	72.0	23,257	80.0	26,715	89.1
Race/ethnicity
American Indian/Alaska Native	700	71.5	733	74.1	764	76.4	779	77.1	806	79.0
Asian^b	2,134	27.5	2,289	28.6	2,421	29.3	2,543	30.1	2,660	30.8
Black/African American	132,019	765.0	134,346	770.6	136,657	776.2	138,711	780.8	140,815	785.4
Hispanic/Latino^c	43,557	204.7	44,452	203.8	45,450	203.4	46,419	203.0	47,294	202.5
Native Hawaiian/other Pacific Islander	127	56.7	129	56.3	134	57.2	138	57.6	142	58.1
White	37,110	42.5	37,800	43.3	38,436	44.0	39,089	44.7	39,929	45.7
Multiracial	11,523	524.8	11,517	507.7	11,468	489.3	11,421	472.1	11,396	456.4
Region of residence^d
Northeast	67,085	272.3	67,837	275.2	68,027	275.7	68,236	276.4	68,306	276.7
Midwest	23,219	80.3	23,961	82.6	24,634	84.7	25,295	86.7	25,996	88.9
South	113,536	219.5	115,314	220.2	117,840	222.5	120,008	224.3	122,463	226.5
West	23,539	74.3	24,363	75.9	25,037	77.2	25,769	78.7	26,484	80.1
Subtotal	227,379	166.0	231,475	167.6	235,538	169.2	239,308	170.8	243,249	172.5
Total	948,989	354.2	973,580	360.4	997,448	366.3	1,020,452	372.2	1,043,284	378.0

Note: Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020.

^aRates are per 100,000 population.
^bIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
^cHispanic/Latino persons can be of any race.
^dData are based on address of residence at the end of the specified year (i.e., most recent known address).

Table 17b. Adults and adolescents living with diagnosed HIV infection, by year, sex at birth, and selected characteristics, 2015–2019—United States and 6 dependent areas
	2015		2016		2017		2018		2019
	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a
Male adult or adolescent
Age at end of year
13–14	339	7.9	313	7.4	301	7.1	299	7.0	307	7.1
15–19	3,160	28.9	2,980	27.3	2,988	27.4	2,884	26.5	2,849	26.2
20–24	25,060	212.8	24,435	210.4	23,342	204.1	22,232	196.9	21,484	192.0
25–29	53,997	468.9	57,275	486.2	59,510	495.7	60,167	496.7	59,089	487.2
30–34	59,152	538.7	62,965	567.4	66,863	598.4	72,119	640.0	77,500	676.5
35–39	63,406	618.2	66,262	631.3	68,950	644.4	71,344	656.0	73,913	672.8
40–44	72,817	720.4	69,594	704.2	68,883	700.8	69,595	703.9	71,465	713.7
45–49	108,426	1041.6	102,809	981.4	96,924	926.0	91,077	879.0	85,553	839.1
50–54	130,544	1182.1	130,412	1204.2	127,156	1199.0	122,203	1,177.4	115,967	1137.0
55–59	99,695	933.9	106,066	984.0	112,852	1046.4	119,641	1,110.7	125,567	1167.5
60–64	62,230	677.2	68,540	729.0	75,028	778.7	81,073	825.2	87,120	874.5
≥65	54,514	255.6	62,205	281.8	70,724	309.9	80,035	339.3	90,826	372.4
Race/ethnicity
American Indian/Alaska Native	1,879	—	2,018	—	2,151	—	2,272	—	2,405	—
Asian^b	9,863	—	10,615	—	11,434	—	12,190	—	12,845	—
Black/African American	251,985	—	259,572	—	266,722	—	273,836	—	281,152	—
Hispanic/Latino^c	182,905	—	190,579	—	198,015	—	205,443	—	212,835	—
Native Hawaiian/other Pacific Islander	626	—	655	—	697	—	748	—	796	—
White	248,697	—	252,616	—	256,498	—	260,166	—	263,632	—
Multiracial	36,840	—	37,260	—	37,464	—	37,474	—	37,438	—
Region of residence^d
Northeast	158,956	691.0	162,350	704.4	164,219	711.3	166,141	718.8	167,941	726.3
Midwest	88,896	320.2	91,806	329.5	94,294	337.2	96,766	344.9	98,809	351.0
South	312,392	637.9	321,138	647.8	331,632	661.6	341,792	675.3	352,323	689.3
West	161,366	517.6	166,811	528.2	171,765	537.7	176,445	546.7	180,962	555.4
U.S. dependent areas	11,730	752.9	11,751	764.8	11,611	767.5	11,525	783.1	11,605	785.1
Subtotal	733,340	553.6	753,856	564.3	773,521	574.5	792,669	584.9	811,640	594.9
Female adult or adolescent
Age at end of year
13–14	390	9.5	366	9.0	371	9.0	373	9.1	342	8.3
15–19	1,864	17.9	1,694	16.2	1,580	15.1	1,491	14.3	1,389	13.3
20–24	6,112	54.7	5,693	51.7	5,337	49.1	4,964	46.1	4,684	43.8
25–29	11,848	106.3	11,770	103.4	11,541	99.7	11,331	97.3	10,821	93.1
30–34	17,568	161.5	17,098	156.2	16,797	153.0	16,424	148.9	16,524	147.7
35–39	24,847	241.4	24,631	234.1	24,092	225.0	23,445	215.6	22,713	207.2
40–44	30,183	293.9	29,351	292.5	28,689	287.5	28,580	285.3	28,179	278.2
45–49	36,447	343.6	35,730	334.5	35,313	330.8	34,252	323.4	33,518	321.3
50–54	38,646	337.0	39,082	348.2	38,709	352.5	38,283	357.0	37,563	357.2
55–59	30,339	268.3	32,257	282.7	34,197	299.8	35,936	315.5	37,619	331.0
60–64	18,486	184.0	20,712	201.6	22,897	217.6	25,173	235.0	27,263	251.5
≥65	15,802	58.5	18,194	65.4	20,985	73.3	23,970	81.3	27,529	90.6
Race/ethnicity
American Indian/Alaska Native	700	—	733	—	764	—	779	—	806	—
Asian^b	2,145	—	2,300	—	2,432	—	2,554	—	2,671	—
Black/African American	132,153	—	134,475	—	136,785	—	138,838	—	140,945	—
Hispanic/Latino^c	48,536	—	49,387	—	50,251	—	51,167	—	52,020	—
Native Hawaiian/other Pacific Islander	135	—	136	—	141	—	143	—	148	—
White	37,126	—	37,816	—	38,454	—	39,106	—	39,947	—
Multiracial	11,527	—	11,521	—	11,472	—	11,426	—	11,399	—
Region of residence^d
Northeast	67,085	272.3	67,837	275.2	68,027	275.7	68,236	276.4	68,306	276.7
Midwest	23,219	80.3	23,961	82.6	24,634	84.7	25,295	86.7	25,996	88.9
South	113,536	219.5	115,314	220.2	117,840	222.5	120,008	224.3	122,463	226.5
West	23,539	74.3	24,363	75.9	25,037	77.2	25,769	78.7	26,484	80.1
U.S. dependent areas	5,153	298.1	5,103	298.4	4,970	295.2	4,914	300.2	4,895	297.4
Subtotal	232,532	167.6	236,578	169.2	240,508	170.7	244,222	172.3	248,144	173.9
Total	965,872	356.2	990,434	362.2	1,014,029	368.1	1,036,891	373.9	1,059,784	379.7

Note: Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020.

^aRates are per 100,000 population. Rates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas.
^bIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
^cHispanic/Latino persons can be of any race.
^dData are based on address of residence at the end of the specified year (i.e., most recent known address).

Table 18a. Transgender adults and adolescents living with diagnosed HIV infection, by year and selected characteristics, 2015–2019—United States
	2015	2016	2017	2018	2019
	No.	No.	No.	No.	No.
Transgender male-to-female^a
Age at end of year
13–14	0	0	0	0	0
15–19	112	94	83	60	58
20–24	805	806	754	721	689
25–29	1,670	1,775	1,816	1,806	1,723
30–34	1,414	1,535	1,740	1,932	2,172
35–39	1,190	1,333	1,423	1,529	1,639
40–44	1,054	1,068	1,091	1,161	1,236
45–49	1,057	1,061	1,056	1,071	1,116
50–54	813	874	955	1,003	999
55–59	478	539	587	664	754
60–64	233	263	301	334	367
≥65	115	131	168	196	247
Race/ethnicity
American Indian/Alaska Native	35	38	40	48	52
Asian^b	133	138	155	164	176
Black/African American	4,063	4,329	4,570	4,809	5,039
Hispanic/Latino^c	3,019	3,220	3,391	3,588	3,800
Native Hawaiian/other Pacific Islander	24	25	27	30	34
White	926	960	1,011	1,046	1,108
Multiracial	741	769	780	792	791
Region of residence^d
Northeast	2,406	2,604	2,723	2,861	2,964
Midwest	1,149	1,227	1,301	1,386	1,430
South	3,154	3,312	3,508	3,657	3,856
West	2,232	2,336	2,442	2,573	2,750
Subtotal	8,941	9,479	9,974	10,477	11,000
Transgender female-to-male^a
Age at end of year
13–14	1	0	0	0	0
15–19	4	6	7	6	4
20–24	18	13	17	21	29
25–29	34	40	56	68	72
30–34	49	49	42	57	78
35–39	44	50	62	64	64
40–44	43	42	40	49	53
45–49	43	42	45	49	52
50–54	38	45	46	45	42
55–59	25	26	26	23	32
60–64	10	15	19	25	21
≥65	8	8	8	10	13
Race/ethnicity
American Indian/Alaska Native	4	4	4	4	4
Asian^b	2	3	6	8	9
Black/African American	155	159	168	188	206
Hispanic/Latino^c	65	71	78	88	100
Native Hawaiian/other Pacific Islander	0	0	0	0	0
White	65	70	81	97	107
Multiracial	26	29	31	32	34
Region of residence^d
Northeast	65	64	69	75	82
Midwest	94	99	105	115	119
South	91	96	109	125	143
West	67	77	85	102	116
Subtotal	317	336	368	417	460
Total	9,258	9,815	10,342	10,894	11,460

Note: Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020. Additional gender identity not included due to small numbers. Numbers less than 12 should be interpreted with caution.

^aTransgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
^bIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
^cHispanic/Latino persons can be of any race.
^dData are based on address of residence at the end of the specified year (i.e., most recent known address).

Table 18b. Transgender adults and adolescents living with diagnosed HIV infection, by year and selected characteristics, 2015–2019—United States and 6 dependent areas
	2015	2016	2017	2018	2019
	No.	No.	No.	No.	No.
Transgender male-to-female^a
Age at end of year
13–14	0	0	0	0	0
15–19	113	94	83	60	58
20–24	809	810	757	724	693
25–29	1,674	1,779	1,819	1,810	1,727
30–34	1,419	1,539	1,747	1,937	2,176
35–39	1,194	1,338	1,426	1,531	1,640
40–44	1,055	1,070	1,093	1,166	1,242
45–49	1,062	1,063	1,058	1,071	1,117
50–54	817	878	958	1,004	1,002
55–59	480	543	592	669	758
60–64	233	264	302	335	369
≥65	117	133	170	198	248
Race/ethnicity
American Indian/Alaska Native	35	38	40	48	52
Asian^b	133	138	155	164	176
Black/African American	4,063	4,329	4,570	4,809	5,039
Hispanic/Latino^c	3,051	3,252	3,422	3,616	3,829
Native Hawaiian/other Pacific Islander	24	25	27	30	35
White	926	960	1,011	1,046	1,108
Multiracial	741	769	780	792	791
Region of residence^d
Northeast	2,406	2,604	2,723	2,861	2,964
Midwest	1,149	1,227	1,301	1,386	1,430
South	3,154	3,312	3,508	3,657	3,856
West	2,232	2,336	2,442	2,573	2,750
US dependent areas	32	32	31	28	30
Subtotal	8,973	9,511	10,005	10,505	11,030
Transgender female-to-male^a
Age at end of year
13–14	1	0	0	0	0
15–19	5	7	8	7	4
20–24	18	13	17	21	30
25–29	34	40	56	68	72
30–34	49	49	42	57	78
35–39	44	50	62	64	64
40–44	43	42	40	49	53
45–49	43	42	45	49	52
50–54	38	45	46	45	42
55–59	25	26	26	23	32
60–64	10	15	19	25	21
≥65	8	8	8	10	13
Race/ethnicity
American Indian/Alaska Native	4	4	4	4	4
Asian^b	2	3	6	8	9
Black/African American	155	159	168	188	206
Hispanic/Latino^c	66	72	79	89	101
Native Hawaiian/other Pacific Islander	0	0	0	0	0
White	65	70	81	97	107
Multiracial	26	29	31	32	34
Region of residence^d
Northeast	65	64	69	75	82
Midwest	94	99	105	115	119
South	91	96	109	125	143
West	67	77	85	102	116
US dependent areas	1	1	1	1	1
Subtotal	318	337	369	418	461
Total	9,291	9,848	10,374	10,923	11,491

Note: Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020. Additional gender identity not included due to small numbers. Numbers less than 12 should be interpreted with caution.

^aTransgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
^bIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
^cHispanic/Latino persons can be of any race.
^dData are based on address of residence at the end of the specified year (i.e., most recent known address).

Table 19a. Adolescents and young adults living with diagnosed HIV infection, by 2-year and 3-year age groups, and selected characteristics, year-end 2019—United States
	13–14 years of age at end of year		15–17 years of age at end of year		18–19 years of age at end of year		20–22 years of age at end of year		23–24 years of age at end of year		Total
	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a
Gender
Male	304	—	769	—	2,003	—	8,986	—	11,595	—	23,657	—
Female	341	—	657	—	718	—	2,127	—	2,475	—	6,318	—
Transgender male-to-female^b	0	—	5	—	53	—	313	—	376	—	747	—
Transgender female-to-male^b	0	—	0	—	4	—	21	—	8	—	33	—
Additional gender identity^c	0	—	0	—	4	—	12	—	11	—	27	—
Race/Ethnicity
American Indian/Alaska Native	1	1.4	5	4.8	7	9.6	45	41.5	67	91.6	125	29.1
Asian^d	30	7.1	52	8.0	44	9.6	171	23.9	240	44.4	537	19.3
Black/African American	412	36.4	861	51.0	1,647	136.6	6,465	357.0	7,677	614.6	17,062	240.7
Hispanic/Latino^e	83	3.9	262	8.7	677	33.6	2,842	97.6	3,759	194.4	7,623	63.6
Native Hawaiian/Other Pacific Islander	1	5.9	2	8.1	3	17.9	10	39.9	15	83.7	31	30.6
White	77	1.8	175	2.7	307	6.8	1,491	21.7	2,107	44.7	4,157	15.5
Multiracial	41	12.2	74	16.1	96	32.7	431	104.2	599	231.3	1,241	70.4
Transmission Category^f
Males
Male-to-male sexual contact	6	—	262	—	1,615	—	8,058	—	10,494	—	20,435	—
Injection drug use	1	—	2	—	9	—	85	—	144	—	240	—
Male-to-male sexual contact and injection drug use	0	—	6	—	31	—	236	—	419	—	692	—
Heterosexual contact^g	0	—	13	—	51	—	233	—	352	—	649	—
Perinatal^h	243	—	380	—	305	—	625	—	533	—	2,086	—
Otherⁱ	54	—	111	—	48	—	74	—	39	—	326	—
Subtotal	304	7.1	774	12.2	2,059	46.9	9,310	141.8	11,982	266.3	24,429	93.7
Females
Injection drug use	1	—	11	—	27	—	125	—	186	—	350	—
Heterosexual contact^g	8	—	86	—	261	—	1,212	—	1,562	—	3,128	—
Perinatal^h	273	—	446	—	379	—	752	—	686	—	2,536	—
Otherⁱ	60	—	114	—	56	—	60	—	48	—	339	—
Subtotal	341	8.4	657	10.8	723	17.2	2,149	34.2	2,483	57.9	6,353	25.5
Region of Residence^j
Northeast	114	8.7	265	13.1	488	33.0	1,837	84.7	2,397	165.4	5,101	60.5
Midwest	145	8.2	228	8.6	427	23.6	1,720	62.4	2,100	115.1	4,620	42.8
South	279	8.6	692	14.4	1,505	45.8	6,165	126.2	7,517	225.8	16,158	82.6
West	107	5.3	246	8.2	362	18.0	1,737	57.2	2,451	112.3	4,903	40.1
Total^k	645	7.7	1,431	11.5	2,782	32.4	11,459	89.2	14,465	164.6	30,782	60.3

Note: Numbers less than 12, and rates based on these numbers, should be interpreted with caution. Data for the year 2019 are considered preliminary and based on death data received by CDC through December 2020.

^aRates are per 100,000 population. Rates are not calculated by transmission category because of the lack of denominator data.
^b“Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
^cAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
^dIncludes Asian/Pacific Islander legacy cases.
^eHispanic/Latino persons can be of any race.
^fData have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
^gHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
^hIndividuals were ≥13 years of age at time of diagnosis of HIV infection.
ⁱIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
^jData are based on address of residence at the end of the specified year (i.e., most recent known address).
^kIncludes persons whose race/ethnicity is unknown.

Table 19b. Adolescents and young adults living with diagnosed HIV infection, by 2-year and 3-year age groups, and selected characteristics, year-end 2019—United States and 6 dependent areas
	13–14 years of age at end of year	15–17 years of age at end of year	18–19 years of age at end of year	20–22 years of age at end of year	23–24 years of age at end of year	Total
	No.	No.	No.	No.	No.	No.
Gender
Male	307	773	2,015	9,059	11,710	23,864
Female	342	662	722	2,148	2,505	6,379
Transgender male-to-female^a	0	5	53	314	379	751
Transgender female-to-male^a	0	0	4	22	8	34
Additional gender identity^b	0	0	4	12	11	27
Race/Ethnicity
American Indian/Alaska Native	1	5	7	45	67	125
Asian^c	30	52	44	171	240	537
Black/African American	412	863	1,647	6,466	7,677	17,065
Hispanic/Latino^d	87	268	693	2,935	3,905	7,888
Native Hawaiian/Other Pacific Islander	1	2	3	11	15	32
White	77	175	307	1,492	2,108	4,159
Multiracial	41	75	96	431	600	1,243
Transmission Category^e
Males
Male-to-male sexual contact	6	262	1,622	8,108	10,586	20,585
Injection drug use	1	2	9	86	145	242
Male-to-male sexual contact and injection drug use	0	6	31	238	422	697
Heterosexual contact^f	0	13	51	236	360	661
Perinatal^g	246	384	310	641	545	2,126
Other^h	54	111	48	76	40	329
Subtotal	307	778	2,071	9,384	12,100	24,640
Females
Injection drug use	1	11	27	125	186	351
Heterosexual contact^f	8	87	261	1,224	1,583	3,163
Perinatal^g	274	450	383	759	695	2,561
Other^h	60	114	56	62	48	341
Subtotal	342	662	727	2,171	2,513	6,415
Region of Residenceⁱ
Northeast	114	265	488	1,837	2,397	5,101
Midwest	145	228	427	1,720	2,100	4,620
South	279	692	1,505	6,165	7,517	16,158
West	107	246	362	1,737	2,451	4,903
U.S. dependent areas	4	9	16	96	148	273
Total^j	649	1,440	2,798	11,555	14,613	31,055

Note: Numbers less than 12 should be interpreted with caution. Data for the year 2019 are considered preliminary and based on death data received by CDC through December 2020.

^a“Transgender male-to-female” includes individuals who were assigned “male” sex at birth but have ever identified as “female” gender. “Transgender female-to-male” includes individuals who were assigned “female” sex at birth but have ever identified as “male” gender.
^bAdditional gender identity examples include “bigender,” “gender queer,” and “two-spirit.”
^cIncludes Asian/Pacific Islander legacy cases.
^dHispanic/Latino persons can be of any race.
^eData have been statistically adjusted to account for missing transmission category; therefore, values may not sum to column subtotals and total.
^fHeterosexual contact with a person known to have, or with a risk factor for, HIV infection.
^gIndividuals were ≥13 years of age at time of diagnosis of HIV infection.
^hIncludes hemophilia, blood transfusion, and risk factor not reported or not identified.
ⁱData are based on address of residence at the end of the specified year (i.e., most recent known address).
^jIncludes persons whose race/ethnicity is unknown.

Table 20. Diagnoses of HIV infection, 2019, and persons living with diagnosed HIV infection (prevalence), year-end 2019, by area of residence—United States and 6 dependent areas
	Diagnoses						Prevalence of diagnosed HIV infection, year-end 2019
	Adults and Adolescents		Children		Total		Adults and Adolescents		Children		Total
Area of residence	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a	No.	Rate^a
Alabama	638	15.5	0	0.0	638	13.0	13,875	336.4	37	4.7	13,912	283.7
Alaska	27	4.5	0	0.0	27	3.7	724	120.9	2	1.5	726	99.2
Arizona	761	12.5	2	0.2	763	10.5	17,296	283.1	34	2.9	17,330	238.1
Arkansas	287	11.4	0	0.0	287	9.5	5,939	236.0	13	2.6	5,952	197.2
California	4,354	13.1	4	0.1	4,358	11.0	132,911	401.1	105	1.6	133,016	336.6
Colorado	461	9.5	4	0.4	465	8.1	13,025	267.9	36	4.0	13,061	226.8
Connecticut	213	7.0	1	0.2	214	6.0	10,597	346.0	11	2.2	10,608	297.5
Delaware	93	11.2	0	0.0	93	9.6	3,381	408.2	5	3.4	3,386	347.7
District of Columbia	255	42.2	2	2.0	257	36.4	14,041	2,325.4	15	14.7	14,056	1991.6
Florida	4,378	23.7	6	0.2	4,384	20.4	113,478	615.0	143	4.7	113,621	529.0
Georgia	2,439	27.6	10	0.6	2,449	23.1	56,446	638.5	93	5.2	56,539	532.5
Hawaii	65	5.4	0	0.0	65	4.6	2,387	199.8	2	0.9	2,389	168.7
Idaho	28	1.9	0	0.0	28	1.6	1,234	84.0	8	2.5	1,242	69.5
Illinois	1,252	11.7	3	0.2	1,255	9.9	35,841	335.7	103	5.2	35,944	283.7
Indiana	486	8.7	2	0.2	488	7.2	11,638	207.3	58	5.2	11,696	173.7
Iowa	100	3.8	0	0.0	100	3.2	2,888	109.6	15	2.9	2,903	92.0
Kansas	131	5.4	1	0.2	132	4.5	3,174	131.6	12	2.4	3,186	109.4
Kentucky	326	8.7	2	0.3	328	7.3	7,638	203.8	15	2.1	7,653	171.3
Louisiana	881	22.8	0	0.0	881	19.0	21,289	551.4	31	3.9	21,320	458.6
Maine	30	2.6	0	0.0	30	2.2	1,649	140.9	13	7.5	1,662	123.6
Maryland	918	18.0	0	0.0	918	15.2	33,378	656.2	49	5.1	33,427	552.9
Massachusetts	535	9.0	0	0.0	535	7.8	21,065	354.6	24	2.5	21,089	306.0
Michigan	674	8.0	1	0.1	675	6.8	16,586	195.8	61	4.0	16,647	166.7
Minnesota	274	5.8	0	0.0	274	4.9	8,816	187.4	40	4.3	8,856	157.0
Mississippi	477	19.2	0	0.0	477	16.0	9,832	396.7	5	1.0	9,837	330.5
Missouri	488	9.5	0	0.0	488	8.0	12,803	248.3	30	3.1	12,833	209.1
Montana	25	2.8	0	0.0	25	2.3	669	74.0	2	1.2	671	62.8
Nebraska	81	5.1	0	0.0	81	4.2	2,236	140.6	8	2.3	2,244	116.0
Nevada	512	19.8	0	0.0	512	16.6	10,733	415.8	7	1.4	10,740	348.7
New Hampshire	31	2.6	0	0.0	31	2.3	1,306	110.4	7	4.0	1,313	96.6
New Jersey	1,057	14.1	2	0.1	1,059	11.9	35,131	468.0	47	3.4	35,178	396.1
New Mexico	156	8.9	0	0.0	156	7.4	3,734	212.2	9	2.7	3,743	178.5
New York	2,330	14.1	4	0.1	2,334	12.0	126,630	765.0	83	2.9	126,713	651.4
North Carolina	1,365	15.4	4	0.2	1,369	13.1	33,009	373.0	69	4.2	33,078	315.4
North Dakota	40	6.4	0	0.0	40	5.2	493	78.6	5	3.7	498	65.3
Ohio	980	9.9	1	0.1	981	8.4	23,179	235.3	52	2.8	23,231	198.7
Oklahoma	320	9.8	1	0.1	321	8.1	6,351	194.2	25	3.6	6,376	161.1
Oregon	199	5.5	0	0.0	199	4.7	7,280	202.4	17	2.7	7,297	173.0
Pennsylvania	989	9.0	0	0.0	989	7.7	36,494	333.9	60	3.2	36,554	285.5
Rhode Island	72	7.9	0	0.0	72	6.8	2,653	289.7	5	3.5	2,658	250.9
South Carolina	680	15.6	1	0.1	681	13.2	17,589	404.0	26	3.3	17,615	342.1
South Dakota	33	4.5	0	0.0	33	3.7	652	89.8	5	3.1	657	74.3
Tennessee	773	13.4	1	0.1	774	11.3	17,667	307.3	55	5.1	17,722	259.5
Texas	4,302	18.2	6	0.1	4,308	14.9	95,196	402.1	141	2.7	95,337	328.8
Utah	135	5.3	0	0.0	135	4.2	3,089	121.7	14	2.1	3,103	96.8
Vermont	11	2.0	0	0.0	11	1.8	722	132.7	5	6.3	727	116.5
Virginia	822	11.4	2	0.1	824	9.7	23,691	329.0	36	2.7	23,727	278.0
Washington	483	7.5	0	0.0	483	6.3	14,019	218.8	30	2.5	14,049	184.5
West Virginia	146	9.5	0	0.0	146	8.1	1,986	129.2	3	1.2	1,989	111.0
Wisconsin	211	4.3	1	0.1	212	3.6	6,499	131.9	20	2.2	6,519	112.0
Wyoming	13	2.7	0	0.0	13	2.2	345	71.5	2	2.1	347	60.0
Subtotal	36,337	13.2	61	0.1	36,398	11.1	1,043,284	378.0	1,693	3.2	1,044,977	318.4
U.S. dependent areas
American Samoa	0	0.0	0	0.0	0	0.0	1	2.6	0	0.0	1	2.0
Guam	10	7.8	0	0.0	10	5.9	107	83.8	1	2.5	108	64.2
Northern Mariana Islands	2	4.9	0	0.0	2	3.9	16	39.4	0	0.0	16	30.9
Puerto Rico	383	13.6	0	0.0	383	12.0	15,837	563.3	2	0.5	15,839	495.9
Republic of Palau	0	0.0	0	0.0	0	0.0	9	49.4	0	0.0	9	41.7
U.S. Virgin Islands	8	9.1	0	0.0	8	7.5	530	603.2	2	10.7	532	498.9
Subtotal	403	12.9	0	0.0	403	11.2	16,500	528.2	5	1.1	16,505	459.5
Total	36,740	13.2	61	0.1	36,801	11.1	1,059,784	379.7	1,698	3.2	1,061,482	319.9

Note: Numbers less than 12, and rates based on these numbers, should be interpreted with caution. Diagnoses data are based on residence at time of diagnosis of HIV infection.
Prevalence data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020.

^aRates are per 100,000 population.

Table 21. Adults and adolescents living with diagnosed HIV infection, by race/ethnicity and area of residence, year-end 2019—United States and 6 dependent areas
	American Indian/Alaska Native		Asian^a		Black/African American		Hispanic/Latino^b		Native Hawaiian/other Pacific Islander		White		Multiracial		Total^c
Area of residence	No.	Rate^d	No.	Rate^d	No.	Rate^d	No.	Rate^d	No.	Rate^d	No.	Rate^d	No.	Rate^d	No.	Rate^d
Alabama	6	24.5	39	63.7	8,767	817.7	497	319.3	3	143.8	3,722	134.9	799	1,598.1	13,875	336.4
Alaska	192	231.0	29	72.7	95	472.6	83	211.3	4	51.3	277	73.7	44	132.9	724	120.9
Arizona	674	294.7	221	102.0	2,340	876.9	5,507	308.0	26	221.4	7,905	226.3	579	558.0	17,296	283.1
Arkansas	7	35.8	25	61.7	2,592	689.5	431	250.6	6	75.6	2,576	138.3	298	778.1	5,939	236.0
California	299	215.0	5,580	108.6	21,751	1,144.8	51,551	420.8	238	193.5	48,112	376.0	5,371	682.8	132,911	401.1
Colorado	82	257.1	150	90.6	1,950	1,006.4	3,148	323.1	17	255.9	7,321	215.5	310	332.8	13,025	267.9
Connecticut	10	158.4	108	73.7	3,540	1,140.4	3,634	776.4	7	680.3	3,044	145.8	253	584.1	10,597	346.0
Delaware	3	112.9	7	21.1	1,923	1,081.4	319	464.2	1	359.7	987	186.0	140	943.3	3,381	408.2
District of Columbia	14	1,117.3	74	264.1	9,848	3757.8	1,213	1,967.0	7	2,456.1	2,102	880.6	778	6,587.6	14,041	2325.4
Florida	73	152.0	621	116.2	50,270	1,841.7	28,795	615.0	47	397.7	30,862	302.5	2,806	1,157.0	113,478	615.0
Georgia	22	104.2	273	71.1	38,693	1,400.4	4,437	573.0	16	298.1	9,998	209.8	3,000	2,351.7	56,446	638.5
Hawaii	6	223.8	391	83.5	120	515.0	310	289.4	222	199.9	1,068	391.8	270	128.5	2,387	199.8
Idaho	15	93.4	7	31.4	115	1,091.9	213	125.5	2	76.9	838	68.6	44	174.9	1,234	84.0
Illinois	31	186.1	494	78.7	16,534	1,118.2	7,372	427.4	20	658.3	9,384	140.3	2,004	1,454.0	35,841	335.7
Indiana	8	58.9	216	150.9	4,333	836.3	1,189	329.7	2	98.3	5,387	119.8	502	628.9	11,638	207.3
Iowa	5	65.0	60	86.9	655	704.2	302	211.2	3	96.4	1,703	74.5	160	483.2	2,888	109.6
Kansas	14	70.6	51	66.4	795	585.2	567	216.7	1	44.9	1,598	85.7	145	291.1	3,174	131.6
Kentucky	6	72.7	64	111.1	2,410	799.7	573	456.4	3	122.3	4,246	132.6	335	654.3	7,638	203.8
Louisiana	33	129.7	75	108.0	14,409	1,182.9	1,196	649.4	4	261.4	5,138	221.6	431	986.1	21,289	551.4
Maine	7	94.2	7	46.6	294	1,823.8	115	619.9	0	0.0	1,181	107.6	44	279.9	1,649	140.9
Maryland	20	157.6	249	72.9	23,803	1,567.4	2,428	510.5	3	119.7	4,175	158.3	2,700	2,768.2	33,378	656.2
Massachusetts	27	254.1	468	111.1	6,294	1,500.3	5,717	861.3	8	321.8	8,117	187.2	432	496.7	21,065	354.6
Michigan	32	66.3	143	50.5	9,091	807.7	1,102	276.7	2	85.1	5,611	86.8	602	398.2	16,586	195.8
Minnesota	105	227.3	177	76.4	3,212	1,128.6	1,002	436.0	5	222.2	3,890	101.6	420	514.5	8,816	187.4
Mississippi	13	107.5	24	86.7	7,209	794.5	355	481.7	2	227.3	1,827	127.3	367	1,671.4	9,832	396.7
Missouri	9	39.2	91	81.7	5,557	960.6	821	413.3	6	93.4	5,823	140.2	494	574.9	12,803	248.3
Montana	28	57.2	4	47.9	22	470.0	49	154.7	1	151.3	529	66.9	36	189.5	669	74.0
Nebraska	30	241.7	50	118.6	622	839.8	370	237.6	4	408.6	1,089	84.9	70	300.2	2,236	140.6
Nevada	50	224.3	348	152.3	2,802	1,202.9	2,851	410.1	45	272.7	4,257	324.3	378	517.2	10,733	415.8
New Hampshire	1	38.6	16	47.1	158	960.3	196	462.1	0	0.0	885	82.5	49	325.3	1,306	110.4
New Jersey	15	136.3	377	51.1	15,169	1,572.9	10,519	720.9	8	316.5	6,567	154.9	2,427	2,612.6	35,131	468.0
New Mexico	318	210.8	19	65.7	231	689.7	1,790	216.0	1	84.0	1,267	182.9	107	458.6	3,734	212.2
New York	50	102.4	2,034	137.5	47,024	1,974.2	45,350	1508.2	25	335.5	22,213	236.6	9,642	4,066.3	126,630	765.0
North Carolina	177	181.1	197	73.4	20,025	1,069.8	2,964	401.1	15	266.2	8,004	139.6	1,620	1,222.6	33,009	373.0
North Dakota	18	62.1	3	28.8	198	1,064.5	33	151.1	1	247.5	224	41.7	16	163.2	493	78.6
Ohio	12	60.7	134	55.5	10,157	848.3	1,692	486.8	4	104.0	9,970	126.5	1,108	691.2	23,179	235.3
Oklahoma	332	124.7	94	121.6	1,505	628.5	736	234.8	9	163.6	3,250	146.9	425	272.6	6,351	194.2
Oregon	57	143.7	146	83.9	548	811.9	1,129	264.0	18	126.0	5,140	185.3	242	241.3	7,280	202.4
Pennsylvania	35	219.6	312	78.0	17,170	1,497.0	6,490	862.5	16	499.7	10,630	125.5	1,837	1,315.0	36,494	333.9
Rhode Island	5	131.5	40	122.9	615	1,139.2	756	568.4	2	369.0	1,156	170.9	79	506.2	2,653	289.7
South Carolina	13	79.5	56	71.8	11,835	1,049.2	1,004	444.8	3	117.3	4,147	145.7	522	935.1	17,589	404.0
South Dakota	94	176.3	5	45.3	148	1,025.7	59	235.4	1	259.7	321	52.7	24	201.4	652	89.8
Tennessee	11	63.3	86	78.2	9,659	1,033.1	1,046	379.8	4	130.6	6,127	141.5	732	941.1	17,667	307.3
Texas	36	44.1	858	69.8	28,404	987.2	42,376	477.0	21	100.2	19,842	192.7	3,652	1,276.2	95,196	402.1
Utah	31	128.9	70	99.6	293	991.8	762	224.8	9	36.9	1,840	91.7	81	186.8	3,089	121.7
Vermont	0	0.0	19	186.9	74	1,115.5	60	579.6	0	0.0	538	106.2	31	374.0	722	132.7
Virginia	19	94.9	344	69.6	13,354	976.2	2,400	378.6	9	164.5	6,504	143.7	1,034	681.8	23,691	329.0
Washington	125	157.2	483	78.2	2,335	937.6	2,265	311.0	57	127.6	7,753	173.4	993	459.8	14,019	218.8
West Virginia	3	88.2	12	95.3	384	719.1	96	405.3	0	0.0	1,368	96.1	119	597.9	1,986	129.2
Wisconsin	25	59.3	95	68.3	2,427	833.9	955	315.3	2	111.1	2,738	67.0	256	405.0	6,499	131.9
Wyoming	11	116.2	4	74.4	19	357.7	64	146.1	0	0.0	236	57.4	11	156.7	345	71.5
Subtotal	3,209	160.9	15,450	94.8	421,778	1,241.9	248,889	529.4	910	185.5	303,487	177.1	48,819	1,005.4	1,043,284	378.0
U.S. dependent areas^e
American Samoa	0	—	0	—	0	—	0	—	0	—	0	—	1	—	1	2.6
Guam	0	—	55	—	4	—	9	—	21	—	12	—	6	—	107	83.8
Northern Mariana Islands	1	—	5	—	0	—	0	—	6	—	2	—	2	—	16	39.4
Puerto Rico	1	—	2	—	21	—	15,767	—	1	—	39	—	6	—	15,837	563.3
Republic of Palau	0	—	2	—	0	—	1	—	6	—	0	—	0	—	9	49.4
U.S. Virgin Islands	0	—	2	—	294	—	189	—	0	—	39	—	3	—	530	603.2
Subtotal	2	—	66	—	319	—	15,966	—	34	—	92	—	18	—	16,500	528.2
Total	3,211	—	15,516	—	422,097	—	264,855	—	944	—	303,579	—	48,837	—	1,059,784	379.7

Note: Data for the year 2019 are preliminary and based on deaths reported to CDC as of December 2020. Data are based on address of residence at the end of the specified year (i.e., most recent known address). Numbers less than 12, and rates based on these numbers, should be interpreted with caution.

^aIncludes Asian/Pacific Islander legacy cases (see Technical Notes).
^bHispanic/Latino persons can be of any race.
^cIncludes persons whose race/ethnicity is unknown.
^dRates are per 100,000 population.
^eRates by race/ethnicity are not provided because U.S. census information is limited for U.S. dependent areas.

Table 22. Diagnoses of HIV infection, 2019, and persons living with diagnosed HIV infection (prevalence), year-end 2019, by metropolitan statistical area of residence—United States and Puerto Rico
	Diagnosis, 2019^a			Prevalence of diagnosed HIV infection, year-end 2019^b
Metropolitan statistical area of residence	No.	Rate^c	Rank^d	No.	Rate^c
Akron, OH	54	7.7	70	1,047	148.8
Albany-Schenectady-Troy, NY	48	5.5	90	2,166	246.0
Albuquerque, NM	71	7.7	69	1,914	208.5
Allentown-Bethlehem-Easton, PA-NJ	54	6.4	81	1,626	192.6
Atlanta-Sandy Springs-Alpharetta, GA	1,661	27.6	2	38,445	638.6
Augusta-Richmond County, GA-SC	121	19.9	11	2,553	419.2
Austin-Round Rock-Georgetown, TX	242	10.9	51	6,550	294.1
Bakersfield, CA	179	19.9	10	1,785	198.3
Baltimore-Columbia-Towson, MD	405	14.5	25	16,492	589.0
Baton Rouge, LA	201	23.5	4	5,259	615.2
Birmingham-Hoover, AL	143	13.1	34	4,292	393.6
Boise City, ID	19	2.5	109	226	30.2
Boston-Cambridge-Newton, MA-NH^e	381	7.8	67	14,507	297.7
Boston, MA	203	10.0	—	8,270	407.0
Cambridge-Newton-Framingham, MA	172	7.2	—	5,953	248.0
Bridgeport-Stamford-Norwalk, CT	42	4.5	100	2,705	286.7
Buffalo-Cheektowaga, NY	65	5.8	88	2,548	225.9
Cape Coral-Fort Myers, FL	78	10.1	55	2,218	287.8
Charleston-North Charleston, SC	106	13.2	33	2,703	337.0
Charlotte-Concord-Gastonia, NC-SC	414	15.7	20	9,068	343.9
Chattanooga, TN-GA	60	10.6	52	1,257	222.4
Chicago-Naperville-Elgin, IL-IN-WI	1,118	11.8	43	30,187	319.2
Chicago-Naperville-Evanston, IL	974	13.7	—	27,390	384.5
Elgin, IL	35	4.6	—	510	66.6
Gary, IN	63	9.0	—	1,245	177.0
Lake County-Kenosha County, IL-WI	46	5.3	—	1,042	120.3
Cincinnati, OH-KY-IN	257	11.6	44	4,631	208.5
Cleveland-Elyria, OH	190	9.3	60	5,580	272.4
Colorado Springs, CO	44	5.9	86	1,016	136.2
Columbia, SC	147	17.5	15	4,212	502.4
Columbus, OH	239	11.3	49	5,977	281.6
Dallas-Fort Worth-Arlington, TX	1,259	16.6	17	29,513	389.7
Dallas-Plano-Irving, TX	939	18.5	—	23,029	453.2
Fort Worth-Arlington, TX	320	12.8	—	6,484	260.3
Dayton-Kettering, OH	112	13.9	30	1,771	219.3
Deltona-Daytona Beach-Ormond Beach, FL	98	14.7	23	2,043	305.7
Denver-Aurora-Lakewood, CO	342	11.5	45	9,675	326.1
Des Moines-West Des Moines, IA	29	4.1	103	968	138.4
Detroit-Warren-Dearborn, MI	438	10.1	54	10,562	244.5
Detroit-Dearborn-Livonia, MI	285	16.3	—	6,960	397.9
Warren-Troy-Farmington Hills, MI	153	6.0	—	3,602	140.1
Durham-Chapel Hill, NC	93	14.4	26	2,526	392.0
El Paso, TX	116	13.7	32	2,337	276.9
Fayetteville, NC	94	17.8	14	1,939	368.1
Fayetteville-Springdale-Rogers, AR	22	4.1	104	639	119.5
Fresno, CA	115	11.5	46	2,063	206.5
Grand Rapids-Wyoming, MI	53	4.9	94	1,290	119.7
Greensboro-High Point, NC	148	19.2	13	2,940	380.9
Greenville-Anderson, SC	105	11.4	48	2,168	235.5
Harrisburg-Carlisle, PA	33	5.7	89	1,510	261.3
Hartford-East Hartford-Middletown, CT	83	6.9	77	3,546	294.3
Honolulu (Urban), HI	52	5.3	91	1,515	155.5
Houston-The Woodlands-Sugar Land, TX	1,436	20.3	9	27,310	386.5
Indianapolis-Carmel-Anderson, IN	265	12.8	36	5,729	276.2
Jackson, MS	125	21.0	7	3,425	575.8
Jacksonville, FL	317	20.3	8	7,285	467.1
Kansas City, MO-KS	206	9.5	59	4,919	227.9
Knoxville, TN	91	10.5	53	1,333	153.4
Lakeland-Winter Haven, FL	125	17.2	16	2,584	356.5
Lancaster, PA	25	4.6	97	798	146.2
Lansing-East Lansing, MI	24	4.4	101	634	115.2
Las Vegas-Henderson-Paradise, NV	449	19.8	12	9,048	399.2
Lexington-Fayette, KY	33	6.4	82	1,153	223.0
Little Rock-North Little Rock-Conway, AR	123	16.6	18	2,388	321.7
Los Angeles-Long Beach-Anaheim, CA	1,730	13.1	35	56,692	429.0
Anaheim-Santa Ana-Irvine, CA	246	7.7	—	6,990	220.1
Los Angeles-Long Beach-Glendale, CA	1,484	14.8	—	49,702	495.1
Louisville/Jefferson County, KY-IN	175	13.8	31	3,726	294.5
Madison, WI	17	2.6	108	820	123.3
McAllen-Edinburg-Mission, TX	57	6.6	80	1,501	172.8
Memphis, TN-MS-AR	310	23.0	5	7,332	544.7
Miami-Fort Lauderdale-Pompano Beach, FL	1,984	32.2	1	54,492	883.7
Fort Lauderdale-Pompano Beach-Sunrise, FL	594	30.4	—	19,836	1,015.8
Miami-Miami Beach-Kendall, FL	1,152	42.4	—	26,624	979.9
West Palm Beach-Boca Raton-Boynton Beach, FL	238	15.9	—	8,032	536.6
Milwaukee-Waukesha, WI	118	7.5	72	3,300	209.5
Minneapolis-St. Paul-Bloomington, MN-WI	227	6.2	83	7,490	205.8
Modesto, CA	42	7.6	71	822	149.3
Nashville-Davidson-Murfreesboro-Franklin, TN	240	12.4	39	5,440	281.2
New Haven-Milford, CT	68	8.0	66	3,325	389.0
New Orleans-Metairie, LA	282	22.2	6	8,141	640.8
New York-Newark-Jersey City, NY-NJ-PA^e	2,820	14.7	22	137,245	714.2
Nassau County-Suffolk County, NY	182	6.4	—	5,858	206.7
Newark, NJ-PA	351	16.2	—	12,918	595.9
New Brunswick-Lakewood, NJ	192	8.1	—	5,105	214.5
New York-Jersey City-White Plains, NY-NJ	2,095	17.7	—	113,364	957.9
North Port-Sarasota-Bradenton, FL	70	8.4	63	2,086	249.2
Ogden-Clearfield, UT	16	2.3	110	415	60.7
Oklahoma City, OK	167	11.9	42	2,884	204.7
Omaha-Council Bluffs, NE-IA	58	6.1	85	519	54.7
Orlando-Kissimmee-Sanford, FL	654	25.1	3	12,622	483.9
Oxnard-Thousand Oaks-Ventura, CA	45	5.3	92	1,100	130.0
Palm Bay-Melbourne-Titusville, FL	85	14.1	28	1,659	275.6
Pensacola-Ferry Pass-Brent, FL	45	9.0	61	1,544	307.2
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD	774	12.7	37	26,606	436.0
Camden, NJ	111	8.9	—	2,978	239.5
Montgomery County-Bucks County-Chester County, PA	85	4.3	—	2,429	122.4
Philadelphia, PA	514	23.9	—	18,815	874.8
Wilmington, DE-MD-NJ	64	8.8	—	2,384	329.3
Phoenix-Mesa-Scottsdale, AZ	591	11.9	40	12,853	259.8
Pittsburgh, PA	105	4.5	99	3,602	155.4
Portland-South Portland, ME	18	3.3	107	892	165.6
Portland-Vancouver-Hillsboro, OR-WA	169	6.8	78	5,705	228.9
Poughkeepsie-Newburgh-Middletown, NY	50	7.4	73	1,851	272.5
Providence-Warwick, RI-MA	101	6.2	84	3,137	193.1
Provo-Orem, UT	23	3.5	106	245	37.8
Raleigh-Cary, NC	159	11.4	47	3,995	287.2
Richmond, VA	103	8.0	65	3,547	274.6
Riverside-San Bernardino-Ontario, CA	555	11.9	41	14,187	305.1
Rochester, NY	56	5.2	93	2,813	263.0
Sacramento-Roseville-Folsom, CA	171	7.2	75	5,260	222.5
St. Louis, MO-IL	282	10.1	56	7,124	254.1
Salt Lake City, UT	82	6.7	79	2,097	170.1
San Antonio-New Braunfels, TX	357	14.0	29	7,213	282.8
San Diego-Chula Vista-Carlsbad, CA	367	11.0	50</

Diagnoses of HIV Infection in the United States and Dependent Areas 2019: Tables

Download the Full Report pdf icon[PDF – 20 MB]

Report Contents

Other Reports